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ABSTRACT 
The main concern of this thesis is with desmoplasia - a process in 
which excessive connective tissue is deposited in a neoplasm. This is 
a common phenomenon in neoplasia but one whose mechanisms are poorly 
understood. 
To study the process I used a human malignant melanoma cell line 
(UCT-Mel 7) that was established in this laboratory and that, when _ 
injected into athymic mice, gave rise to tumours that showed a number 
of interesting features. 
Firstly, the tumour induced a marked desmoplastic response as 
evidenced by a high content of hydroxyproline in tumour lysates, 
intense staining for reticulin in sections of the tumour and 
infiltration of the tumour by host mesenchymal cells. 
Secondly, the desmoplasia was associated in UCT-Mel 7-derived tumours 
with an unusual phasic pattern of growth that was related to the in 
vitro passage number of the melanoma cells. On occasions, murine 
tumours developed at the site of inoculation of human tumour cells. 
I have identified 2 possible mechanisms by which UCT-Mel 7 cells could 
have induced the desmoplastic response: either the tumour cells could 
have exerted their effect indirectly, i.e. via macrophages, or they 
could have stimulated the host's stromal cells directly. 
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• 
UCT-Mel 7 cells were shown to be chemotactic for mouse macrophages 
and human foreskin fibroblasts were stimulated, in a dose-dependent 
manner, to synthesize increased amounts of collagen when co-cultured 
with mouse peritoneal exudate cells. Stimulation could only be 
effected by direct cell:cell contact; medium conditioned by 
macrophages was not effective. The amount of stimulation was not 
dependent on the state of activation of the peritoneal cells nor on 
the strain of mouse used. 
Tumour cells were also found to act directly. Co-culture of UCT-Mel 7 
cells and fibroblasts resulted in increased collagen synthesis by the 
fibroblasts. Increased synthesis of the protein was reflected in an 
increase in the amount of collagen mRNA. 
UCT-Mel 7 cell stimulated in a dose-dependent manner with an absolute 
requirement for intimate cell:cell contact with the fibroblasts. DNA 
synthesis was not required. Dexamethasone, retinoic acid and the 
tumour promoter, phorbol myristate acetate, had significant primary 
effects on fibroblast collagen synthesis but did not modify the 
response to melanoma cells. Indomethacin, however, had a minimal 
primary effect upon the fibroblasts but significantly augmented the 
melanoma cell effect. 
The nature of the stimulatory cell:cell contact is still uncertain. 
The gap junction inhibitor, a-glycyrrhetinic acid, did not diminish the 
melanoma cell effect. Preliminary findings suggested that cell-surface 
proteoglycans may be important. Removal of the proteoglycans with the 
inhibitor of proteoglycan assembly, 4-methylumbelliferyl-fi-D-xyloside, 
abrogated the melanoma cell:fibroblast interaction. 
Recombinant basic fibroblast growth factor did. not seem to be involved 
irr' the desmoplastic response. It was of incidental interest to note 
that this compound inhibited fibroblast collagen synthesis in a manner 
that was augmented by the concomitant addition of heparin. 
A surprising finding was the production of a potent inhibitor of 
collagen synthesis by superinduced cells of the mouse macrophage cell 
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LITERATURE REVIEW 
Desmoplasia 
Solid tumours growing in vivo invariably comprise two distinct 
components. The first of these is made up of the neoplastic cells 
themselves; the second is the complex supporting stroma that consists 
of mesenchymal cells and the various macromolecular structural 
elements that characterize connective tissues (Robbins et al., 1984). 
The amount of stroma varies from one tumour to another. In anaplastic 
carcinomas and sarcomas, it is usually scanty and devoid of 
recognizable arrangement, whereas in most well differentiated 
malignant tumours and in benign tumours, the stroma is moderate and 
ordered. Not infrequently one encounters neoplasms, such as the 
scirrhous carcinomas, that belong to a third category where the stroma 
is so abundant and dense that it contributes substantially to the mass 
of the tumour (Willis, 1967). The development of fibrous stromal 
tissue within and around a tumour is known as desmoplasia (from the 
Greek desmos - ligament or band)(Liotta, 1982; Robbins et al., 1984). 
The extent of this development is referred to as the "desmoplastic 
response", implying that neoplastic cells will, to a greater or lesser 
degree, induce the mesenchymal reaction that leads to the deposition 
of stromal elements. 
In recent years there has been a subtle shift in emphasis, away from 
the narrow view of stromal proliferation as purely a "response" to 
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tumour cells, to the concept of an interdependence between the 
parenchyma and the stroma in which the latter may govern such 
attributes of the former as growth rate, differentiation and invasion. 
The stromal cells - fibroblasts and endothelial cells - grow in 
response to mitogenic factors produced by the tumour cells . Tumour 
cell growth, in its turn is dependent on the rate at which the 
endothelial cells can form a vascular system (Steel, 1977). This 
so-called "stromal reaction" provides the support needed for a rapidly 
growing cell population (Strauli, 1980) . As early as 1958, Vasiliev 
(1958) noted that invasive growth, whether normal or malignant, 
requires the proliferation of connective tissue. The formation of 
undifferentiated connective tissue provides a substratum along which 
invading cells may migrate; it has chemotactic properties; and it 
provides a favourable environment for invasion. Furthermore the 
stromal cells underlying tumours exhibit abnormal growth patterns and 
altered surface properties (Van den Hooff, 1983) . There is, thus, a 
complex regulatory interplay between the tumour and its host. The 
desmoplastic response becomes prominent when the host overreacts to 
the presence of the tumour and produces excessive amounts of 
connective tissue. 
The dense fibrous stroma that surrounds the tumour and characterizes 
the desmoplastic response is due to excessive production of collagen -
mainly Types I and III but also Type V (Barsky et al., 1982; Schurch 
et al., 1981). Overproduction of other extracellular matrix 
components , e . g . elastin (Martinez-Hernandez et al. , 1980) and 
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proteoglycans (Iozzo, 1984; Iozzo and Muller-Glauser, 1985) , may also 
be a feature. 
Ohtani and Sasano (1983) noted changes in the stromal fibroblasts in 
human colorectal carcinoma samples, that they referred to as 
"activation", that correlated with the histological assessment of 
malignancy. These changes included the nuclear enlargement and 
prominent rough endoplasmic reticulum that are indicative of actively 
secreting cells. In adenomas with mild atypia the fibroblasts were 
mildly activated; in adenomas with severe atypia (carcinoma in situ) 
they were more so and in invasive adenocarcinomas, showing a 
desmoplastic response, the fibroblasts showed prominent activation. 
Generally speaking, the desmoplastic response to carcinomas is related 
to the degree of invasion (Ohtani and Sasano, 1983; Schurch et al., 
1981) and it would seem that penetration of the basal lamina is a 
requirement for induction of a stromal reaction. 
The source of the stromal elements in neoplasms has been a 
controversial subject. Workers studying desmoplastic melanomas have 
suggested the tumour cells as the origin of the excess connective 
tissue (Bryant et al., 1982; From et al., 1983; Moreno et al., 1986; 
Valensi, 1979), basing their views upon light and electron microscopic 
findings. The atypical spindle cells contain melanosomes in various 
stages of maturation and desmosomes between the spindle cells (both 
features of melanocytes). They also contain abundant, dilated rough 
endoplastic reticulum (a feature of fibroblasts) thus supporting the 
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view that the collagenous matrix is produced by dedifferentiated 
melanoma cells with fibroblastic features and functions. 
Others have favoured the host cells (Barsky et al . , 1982; Gullino and 
Grantham, 1963; Iozzo and Muller-Glauser, 1985; Labrecque et al., 
1976; Liotta, 1982; Martinez-Hernandez and Catalano, 1980; Naito et 
al., 1984). It is now generally accepted that the host cells provide 
the stroma while the tumour governs the amount that is produced 
(Gullino and Grantham, 1963) either by a direct effect on surrounding 
mesenchymal cells or, indirectly, by eliciting a chronic inflammatory 
response (Labrecque et al . , 1976) . The putative factors responsible 
for the induction of desmoplasia have not been identified save for the 
factors that induce angiogenesis - an important component of 
desmoplasia (Folkman and Klagsbrun, 1987; Strauli , 1980) . 
A teleological view of desmoplasia would see it as an attempt by the 
host to "wall off" the tumour both physically and immunologically 
(Liotta, 1982). Whether, as is implied by this view, the desmoplastic 
response is, in fact, beneficial to the host is debatable . 
In some instances, a desmoplastic r ,esponse does appear to be 
associated with a better prognosis (e ; g. in nodular sclerosing 
Hodgkin's disease (Seemayer et al., 1980) and the experimental results 
obtained by Dvorak (Dvorak et al., 1979) who showed that Line 1 
hepatocarcinoma, which induced a fibroblastic response in guinea pigs, 
regressed 8-13 days after implantation whereas the Line 10 
hepatocarcinoma failed to induce a fibrous response and grew unchecked . 
5 
Indirect evidence to suggest that collagen may be important i n 
limiting tumour growth and spread is provided by observations that the 
induction and growth of tumours is accelerated in lathyritic rats 
(Schweppe et al., 1965) and that inhibition of the desmoplastic 
response by the administration of praline analogues (Barsky and 
Gopalakrishna , 1987) or corticoids (Takahashi and Biempica, 1985) 
favours invasion and metastatic spread . Furthermore, Liotta et al. 
(1980), Bauer et al. (1977), Biswas and Toole (1987) have shown that 
rapidly metastasizing tumours contain high levels of collagenase. 
Common clinical experience, however, and a number of well documented 
studies of the relationship between the desmoplastic response and the 
invasive phenotype tend to support a contrary view. Although 
desmoplasia is often a feature of benign as well as malignant 
tumours, it generally true that desmoplastic tumours are associated 
with a poorer prognosis than their nondesmoplastic counterparts 
(Cantin et al., 1982; Conley et al . ; de Vita et al., 1985). Patient 
survival time is shortened; metastases are more frequent and it is 
known that human scirrhous carcinomas tend to invade vigorously 
(Strauli, 1980). The collagenous stroma does not constitute an 
effective barrier: it is either degraded or it accompanies the 
advance of the tumour. 
The intensity of a desmoplastic response tends to be related to the 
tumour rather than the tissue in which it resides, so that secondary 
deposits of scirrhous carcinomas are usually desmoplastic in other 
locations e.g. lung, liver , bone marrow and lymph glands (Willis, 
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1967; Urmacher, 1984). Occasionally, non desmoplastic metastatic 
deposits are found (Frolow et al., 1975) and both fibrotic and 
parenchymatous metastases from the same primary tumour may occur 
within a single individual (Conley et al., 1971). 
Tumours that are commonly desmoplastic include infiltrating ductal 
carcinoma of the breast, colorectal carcinoma, diffuse mesothelioma 
and carcinomas of the stomach and pancreas (Barsky et al., 1982; 
Cantin et al., 1982; Dvorak, 1986). In some cases, the excessive 
stroma can account for more than 90% of the total tumour mass . 
Tumours that are rarely desmoplastic include medullary carcinoma of 
the breast (Dvorak, 1986) and malignant melanoma, although there have 
been a number of reports in the literature of a rare variant of the 
malignant melanoma, the desmoplastic malignant melanoma (Bryant et 
al., 1982; Conley et al., 1971; Frolow et al. , 1975; From et al., 
1983; Labrecque et al., 1976; Moreno et al. , 1986; Urmacher, 1984; 
Valensi, 1979). 
If one assumes that the amount of connective tissue in a tumour 
reflects the balance between synthesis and degradation, then clearly 
the intensity of the desmoplastic response might be influenced by 
factors that contribute to either side of this equation . Neoplastic 
induction of increased rates of collagen synthesis has been 
demonstrated for collagen, both in vitro (Naito et al., 1984) and in 
vivo (Barsky and Gopalakrishna, 1987 ; Bano et al., 1983), and for 
proteoglycans, in vitro (Knudson et al ., 1984; Merrilees and Findlay, 
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1985; Biswas and Toole, 1987) and in vivo (Iozzo and Muller-Glauser, 
1985; Toole et al., 1979) ; In some instances, there has been a 
documented requirement for direct contact between the tumour cells and 
the fibroblasts (Knudson et al., 1984) whereas in other cases, tumour 
cells released uncharacterized soluble factors that were capable of 
stimulating the fibroblasts (Merrilees and Findlay, 1985). Biswas 
and Toole (1987) have described experiments in which they isolated the 
membranous fraction from homogenated cells that induce a desmoplastic 
response and found that these appeared to be active in stimulating 
proteoglycan synthesis . In most cases, fibroblasts have been 
identified as the cells responsible for the increased production of 
the extracellular matrix, although the tumour cells themselves are 
able to produce some of these components (Merrilees and Findlay, 
1985). 
Decreased degradation of the matrix might be due either to decreased 
synthesis of proteases (Bauer et al., 1986) or to increased synthesis 
of protease inhibitors . Barsky and Gopalakrishna, for example, have 
shown that desmoplastic breast carcinomas contain high levels of 
inhibitors of both Type I and Type IV collagenases (Barsky and 
Gopalakrishna, 1986). 
Increased synthesis and inhibition of degradation are not mutually 
exclusive and probably act in concert. In a case reported by Bauer et 
.al. (1986) of "progressive nodular fibrosis of the skin", the 
underlying defects were found to involve both increased synthesis of 
collagen and decreased levels of collagenase. 
8 
_...:: 
Desmoplasia has been likened to the process of wound healing (Dvorak 
et al., 1984a; Dvorak, 1986) in which the initial fibrin-fibronectin 
gel is replaced by granulation tissue. This is then remodelled to 
give predominantly collagenous scar tissue. Fibrin is a regular 
stromal component of twiours and is present in amounts that are 
determined by increased permeability of the neoplastic vascular bed 
(Senger et al., 1983); by the procoagulant activity in tumours (Bach 
et al., 1981; Dvorak et al., 1983; van de Water et al., 1985); and by 
local fibrinolytic mechanisms (Dvorak et al., 1984b; Dano et al., 
1985). It is well known that the provisional fibrin-fibronectin 
matrix that is seen in early experimental tumours is replaced by 
stroma which closely resembles granulation tissue and that this then 
matures into dense, relatively acellular and poorly vascularised 
connective tissue that is very similar in appearance to scar tissue 
(Dvorak et al., 1979; Dvorak et al., 1984a; Schurch et al., 1981). 
Dvorak and his associates have shown, both in guinea pigs (Dvorak et 
al., 1979; Dvorak et al., 1984a) and in humans (Dvorak et al., 1981), 
that there is a strong correlation between the amount of fibrin 
surrounding a tumour and the magnitude of the desmoplastic response 
that is induced. 
The host stromal response to malignant tumours may, therefore, be 
regarded as an exaggerated but normal quantitative response rather 
than as a qualitatively abnormal reaction. It is also a relatively 
specific phenomenon in the sense that it is found only in some tumours 
and mainly those of epithelial origin. It is not merely a 
non-specific reaction by the host to injury or to a "foreign body". 
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Although the phenomenon is common, the factors and mechanisms involved 
in desmoplasia are poorly understood and few studies have been 
specifically designed to investigate the phenomenon. 
In this thesis I describe the results of a series of experiments that 
I performed in an attempt to understand the induction of desmoplasia. 
I used, as my experimental system, a human melanoma cell line that was 
tumorigenic in nude mice, consistently giving rise to slowly growing 
tumours that were heavily infiltrated with murine fibroblasts, 
macrophages and collagen. These same cells, when co-cultivated with 
human fibroblasts in vitro, reproducibly induced an increased rate of 
fibroblast collagen synthesis. Before presenting my results I should 
like te review the biosynthesis of collagen giving emphasis to the 
way in which it is regulated and to the factors that affect it. 
Collagen Synthesis 
Collagen is a major component of connective tissue. With its triple 
helical rod-like structure and its ability to polymerize into 
extracellular fibres, it gives interstitial substance to tissues and 
plays a major role in defining organ structure. 
Collagen consists of three polypeptide "a" chains. As synthesized, 
each a chain can be divided into three domains: an N-terminal 
propeptide; a lengthy, triple-helical domain flanked by short 
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non-helical telopeptides; and a C-terminal propeptide (Prockop et 
al., 1979a). 
The triple helical domain contains about 1000 amino acid residues with 
every third residue being glycine. This can be represented by the 
general molecular formula (X-Y-Gly)n, where X and Y represent amino 
acids other than glycine. About 100 of the X residues are proline and 
about 100 of the Y resides are hydroxyproline, making collagen unique 
in the high concentration of these two residues that it contains. 
Both proline and hydroxyproline are rigid, cyclic amino acids and thus 
contribute to the stability of the triple helix. Glycine is the 
smallest amino acid and occupies the restricted space in the centre of 
the triple helix. The amino acid residues in the helical portion of 
the collagen molecule are generally basic. (Prockop et al., 1979a) 
Collagen is first synthesised as a longer molecule, procollagen, that 
contains additional propeptides on both the N-terminal and C-terminal 
ends of the a chains. These account for about a third of the size of 
the procollagen molecule. The N-terminal propeptide contains 3 
domains: a globular amino-terminal domain, a central collagen-like 
domain, and another short globular domain. The C-terminal propeptide 
is globular without any collagen-like domain. Both propeptides 
contain cysteine, which is not found in the helical portion of the 
peptide chains. The cysteines are involved in intra- and inter-chain 
disulphide bonds. The propeptides contain relatively high levels of 
acidic and hydrophobic residues. The N-terminal propeptide acts as a 
feedback inhibitor of procollagen synthesis (Wiestner et al., 1979). 
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The C-terminal propeptide has a role in directing chain association. 
The interchain disulphide bonds formed in the C-terminal propeptide 
are an absolute requirement for triple helix formation (Kivirikko and 
Myllyla, 1979; Prockop et al., 1979a). 
Collagen is unique in that it undergoes extensive post-translational 
processing. Firstly, prolyl residues are hydroxylated to 
4-hydroxyproline or 3-hydroxyproline (by the enzymes prolyl 
4-hydroxylase (EC 1.14.11.2) or prolyl 3-hydroxylase (EC 1.14.11.?), 
respectively) and lysyl residues are converted to hydroxylysine (by 
the enzyme lysyl hydroxylase (EC 1.14.11.4)). All three hydroxylases 
require ferrous ions, molecular oxygen, a-ketoglutarate and ascorbic 
acid as co-factors. 
The residues are hydroxylated only after their incorporation into the 
collagen peptide. Prolyl 4-hydroxylase and lysyl hydroxylase act only 
on praline or lysine residues in the Y position of the X-Y-Gly 
sequence. In contrast, prolyl 3-hydroxylase acts on praline in the X 
position but only if the Y position is 4-hydroxyproline. Thus 
3-hydroxyproline occurs in sequences of 3-Hyp-4-Hyp-Gly. The 
hydroxylases act only on the unfolded peptide chains. Further 
hydroxylation is prevented when the peptide chains fold into their 
triple-helical conformation. 
The function of the hydroxy group of the 4-hydroxyproline residues is ·-
to stabilize the triple helix at 37°C (Kivirikko and Myllyla, 1984); a 
chains which are underhydroxylated cannot form a stable helix and are 
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rapidly degraded intracellularly. The role of the 3-hydroxyproline is 
unknown. The hydroxy group of the hydroxylysine has at least 2 
functions: it acts as a site for the attachment of the glycosyl units 
and it is essential for the stability of the intermolecular collagen 
crosslinks formed du~ing fibril formation (Prockop et al., 1979a; 
Kivirikko and Myllyla, 1984). 
The hydroxylated lysine residues are further modified by 
glycosylation. The sugar residues, galactose and glucose are added 
sequentially through 0-glycosidic linkages. Galactosyltransferase (EC 
2.4.1.50) adds galactose to the hydroxylysine resides and 
glucosyltransferase (EC 2.4.9.66) adds glucose to the 
galactosyl-hydroxylysine residues. Both enzymes require the presence 
of a bivalent cation (preferably manganese) and a nonhelical 
conformation of the peptide chains. Glycosylation ceases when the 
~ollagen peptides fold into a triple helix. The function of the 
glycosyl residue is uncertain; it is possible that they affect fibril 
morphology.(Prockop et al., 1979a; Kivirikko and Myllyla, 1984) 
Two essential requirements must be met for collagen to assume its 
triple-helical confirmation . In the first place, there is an absolute 
need for the formation of inter-chain disulphide bonds. Since these 
are established between carboxy-terminal propeptides, the triple-helix 
cannot form until most of the chains have been translated. Secondly, 
helix formation requires that most , if not all, of the proline 
residues in the Y position of the X-Y-Gly triplet be 4-hydroxylated 
(Kivirikko and Myllyla, 1984). 
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The protein is assembled in the rough endoplasmic reticulum and pa
sses 
through the Golgi apparatus before being secreted. The rate of 
secretion depends upon the intracellular processing of the protein
 and 
particularly upon the folding of the prochains into a triple helix
. 
(Prockop et al., 1979a; Kivirikko et al., 1984)' . 
Once the procollagen has been secreted it is acted upon by two 
· proteases, both of which require a divalent metal such as calcium
. A 
procollagen aminoprotease removes the aminopropeptides and a 
procollagen carboxyprotease removes the carboxypropeptides. This 
proteolytic conversion is essential _for normal fibril formation . 
After assembly to form fibrils the collagen molecules are then 
crosslinked by a series of covalent bonds that give collagen its 
tensile strength. 
To date, 11 structurally and genetically distinct collagens have b
een 
identified and characterised. All are composed of 3 a chains and 
all 
contain a region which has the general structure of (X-Y-Gly)n, bu
t 
that varies in amino acid and carbohydrate composition. They have 
recently been divided into 3 groups according to their size and 
physicochemical properties. (Miller and Gay, 1987) 
Group 1 molecules are composed of chains with a molecular mass of 
95 
kilodaltons or greater and they are characterized by the presence 
of a 
lengthy, uninterrupted helical domain. The group 1 molecules, 
comprising Types I, II, III, V and K, are the major fibril- and 
fibre-forming species of collagen. 
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Type I collagen is the major connective tissue protein of skin, 
bone and tendon . It consists of two identical al(I) cha ins and one 
a2(I) chain. 
Type II collagen is found in hyaline cartilage and consists of 3 
identical a chains, al(II). 
Type III collagen is a minor constituent of tissues such as lung, 
skin and arteries . It consists of 3 al(III) chains. 
Type V and Type Kare minor components of the total collagen . 
The structure and function of different tissues appear to be 
intimately associated with the relative amounts of Type I and Type III 
collagen. Rigid tissues e.g. bone and tendon contain only Type I. 
More pliable tissues e.g. skin and lung contain both Types I and III. 
Group 2 molecules also contain chains of molecular mass 95 kilodaltons 
or greater but, unlike Group 1 collagens, these contain several 
helical domains separated by sequences of nonhelical conformation . 
The Group 2 molecules , including Types IV, VI, VII and VIII, do not 
readily form fibres but tend to aggregate through end-to-end 
association forming large networks with an open mesh-like structure . 
Type IV collagen is associated with basement membranes . It consists 
of two al(IV) chain and one a2(IV) chain. This collagen differs from 
the group 1 collagens in that the globular propeptides are no t removed 
during the ex tracellular processing of the protein. Much interest has 
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been focussed on Type IV collagen and the possible role it may play in 
tumour invasion and metastasis. 
Finally, group 3 molecules are composed of chains of molecular weight 
less than 95 kilodaltons. They consist of Types IX and X. 
At least 20 collagen genes have been identified. Present data suggest 
that each gene is present as a single copy within a haploid set of 
chromosomes. Collagen genes have been located on chromosome 17 
(al(I)), chromosome 7 (a2(I)), chromosome 12 (al(II)) , chromosome 2 
(al(III) and a2(V)) and chromosome 13 (al(IV) and a2(IV)). Collagen genes 
are very large - about 40 kilobases - and can contain up to 51 
introns. The gene consists of 6 domains: the signal peptide, 2 
terminal propeptides, 2 telopeptides and the triple helical domain 
(Cheah and Grant, 1982; Ramirez et al., 1985). In the Group 1 
collagens, the domain coding for the triple helix has been found to 
contain a number of exons containing 54 base pairs. There are also 
exons of 45, 99 and 108 base pairs. These exons encode multiples of 
the X-Y-Gly triplet. This suggests that the fibrillar collagen genes 
arose from an ancestral 54 base-pair, primordial gene. 
Regulation of collagen biosynthesis 
The biosynthesis of collagen may, in theory, be regulated at a number 
of transcriptional and post-transcriptional steps: gene selection, 
t ranscription, RNA processing, translation, post-translational 
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modification, translocation, secretion, extracellular modification and 
assembly of collagen fibrils. Collagen can be regulated in terms of 
both the amount of collagen produced and the type of collagen produced. 
Collagen genes have been shown to possess promoter sequences upstream 
to the transcription initiation site and enhancer sequences within the 
first intron. (Horton et al., 1987; Rossi and de Crombrugghe, 1987). 
The promoter squences of the mouse a2(I) collagen gene and the al(III) 
collagen gene contain binding sites for nuclear factor 1 (Rossi et 
al., 1988) indicating that their rate of transcription could be 
regulated by molecules that interact with these 2 regions. The DNA 
binding proteins, transcription factor Spl and a viral core enhancer, 
have been shown to inhibit transcription of the al(!) collagen gene 
(Bornstein et al., 1987). The authors speculate that a sequence 
within the first intron of the gene could regulate transcription 
either positively or negatively depending on the concentration of the 
relevant DNA binding proteins. 
Since the collagen synthesis involves a multi-gene system, production 
of a functional collagen molecule requires the co-ordinated 
transcription of the a chain genes situated on different chromosomes 
e.g. a(I) gene on chromsome 17 and a2(I) gene on chromosome 7 to produce 
Type I collagen. There also needs to be co-ordinated expression of 
the collagen structural genes and the genes coding for the various 
enzymes responsible for post-translational modification.(Olsen, 1981). 
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Various exogenous factors have been shown to influence collagen gene 
expression (Kivirikko and Myllyla, 1984). Chrondrocytes, which 
ordinarily synthesize Type II procollagen exclusively, can be induced 
to switch to producing Type I procollagen by culturing at low cell 
density; by shifting from suspension to monolayer culture or by 
prolonged time in culture. Fibronectin, calcium ions and cyclic AMP 
also have this effect. This type of gene selection has also been 
shown in fibroblasts and mouse embryonic carcinoma cells. Fibroblasts 
can synthesize both Types I and III procollagen simultaneously and the 
_ relative proportions of each can be varied. Early granulation tissue, 
for example, has a very low !:III ratio whilst mature scar tissue has 
a high !:III ratio (Hance and Crystal, 1977). Mouse embryonic 
carcinoma cells, when treated with retinoic acid or plated at a low 
density, switch from producing mainly Type IV collagen to producing 
Type I collagen (Adamson et al., 1979). 
Circumstances that influence the rate of collagen synthesis by a 
direct effect on transcription are illustrated by infection of chicken 
embryo fibroblasts with Rous sarcoma virus. The decrease in collagen 
synthesis that ensues is associated with a decrease in procollagen 
mRNA (Sandmeyer and Bornstein, 1979). 
Regulation at the translational level is more complex and appears to 
be related to qualitative changes in the collagen mRNA. Chondrocytes, 
for example, which produce only Type II procollagen, contain mRNA for 
both Types I and II procollagen. It, thus, appears that the Type I 
collagen gene is transcribed but is not translated. The mechanisms 
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involved are uncertain but possible regulatory mechanisms include 
(i) 
differential utilization of the mRNA due to structural differences
 in 
the mRNAs themsellres or to the presence of other regulatory RNA 
molecules; (ii) differential distribution of mRNA into polysomes 
(which are translated) or in non-translated ribonucleoprotein 
complexes (RNPs); or (iii) the stability of the mRNA. There is 
evidence for all three possibilities. 
Processing of the primary collagen mRNA transcript involves some S
O 
splicing events so that the 28kb transcript of the pro-a2 gene, fo
r 
example, is reduced to a 5 kb functional mRNA. This provides ample
 
opportunity for differential or regulatory splicing to occur so th
at 
differences in processing might lead to altered structural proper
ties 
·· of the mRNA which, in turn, might influence translatability of th
e 
message. This would explain the observation that the Type I 
procollagen mRNA produced by chondrocytes migrates with an 
electrophoretic mobility that is different from that of collagen m
RNA 
from other cell types. (Focht and Adams, 1984). 
A well-documented mechanism for translational regulation involves 
the 
differential distribution of the mRNA among polysomes and 
ribonucleoproteins. Actin synthesis in sea urchin embryos is 
controlled by the mechanisms which regulate this partition (Infant
e 
and Heilmann, 1981). Voss and Bornstein (1986) have produced evid
ence 
to indicate that collagen mRNAs are not subject to this type of 
control. 
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Raghow et al.(1987) have shown that increased intracellular 
concentrations of procollagen mRNA are not the result of increased 
transcription of the collagen genes and have suggested that this 
reflects increased stability of the mRNA molecules. 
As has already been mentioned, the N-terminal propeptides exert a 
negative feedback on collagen synthesis by inhibiting translation of 
the procollagen mRNAs. (Wiestner et al., 1979). Just how they exert 
their effect is unknown. 
Post-translational regulation (Kivirikko and Myllylla, 1984) is 
determined by the efficiency of hydroxylation of the prolyl residues 
and, to a lesser extent, the lysyl residues. The rate of 
hydroxylation, and the consequent post-translational modifications, is 
influenced by four factors: 
(i) The level of active enzyme present. Tissue prolyl 
hydroxylase activity fluctuates with the rate of collagen 
synthesis suggesting that this enzyme is involved in a rate 
controlling step. In most cells and tissues, a large fraction of 
the prolyl hydroxylase is found in an inactive form that contains 
only 1 of the 2 different kinds of subunits present in the active 
form of the enzyme. Activation of the enzyme could thus regulate 
the rate of collagen synthesis (Prockop et al., 1979b). The 
levels of the other post-transcriptional enzymes also vary with 
the rate of collagen synthesis. 
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(ii) The availability of co-factors may affect the rate of 
hydroxylation. Scurvy provides a classical example of this. The 
deficiency of ascorbate that is associated with this disease leads 
to underhydroxylation of the procollagen chains which are then 
degraded intracellularly. 
(iii) The rate of procollagen synthesis. by affecting the ratio of 
enzyme to substrate may influence the rate of hydroxylation. 
Decreased synthesis gives an increased enzyme:substrate ratio that 
leads to increased modification of the chains. Such is the case 
in transformation. Myllyla et al.(1981) have shown that there is 
an increase in lysyl hydroxylation and an increase in the ratio of 
glycosylated to nonglycosylated hydroxylysine in 3 human sarcoma 
cell lines that have reduced rates of procollagen synthesis. 
(iv) The rate at which pro-a chains fold into a triple helix 
influences the degree of modification. If helix formation is 
delayed increased modification of the pro a chains results (Prockop 
et al., 1979b; Kivirikko and Myllyla, 1979). 
Intracellular degradation of collagen provides another important 
mechanism for regulating the net rate of accumulation of this protein. 
This is dramatically illustrated by in vitro experiments that have 
shown that, during the log phase of growth of subconfluent cell 
cultures, as much as 30% of the newly-synthesized and 
under-hydroxylated collagen may be degraded within minutes of 
synthesis. As growth of the cultures slowed with approaching 
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confluence, so hydroxylation increased (from 25% in non-confluent to 
47% in confluent cultures) and intracellular degradation of newly 
synthesized collagen decreased to 10% (Berg et al., 1980). This was 
found for both Type I and Type III collagen. This phenomenon is not 
unique to collagen since other secretory proteins are also subjected to 
intracellular degradation e.g. insulin, parathyroid hormones and 
prolactin (Rennard et al., 1982). 
Rennard et al. (1982) have shown that the rate of intracellular Type I 
collagen degradation is directly related to the intracellular 
concentration of cAMP. They suggested that cAMP-mediated regulation 
of intracellular collagen degradation could be a general mechanism 
whereby a number of external stimuli could influence the rate of 
collagen accumulation and secretion. Intracellular degradation may 
play a role both in monitoring defective collagen molecules and in 
regulating collagen synthesis in response to external stimuli (Baum et 
al., 1980). 
Extracellular matrix: its influence on cell function 
Whereas previously the extracellular matrix, comprising collagen, 
elastin and proteoglycans and glycoproteins was regarded as an inert 
support medium that served no purpose other than to give shape and 
tensile strength to tissues or organs, recent experiments have shown 
that the extracellular matrix plays a far more important role as a 
modulator of function of the cells that it supports. The composition of 
the extracellular matrix has profound effects on cell function and 
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cell-cell interactions, thus influencing cytodifferentiation, 
mitogenesis, morphogenesis, cell adhesion and migration. 
The extracellular matrix has been shown to influence differentiation 
(Blum et al., 1987; Chen and Bissell, 1987; Reh et al., 1987). In 
vitro, the extracellular matrix can maintain or restore a 
differentiated phenotype by increasing the expression of tissue 
specific genes (as measured by increased mRNA and protein levels) and 
decreasing the expression of conunon structural genes (Ben-Ze'ev et al., 
1988; Fujita et al., 1987; Spray et al., 1987) . The matrix influences 
gene expression at the level of transcription (increased mRNA produced) 
and post transcriptionally (e.g. increased mRNA stability or 
translatability)(Blum et al., 1987; Fujita et al., 1987). This effect 
is dependent not only on cell-matrix interactions but also on cell-cell 
interactions. Cells at high density on an unfavourable substrate behave 
like cells at low density on a favourable substrate (Ben-Ze'ev et al., 
1988). 
The extracellular matrix influences proliferation in a number of ways. 
Firstly, it can synergize with growth factors or hormones so that the 
cells require fewer growth hormones at a lower concentration for 
optimal growth in vitro (Gatmaitan et al., 1983; Muschel et al., 1986). 
Secondly, it can influence a cell's response to growth factors (Bano et 
al., 1985; Madri et al., 1988) e.g. endothelial cells treated with 
transforming growth factor p (TGF-P) are inhibited when grown on plastic 
but rapidly form an extensive capillary-like network when grown 
embedded in collagen (Madri et al., 1988). Thirdly, it can mimic or 
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mediate the effect of growth factors (Madri et al ., 1988; Salomon et 
al., 1981) e.g. fibronectin can mimic the effect of TGF-~ on endothelial 
cell proliferation. Lastly, the matrix has been shown to sequester 
growth factors (Folkman et al., 1988; Gordon et al . , 1987; Roberts et 
al., 1988; Vlodavsky et al., 1987). The component of extracellular 
matrix responsible for binding the growth factors is heparan sulphate. 
This, for example, could explain the absolute requirement for close 
contact between bone marrow stromal cells and haematopoietic stem cells 
during haemopoiesis (Gordon et al., 1987; Roberts et al., 1988). 
The extracellular matrix profoundly affects cellular morphology 
(Ben-Ze'ev et al., 1988; Blwn et al., 1987). Epithelial cells are 
polar, with the basal cell surface adjacent to the basement membrane 
and the apical surface free of extracellular matrix . This polarity is 
determined by the matrix (Hall et al., 1982). If the apical surface 
comes into contact with extracellular matrix, the cells rearrange to 
exclude the matrix (Chambard et al., 1981; Hall et al., 1982; Montesano 
et al., 1984). The extracellular matrix is also responsible for 
determining the shape of the basal cell surface with a co-ordinate 
change in the organisation of the cytoskeleton (Hay, 1982; Sugrue and 
Hay, 1981). 
Cell adhesion and migration are also influenced by the matrix. 
Cell-cell adhesion is determined, in part, by cell adhesion molecules 
(CAMs), specific cell surface glycoproteins that mediate cell-cell 
adhesion (Cunningham , 1986). Le Douarin (1984) in a review on cell 
migration in the embryo noted that neural crest cells, which normally 
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express N-CAM, did not do so during migration. Instead they were 
surrounded by fibronectin. By altering their surface molecules, cells 
are able to migrate differentially and to adhere. 
Bissell et al. (1982) have described the interaction between cells and 
their surrounding extracellular matrix as one of "dynamic reciprocity". 
The response of the cells to the extracellular matrix affects the 
composition of the new matrix they secrete. This leads to an altered 
extracellular matrix which, in turn, leads to an altered cellular 
response. Any molecule capable of altering collagen metabolism could, 
therefore, have far reaching consequences. 
The physiology and pharmacology of control of collagen synthesis 
If one takes a less "molecular" and rather more physiological or 
pharmacological view of the way in which the rate of collagen synthesis 
is regulated, there appear to be at least four categories of 
extracellular stimuli that act in this regard. These are provided by: 
Lymphokines and monokines 
Peptide growth factors 
Drugs 
Contacts with other cells 
There is probably little chemical justification for drawing a 
distinction between lymphokines and monokines on the one hand and 
peptide growth factors on the other, since both categories share many 
molecular characteristics. Lymphokines and monokines, however, are 
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intuitively associated with immune reactions and the fibrosis that is 
so frequently seen as part of the host immune response. Peptide growth 
factors comprise diverse molecules, many of which have only recently 
been identified and that have not yet been fully characterized in terms 
of their origin and cellular effect. 
Lymphokines and Monokines 
Mononuclear cells and closely associated mesenchymal cells are seen in 
most inflammatory reactions . The mononuclear cells precede the 
fibroblasts and then exist in close proximity with these cells that 
infiltrate, divide and produce components of the extracellular matrix. 
Much attention has been focussed on interactions between fibroblasts 
and· mononuclear cells in attempts to identify the cytokines involved 
and their mode of action (Freundlich et al., 1986). The situation is 
complex and many contradictory results have been obtained. 
In an in vitro system, the results obtained are dependent on a number 
of variables. The composition of the mononuclear cell population; the 
agent used for stimulation; the origin and passage number of the 
fibroblasts used; and the assay system itself (e.g. presence or absence 
of serum or the time course of the experiment) may all affect the 
results. Furthermore, earlier experiments used crude or partially 
purified preparations of the cytokines. With the advent of recombinant 
cytokines, some of the controversy can now be resolved. 
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Lymphokines and monokines have been shown to affect several fibroblast 
functions, namely, fibroblast chemotaxis, proliferation and matrix 
synthesis. There are both positive and negative modulators of these 
functions (Wahl, 1984). However, not many of these factors have been 
well characterised. Of the many cytokines investigated, three are 
worthy of special mention: interleukin 1, interferon~ and tumour 
necrosis factor. 
Interleukin 1 
Interleukin 1 (IL-1) is a 17,5 kD protein produced by macrophages or 
monocytes in response to stimulation by lipopolysaccharide, immune 
complexes, phagocytosis and lymphokines (Dinarello and Mier, 1986; 
Maury, 1986). In a recent review, Oppenheim et al. (1986) noted that 
IL-1 activity can be produced by virtually all nucleated cell types. 
It has a wide range of effects, both immunological and 
non-immunological. It is genetically unrestricted and immunologically 
non-specific. There are two forms of IL-1, IL-la and IL-lP, that are 
products of different genes and have only 26% homology in their amino 
acid sequence. More than 95% of the IL-1 produced by mononuclear cells 
is of the IL-lp form. Its effects on tissues of mesenchymal origin may 
be either reparative e.g. increased synthesis of fibronectin, 
hyaluronate and collagen or destructive e.g. increased synthesis of 
collagenase and plasminogen activator (Laato and Heino, 1988). It 
induces a proliferative response in dermal, synovial, renal, brain and 
other tissues. This proliferation can lead to fibrosis which results 
in scarring and organ dysfunction (Dinarello and Mier, 1986). IL-1 is 
also chemotactic for neutrophils (Sauder et al . , 1984), monocytes, B 
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and T cells (Miossec et al., 1984). Thus it can amplify and potentiate 
an inflammatory response: the net outcome of which depends on the 
complex interactions between IL-1 , other cytokines and mesenchymal 
tissue. The importance of IL-1 in acute inflammatory events is 
questionable since IL-1 is not stored in cells, but synthesized on 
demand. Maximal mRNA levels are found 6 h after induction of IL-1 
synthesis (Oppenheim et al., 1986): long after acute events have 
occurred (Billingham, 1987). 
IL-lo and IL-lp share a common high affinity (Kd ± 10-10M) plasma membrane 
receptor (Kilian et al., 1986). ·Receptors have been detected on a 
number of cell types and their presence correlates with the capacity of 
the cell type tested to respond to IL-1 (Dower et al., 1985). The 
receptor has recently been cloned and found to belong to the 
immunoglobulin superfamily along with receptor for other hormones , PDGF 
and colony stimulating factor (Sims et al., 1988). Natural inhibitors 
have been isolated and partially characterised from urine (Liao et al., 
1985) and neutrophils (Tiku et al., 1986). 
The complexity of the interactions between IL-1, other cytokines and 
mesenchymal tissue is well illustrated by the manner in which IL-1 
affects collagen synthesis. 
IL-1 can modulate net collagen synthesis in 4 ways: 
i) it can increase collagen synthesis by increasing the levels of 
procollagen mRNA; (Kahari et al., 1987; Postlethwaite et al., 
1988) 
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ii) it can decrease collagen synthesis by increasing the 
intracellular concentration of prostaglandin E2 ; (Laato and 
Heino, 1988; Postlethwaite et al., 1988) 
iii) it can increase the synthesis of collagenase (Postlethwaite et 
al . , 1983) and the tissue inhibitor of metalloproteinases 
(Postlethwaite et al . , 1988) and 
iv) it can increase plasminogen activator synthesis which will then 
activate latent collagenases (Laato and Heino, 1988). 
Thus IL-1 can regulate both collagen production and collagen breakdown . 
The role of IL-1 as a regulator of collagen synthesis in vivo is 
brought into question by the absence of the signal sequence (Blobel 
and Dobberstein, 1975) that is usually required to achieve cellular 
export of proteins (Auron et al . , 1984; March et al . , 1985). Some 
authors have suggested that the IL- 1 leaks out when the macrophages 
are damaged (Gery et al., 1981). 
The Interferons 
The interferons (IFN) are a family of gene products characterized by 
their ability to induce resistance to viral infection . They consist 
of 3 classes: IFN-o, IFN-fi and IFN-~ (Clemens and McNurlan, 1985; 
Virelizier and Arezana-Seisdedos, 1985; Zoon, 1987) . 
IFN-o is produced by null leucocytes and macrophages in response to 
viruses and is coded for by genes located on chromosome 9 in man . The 
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IFN-a family comprises more than 24 species that share >50% sequen
ce 
homology. The mature protein(s) consists of 166 amino acids with 
an 
apparent molecular weights of 16-27k0. Most of the proteins are n
ot 
glycosylated. The functional unit is a monomer. 
IFN-P is produced by fibroblasts in response to viruses. Only one 
type 
of IFN-P has been isolated. The functional unit is a dimer, the mo
nomer 
being a glycoprotein of 166 amino acids with an apparent molecula
r · 
weight of 20kD. The IFN-P gene is located on chromosome 9 in man
. 
IFN-a and IFN-P share a common high affinity cell surface recepto
r 
(Branca and Baglioni, 1981; Tamm et al., 1987) with a dissociation
 
constant of 20-SOOpM. As with many other ligands, the receptor-li
gand 
complex is internalized via receptor-mediated endocytosis, where 
it is 
degraded and then released from the cell. 
IFN-1 consists of multiple protein species produced by post-
translational modifications of the product of a single gene locate
d on 
chromosome 12 in man. It is a glycoprotein of 146 amino acids wi
th an 
apparent molecular weight of 20-25kD. The functional unit is a 
tetramer. IFN-1 is produced by T cells in response to antigen or 
mitogen and is distinguished from the other ihterferons by being 
labile at pH 2. IFN-1 has a separate distinct cell-surface recep
tor 
(Branca and Baglioni, 1981). 
Interferon inducers other than viruses include platelet-derived g
rowth 
factor, tumour necrosis factor, colony stimulating factor 1 and 
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interleukin 1. The interferons are not species specific but have, 
instead, defined host ranges with some interferons being more active 
in some species than in others. They are antigenic only in 
heterologous hosts. 
Their prime effects are to make cells resistant to virus infection, to 
inhibit cell proliferation, to modulate cell differentiation and to 
inhibit transformation (Tamm et al., 1987; Stewart, 1979). The 
interferons have been shown to activate several genes e.g.class I HIA 
genes are induced by all the interferons, class II HIA genes are 
induced predominantly by IFN-7 (Tamm et al., 1987). 
IFN has been shown to regulate collagen synthesis by decreasing the 
levels of procollagen mRNA (Rosenbloom et al., 1984; Stephenson et 
al., 1985). IFN has also been shown to decrease fibroblast 
proliferation (Duncan and Berman, 1985). IFN-7 is the most potent 
inhibitor of collagen synthesis but IFN-a is also effective (Jimenez et 
al., 1984). 
Tumour necrosis factor 
Tumour necrosis factor (TNF) is mentioned for its functional 
similarity to IL-1. It is a 17kD protein produced by 
monocytes/macrophages (Cerami and Beutler, 1988). It is produced as a 
prohormone with an additional 76 amino acids on the amino-terminus. 
The gene for TNF is located on chromosome 6 in man (Cerami and 
Beutler, 1988). 
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Synthesis of TNF is controlled at the post-transcriptional level. 
The mRNA molecules have a consensus AU sequence which confers 
instability on the mRNA. This allows short bursts of intense activity 
before the mRNA is degraded and the activity decreases. TNF is 
species-preferential rather than species-specific. TNF is highly 
conserved and must, therefore, play some important role in the cell, 
presumably mediating resistance to a wide range of organisms and 
tumours.(Cerami and Beutler, 1988). 
TNF has been shown to decrease collagen synthesis in bone (Bertolini 
et al., 1986) and to increase collagenase and prostaglandin E2 
synthesis in synovial cells and dermal fibroblasts (Dayer et al., 
1985). It stimulates the growth of normal fibroblasts (Vilcek et al., 
1986; Sugarman et al, 1985). 
Many of the cytokines can act directly, as already shown, or 
indirectly by inducing the synthesis of other cytokines. Both TNF and 
IFNs, for example, increase IL-1 production by monocytes in response 
to lipopolysaccharide. (Philip and Epstein, 1986). Some of the 
effects of the cytokines are mediated by prostaglandin E2 (Laato and 
Heino, 1988). 
Prolonged exposure of fibroblasts to mononuclear cell products may 
alter the fibroblast phenotype. The synthesis of glycosaminoglycans 
(Worrall et al., 1986) and of prostaglandin E2 (Korn, 1983) have been 
shown to be abnormal after prolonged exposure to mononuclear cell 
products - in all probability due to the selection of a subpopulation 
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of cells which produce high levels of glycosaminoglycans or are high 
producers of prostaglandin E2 • It has been suggested that this i
s 
responsible for the abnormal fibroblast phenotype seen in disease 
states such as progressive systemic sclerosis (Worrall et -al., 1986; 
Korn, 1983). 
Peptide Growth Factors 
A number of peptide growth factors have recently been shown to 
influence the deposition of extracellular matrix and the function of 
mesenchymal cells. Transforming growth factor beta (TGF-P) and 
fibroblast growth factor (FGF) have particular relevance to the theme 
of this thesis. 
Transforming Growth Factor-8 
Transforming growth factor-Pis a homodimeric protein with a monomeric 
molecular weight 25 kD (Sporn et al., 1987). First discovered for 
its ability to promote anchorage-independent growth of normal cells in 
vitro, it is produced by a wide variety of cells, both neoplastic and 
non-neoplastic, and is particularly abundant in platelets and bone. 
The receptors for TGF-P are universally and constitutively expressed. 
It is secreted in a latent form which is unable to bind to its 
receptor. It is most likely activated by the action of proteases 
which disrupt the quaternary structure. 
There are two forms of TGF-p: TGF-Pl, the original isolate from 
platelets and TGF-P2 which constitutes 15-20% of the total TGF-p. Their 
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functions are indistinguishable, but it appears that they may have 
different receptors. Both forms are highly conserved with total 
sequence homology between human, bovine and porcine species and only 
one amino acid substitution in the murine species. 
TGF-P belongs to a larger gene family coding for molecules which all 
have growth regulatory properties. Other members include inhibin, 
activin and Mullerian substance (for review see Sporn et al., 1987). 
The high degree of evolutionary conservation of TGF-P and the striking 
effects that it has in many experimental systems argue in favour of 
its having a critical role to play in development and function of the 
organism. The physiological role of TGF-P, however, is unknown and 
Sporn et al . (1987) suggest that TGF-P is a 'morphogenetic' substance 
that modulates responses to other growth factors and regulates cell 
growth. 
It enhances the proliferation of cells of mesenchymal origin and 
inhibits the proliferation of cells of epithelial origin, endothelial 
cells and Band T lymphocytes. It stimulates the production of 
extracellular matrix by increasing the synthesis of matrix components 
and decreasing their degradation. It antagonises the mitogenic 
actions of epidermal growth factor, platelet-derived growth factor, 
fibroblast growth factor, insulin and insulin-like growth factor. 
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In a recent study on the role of TGF-~ in the development of the mouse 
embryo, it was found that TGF -~ is localized in mesenchyme and 
mesenchymally-derived tissues (Heine et al., 1987). 
TGF-P is a potent desmoplastic agent (Raghow et al., 1987). It 
increases collagen and fibronectin synthesis in chicken, human and rat 
cells (Fine and Goldstein, 1987; Ignotz and Massague, 1986; Ignotz et 
al ., 1987; Varga and Jimenez, 1986); it induces the formation of 
granulation tissue when injected into newborn mice (Roberts et al., 
1986); it promotes wound healing (Sporn et al., 1983); and it is 
chemotactic for both fibroblasts and monocytes (Postlethwaite et al., 
1987; Wahl et al., 1987). 
The increased rates of protein synthesis induced by TGF -P are 
accompanied by increased levels of mRNA . This could be due either to 
increased stability of the mRNA (Raghow et al ., 1987) or due to 
increased transcriptional activity . Rossi et al . (1988) have recently 
shown that TGF-P increases the activity of the promoter region of the 
collagen gene. This is mediated by binding of nuclear factor 1: a 
DNA-binding protein that activates eukaryotic gene transcription 
(Jones et al., 1987). 
TGF-P also increases net matrix accumulation by decreasing degradation 
of the matrix (Laiho et al., 1986). It achieves this in two ways . 
Firstly, it increases the production of protease inhibitors e.g. 
tissue inhibitor of metalloproteinases. Secondly , it decreases the 
production of the proteases themselves e.g . plasminogen activator . 
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Since TGF-P is chemotactic for monocytes, some of its effects may be 
mediated by these cells that can be activated to produce other 
cytokines such as IL-1. 
TGF-P is one of the lymphokines produced by activated T cells (Kehrl et 
al., 1986) and may be responsible for some of the ·fibrogenic activity 
found in mononuclear cell supernatants. Antibodies to TGF-P partially 
abolish the stimulatory activity of such supernatants (Roberts et al., 
1986). 
Fibroblast Growth Factors 
There are two forms of fibroblast growth factor (FGF): acidic FGF and 
basic FGF, which share 55% total sequence homology and a strong 
affinity for binding to heparin. Both are potent mitogens and 
differentiation factors for a wide variety of mesoderm- and 
neuroectoderm-derived cells (for review see Gospodarowicz, 1987). 
Basic FGF (bFGF) is an evolutionary well-conserved single chain 
polypeptide with an apparent molecular weight of 16 kilodaltons. It is 
encoded by a gene on chromosome 4 in man and is found in a wide 
variety of tissues. 
Acidic FGF (aFGF) is a less well-conserved single chain polypeptide, 
with an apparent molecular weight of 14-15 kilodaltons and has been 
found only in brain, retina, bone matrix and osteosarcoma. Its action 
is augmented by heparin (Uhlrich et al., 1986). 
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Both FGFs bind to the same high affinity plasma membrane receptors 
which are found on all cell types capable of responding to FGF 
(Gospodarowicz, 1987). In culture, bFGF is associated mainly with 
cells and basement membranes and is not released into the medium 
(Klagsbrun et al., 1986; Vlodavsky et al., 1987). As with IL-1, there 
is an apparent absence of a secretory-signal sequence in the bFGF 
protein (Abraham et al., 1986) and it is uncertain how FGF is 
transported to the cell exterior. 
In vivo, they induce the formation of highly vascularised granulation 
tissue in sponges implanted subcutaneously in the rat (Davidson et 
al . , 1985). Here the increase in collagen accumulation is due to an 
increase in the number of mesenchymal cells rather than to an increase 
in the cellular rate of collagen synthesis. 
Other Growth Factors 
Other growth factors shown to increase collagen production are insulin 
(Kjellstrom and Malmquist, 1984) and platelet-derived growth factor 
(PDGF)(Ross et al., 1986). PDGF stimulates both general protein 
synthesis and collagen synthesis. It also stimulates collagenase 
synthesis. Thus, PDGF may be important in (i) wound healing, by 
inducing fibroblast migration, proliferation and matrix synthesis; 
(ii) in neoplasia, by inducing adjacent stromal cells to secrete 
matrix components; and (iii) in bone marrow fibrosis, by inducing 
marrow stromal cells to produce excess connective tissue. Epidermal 
growth factor, like FGF, increases collagen accumulation by increasing 
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the number of cells producing collagen rather than increasing collagen 
synthesis (Laato et al., 1987). 
Glucocorticoids 
It is well known that topical treatment with glucocorticoids leads to 
atrophy of the skin (Adamson, 1982; Cockayne et al., 1986) associated 
with a decrease in collagen production that is attributable either to 
a selective decrease in the activity of prolyl hydroxylase (Adamson, 
1982) or due to a decrease in procollagen mRNA levels (Cockayne et 
al., 1986; Raghow et al., 1986; Weiner et al., 1987). The decrease 
in mRNA levels is due either to changes in the rate of transcription 
of the collagen genes (Weiner et al., 1987) or to an increased 
turnover of the procollagen mRNA (Raghow et al., 1986). The 
glucocorticoid effect is receptor mediated: antagonists block the 
inhibition of collagen synthesis, whilst agonists enhance the 
inhibition (Cockayne et al., 1986). 
Retinoids 
Retinoids also inhibit collagen synthesis with a corresponding 
decrease in procollagen mRNA levels (Daly and Weston, 1986; Hein et 
al., 1984; Ohta and Uitto, 1987). 
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Catecholamines 
The p-agonists, isoproterenol and epinephrine, inhibit collagen 
production by increasing the intracellular cAMP levels. This 
inhibition is blocked by the P-blocker, propanalol (Berg et al., 1981). 
Bleomycin 
The bleomycins are a family of chemotherapeutic proteins used in the 
treatment of malignancies. Their major toxic side effect is pulmonary 
fibrosis, caused by an increase in collagen accumulation (Sterling et 
al., 1983). The increase in collagen production is not paralleled by 
an increase in procollagen mRNA levels. Instead there is a 
repartitioning of the available rnRNA between the nucleus, the 
polysomes and the cytoplasm. Nuclear and cytoplasmic mRNA levels 
increase. 
Bleomycin-induced fibrosis in hamsters is self-limiting (Clark and 
Greenberg, 1987; Clark et al., 1983) with a transient rise in collagen 
production that soon returns to normal. These effects are mediated by 
alveolar macrophages that produce factors that both stimulate and 
inhibit collagen synthesis so that at any one time the net result 
reflects the balance between these opposing influences. Some of the 
effects of bleomycin may thus be mediated via secondary interactions 
with other cells. 
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Mast Cells 
The two host cells most commonly associated with neoplasia are th
e 
macrophage and the mast cell. I have already discussed the 
implications of macrophage involvement and its possible role in 
the 
induction of desmoplasia. The mast cell, too, is associated with
 
fibrosis. 
The mast cell is a leucocyte that contains numerous metachromati
c 
granules and is found in connective tissue, particularly where 
potentially noxious substances can enter the body (Pepys and Edw
ards, 
1979). The granules contain a number of mediators: vasoactive/sm
ooth 
muscle reactive mediators e.g. histamine; chemotactic factors; 
proteoglycans e.g. heparin; and enzymes e.g. chymase. They have
 
receptors for the Fe portion of IgE and for C3b and can be trigge
red 
to release the contents of their granules by IgE-antigen interac
tions, 
anaphylatoxins, enzymes, ionophores and polycations. They provok
e a 
biphasic inflammatory response. The first phase, a vasodilatory
 phase 
and the second, a cellular phase. If these responses continue 
unchecked, they can lead to tissue damage and fibrosis. 
Mast cells have been associated with pulmonary fibrosis, wound 
healing, chronic graft-versus-host disease and scleroderma (Clam
an, 
1985). It appears that mast cells through their mediators, hista
mine 
and heparin, stimulate fibroblast growth and not fibroblast colla
gen 




both basic and acidic fibroblast growth factor (Folkman, 1986). 
Heparin also stimulates angiogenesis and the myofibroblasts that form 
part of this response may lead to fibrosis (Beranek and Clevy, 1985). 
Recent experiments with TSK mice have supported the notion of mast 
cell involvement in fibrosis in vivo. These animals have a 
genetically transmitted connective tissue disease analogous to 
scleroderma. If they are treated with disodium chromoglycate, an 
inhibitor of mast cell degranulation, a reduction of both the number 
of degranulated mast cells in the skin and the thickness of the skin 
is observed (Walker et al., 1987). 
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CHAPTER I 
GROWTH AND CHARACTERISTICS OF UCT-MEL 7 DERIVED TUMOURS 
IN THE NUDE MOUSE 
The successful growth of a human tumour as a xenograft in an athyrnic 
nude mouse was first reported in 1969 (Rygaard and Povlsen, 1969), and 
since that time this animal model has been used extensively to study 
malignant cell growth (Freedman and Shin, 1978 ; Giovanella and 
Stehlin, 1974; Houchens and Ovejera, 1978) and the way in which the 
neoplastic phenotype is expressed or can be modulated. Invasion and 
metastasis (De Vore et al., 1980; Fidler et al . , 1978; Thorgeirsson, 
1985), angiogenesis (Folkman, 1975) , and the complex interactions 
between host and tumour are all aspects of neoplasia that are best 
studied in vivo and the nude mouse has provided a very useful 
approximation to the original human situation. 
Tumours that develop following inoculation of malignant cells into an 
athymic mouse usually grow relentlessly and exponentially . If the 
tumour is allowed to remain in situ the host usually dies shortly 
after the growth phase is established. 
My concern in this thesis is with the unusual tumours that developed 
when cells from a human melanoma cell line, UCT-Mel 7 (Hoal-van Helden 
e t al . , 1986) were inoculated into nude mice. These tumours differed 
f rom the usual melanoma xenografts in a number of interesting 
r espects . They showed an atypical growth pattern; they elicited a 
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marked desmoplastic response in the host; and they occasionally gave 
rise to murine tumours. 
f 
MATERIALS AND METHODS 
Melanoma cells 
The UCT-Mel 7 cell line was established from the femoral lymph node of 
a 52 year old African woman who presented, initially, with a chronic 
ulcer on the left heel. This was removed and diagnosed as a malignant 
melanoma, Clark's level V. Two months later a left femoral gland 
dissection revealed nodes that were infiltrated with tumour tissue. 
The node that I received had a firm, rubbery consistency and showed, 
on histological examination, the presence of secondary malignant 
melanoma with a spindle cell morphology and minimal melanin production 
(Fig. 1). 
The sample was minced finely and the fragments digested with trypsin, 
and collagenase. Sparse cultures of slowly growing cells were 
obtained from the enzymatically treated fragments plated in RPMI-10 . 
These were passaged at confluence until a non-pigmented, continuous 
cell line was established. The cells grew as an adherent monolayer 
with a pronounced spindle cell morphology (Fig. 2). Several other 
melanoma cell lines that had been established in this laboratory were 
also available to me and these provided interesting comparison with 
the UCT-Mel 7 line. These lines have been well described in published 
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FIGURE 1 
Histological appearance of original UCT-Mel 7 tumour 
The photomicrograph shows the histological appearance of a fragment 
of the original melanoma..-(;ontaining femoral lymph node from which the 
UCT-Mel 7 line was established. It shows a malignant melanoma with a 
spindle cell morphology and minimal melanin production . 








Morphological appearance of two melanoma cell lines in culture. 
! 
The photomicrographs emphasise the different morphologies of the 
adherent monolayers of melanoma cell lines in· culture. 
Fig. 2a. UCT-Mel 7 cells grew with a pronounced spindle cell 
morphology. 
Fig. 2b. UCT-Mel 1 cells showing triangular/dendritic morphology 
more typical of melanomas. 
The scale marker represents SOµm. 
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reports (Hoal-van Helden et al., 1986). I summarize their general 
characteristics in Table 1. 
Cultures were maintained using standard techniques of tissue culture 
f 
(Freshney, 1987) in RPM! supplemented with antibiotics and 10% foetal 
calf serum. Stocks of cells at different passage numbers were frozen 
and stored in liquid nitrogen (Farrant et al., 1974). 
Nude mice 
Athymic nude mice of N:NIH (S) II - nu/nu strain (Azar et al., 1980) 
were bred in the UCT Animal Unit from breeding stocks imported in June 
1980 and provided by Dr. B.C. Giovanella of the Cancer Research 
Laboratory, St. Joseph's Hospital, Houston, Texas, U.S.A. This strain 
has combined immunodeficiency i.e. in addition to the thymic 
hypoplasia found in the original strain of nu/nu mice, both T-cell and 
B-cell zones of the lymph nodes and spleen are depleted of 
lymphocytes. The colony is maintained by breeding pairs of the 
heterozygous nu/+ females and homozygous nu/nu males. The homozygous 
female offspring were used for experiments. 
The mice were handled under stringent sterile conditions at all times. 
All tumour cell inoculations and other manipulations were conducted in 
a laminar flow hood by personnel clothed in sterile gowns and wearing 
sterile rubber gloves. Athymic mice kept under these conditions 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Inoculation into nude mice 
Cells to be inoculated into the mice were released from the tissue 
culture dish with 0.25% trypsin containing 0.02% EDTA in a buffered 
• ' 
salt solution. The trypsin was neutralized by the addition of foetal 
calf serum to a final concentration of 5%, and the cells were then 
pelleted, washed once with serum-free medium, and adjusted to give the 
requisite number of cells in an inoculum of 0.1 ml. 
The cells were injected subcutaneously into the inter-scapular region 
of 6-8 week old mice. The animals were subsequently examined at 
weekly intervals when tumour growth was recorded. 
The tumour volume was calculated as the product of 3 major diameters. 
When called for by the experimental protocol, tumours were removed 
under light ether anaesthesia and the skin incision closed with 
surgical clips that were removed after one week. Alternatively, the 
tumours were removed after killing the animals. 
Each tumour was divided into several representative portions. One of 
these was placed in buffered formal saline for histology. The other 
fragments were variously used for re-inoculation, re-establishment in 
culture, biochemical analysis or cryopreservation (Farrant et al., 
1974). 
so 
Analysis of the tumours 
a) Histology of the Tumours 
Formalin-fixed samples were embedded in paraffin, sectioned and 
stained according to conventional histological techniques (Mayers' 
haematoxylin and eosin). Sections of the tumours were stained for 
reticulin according to the method of Gordon and Sweets (1936) . 
b) Hydroxyproline Content of the Tumours 
The hydroxyproline content of the tumours was determined using the 
method of Hutterer and Singer (1960) in which tissues were hydrolysed 
in 6N HCl, evaporated to dryness under vacuum and the residue 
dissolved in distilled water. Samples so obtained were assayed for 
hydroxyproline content by reading the absorbance at SOOrun and 560run 
after the addition of p-dimethylaminobenzaldehyde and referred to a 
standard curve. 
c) Phosphoglucoisomerase Analysis 
To determine the relative contributions of human and murine cellular 
elements to tumours that were obtained, lysates were prepared by 
homogenizing the tumours in 2 volumes of O.lM sodium phosphate pH 7.4. 
These were then analysed for the phosphoglucoisomerase (PGI) enzymes 
they contained using standard techniques of starch gel electrophoresis 
and zymography (Siciliano and Shaw, 1976; Harris and Hopkinson, 1976). 
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Hwnan and murine PGI isoenzymes were readily distinguishable by 
differences in their electrophoretic mobilities . 
Chemotaxis 
Chemotaxis was performed using the standard micropore filter assay 
with sawn-off tuberculin-syringe barrels as the upper chamber 
(Wilkinson , 1982). Peritoneal cells were harvested from BALB/c female 
mice and used at a concentration of lxl06 cells/ml. The filters used 
were Sartorius 8 µm filters . Chemotaxis was measured over 5 hours at 
37°c using the leading front method of scoring. A 0.5% solution of 
sodium caseinate (Merck 2242) was used as the positive control. 
Superoxide anion production 
Superoxide anion secretion was assayed by the superoxide 
dismutase-inhibitable reduction of ferricytochrome c. (Johnston et 
al. , 1978). UCT-Mel 7 cells and foreskin fibroblasts were plated at 
lxl05 cells/16mm well in 1 ml Hanks balanced salt solution without 
phenol red (Gibco 076-1201) supplemented with 5.SmM glucose, (BDH 
10117), 25 mM Hepes (Boehringer Mannheim 223778), MEM amino acid mix 
(SOx cone.; Gibco 043-1130H), L-glutamine (Sigma G3126) and MEM 
vitamin mix (lOOx cone . ; Gibco 043-1120H). Thioglycollate-elicited 
mouse peritoneal macrophages were harvested by peritoneal lavage of 
BALB/c mice and plated at 8xl05 cells/16mm well . Non-adherent cells 
were removed by washing after 2 hours incubation. 
At the start of the experiment ferricytochrome c (Sigma C-2506) was 
added to give a final concentration of 10-5M . To some assay wells 
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was added superoxide dismutase (Oxinorm) at a final concentration of 
150U/ml and to other wells tetradecanoyl phorbol acetate (PMA; 
Consolidated Midland Corporation) at a final concentration of 10 ng/ml. 
The cells were incubated at 37°C in 5% CO2 - 95% air. At the 
indicated times, the reaction mixture was removed from the wells, 
centrifuged at 3000g in an Eppendorf microcentrifuge and the optical 
density measured at 550 nm. The concentration of cytochrome c reduced 
was determined using the equation 6E550nm - 2lmM-1cm-1 • 
At the end of the experiment, the cells were digested with lM NaOH and 
10% Na deoxycholate (0/N at 37°C) and the protein content of the 
digest determined by the method of Lowry et al. (1957) using BSA as 
standard. 
RESULTS 
In most cases, malignant melanoma cells injected into nude mice give 
rise to tumours that develop at the site of inoculation and 
subsequently show a characteristic pattern of growth in which there is 
an initial latent period, during which the tumour is growing but 
imperceptible, followed by overt exponential growth. A typical 
example of this behaviour was shown by UCT-Mel 1 (Fig. 3) that grew 
exponentially with a doubling time of 4.6 days. UCT-Mel 7, however, 
consistently showed a different pattern of growth. After a period of 
53 
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FIGURE 3 
Growth of human melanomas in nude mice: comparison of UCT-Mel 1 and 
UCT-Mel 7 derived tumours. 
The figure shows tumour volumes as a function of time after the 
subcutaneous injection of Sxl06 cells into each of 2 mice. 
The tumour that developed following injection of UCT-Mel 1 cells 
(a----•) showed the usual pattern of exponential growth following a 
short latent period. 
The UCT-Mel 7 derived tumour(&~-&) grew exponentially for a short 
while after which growth was arrested at a plateau. 
These results are typical of many similar experiments and record the 
growth of UCT-Mel 7 derived tumours during the first 100 days. 
Subsequent growth kinetics of UCT-Mel 7 derived tumours are shown in 
the figures that follow. 
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early proliferation, growth ceased at a plateau that was maintained 
for 2 to 3 months. 
This period of dormancy was followed by a period of regression during 
which time the tumour diminished in size. After a further dormant 
spell, and by now 4 to 7 months after the initial inoculation, the 
tumour began to grow again, this time showing simple exponential 
kinetics (Fig. 4a). Tumours that emerged from the period of dormancy 
grew much more aggressively than the initial tumour. 
The growth pattern could thus be divided into 5 sequential phases: 
1. a growth phase; 
2. a plateau phase; 
3. a phase of regression; 
4. a dormant phase; and finally 
5. a phase of exponential growth. 
Not all tumours showed all 5 phases of growth. Some entered the 
second phase of exponential growth without regressing. Others 
regressed and then grew exponentially without the second dormant phase 
(Fig. 4b). Once the tumours had entered phase 5, however, they all 
grew with remarkably similar growth kinetics and, if they were removed 
at this stage and reimplanted into fresh recipients, the tumours that 
resulted grew exponentially without a dormant phase and with similar 
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FIGURE 4 
The phasic growth pattern of UCT-Mel 7 tumours in nude mice. 
These two figures depict typical growth patterns observed when each 
of two mice received injections of 5xl06 UCT-Mel 7 cells taken from 
in vitro passage number 30. 
Fig. 4a shows the typical phasic growth patterns referred to in the 
text in which an initial growth phase (1) was followed by a plateau 
phase (2) during which time no increase in tumour size occurred. 
This was followed subsequently by a phase of tumour regression (3), a 
period of dormancy (4) and, finally, an exponentially growth phase 
(5). 
Fig. 4b shows the variation in the growth pattern that was 
occasionally observed. The exponential phase (5) followed the 
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Growth patterns of UCT-Mel 7 tumours derived from fragments of 
tumours passaged in vivo. 
The figure shows the growth patterns of tumours derived either from 
inoculation of 5xl06 UCT-Mel 7 cells or from subcutaneous 
implantation of tumour fragments taken from tumour-bearing mice. 
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The original tumour (NM 656), that developed from UCT-Mel 7 cells 
(A~~•) showed the phasic pattern of growth described previously. 
The tumour (N1M 774) that grew from fragments of NM 656 taken at 273 
days and that (N3M 975) that developed from a second in vivo passage 
of N1M, no longer showed the phasic pattern of the parent NM 656, but 
grew exponentially, without a "plateau" phase. 
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convenience I refer to phase 5 tumours that were passaged in vivo as 
"SP" tumours. 
The pattern of growth that was observed depended upon the number of in 
vitro passages that had elapsed since the establishment of the primary 
cultures. Cells derived from the 8th in vitro passage gave rise to 
tumours that grew exponentially without a plateau phase whereas cells 
from cultures that had been passaged 30 times, gave rise to tumours 
that showed the phasic growth pattern that I have described. Tumours 
arising from cells which had been passaged 56 times, showed a 
prolonged period of dormancy with eventual exponential growth (Fig. 6). 
It was of interest to note the paradoxical inverse relationship 
between growth rates in vivo and the in vitro proliferative rates 
(Fig. 7). The tumours derived from in vitro 8th passage cultures had 
an in vivo doubling time of 65 days and an in vitro doubling time of 
103 hrs. On the other hand, cells from an in vitro passage 56 gave 
rise to tumours which grew slowly in the mouse yet had an in vitro 
doubling time of only 47 hours. Similarly, the SP tumours that were 
serially transplanted into fresh recipient hosts, had short in vivo 
doubling times yet proliferated very slowly in vitro. 
Histological examination of the tumours removed in phase 2 showed an 
intense ' desmoplastic response with heavy staining for reticulin. 
UCT-Mel 7 tumours had an extensive reticulin fibre network (Fig. 8) 
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In vivo growth patterns of tumours derived from different in vitro 
passages of UCT-Mel 7, 
Three mice received inocula of lxl06 UCT-Mel 7 cells of differing in 
vitro passage number. The tumours that developed were measured and 
then plotted as a function of time. 
Cells from in vitro passage number 8 <•·····•) gave rise to a tumour 
that showed exponential growth from the start without any plateau 
phase. 
The tumour derived from cells, from in vitro passage number 29 
(A~~A) showed a period of exponential growth, a plateau phase, a 
phase of regression and, subsequently, exponential growth. 
An inoculum of cells from in vitro passage number 56 <•----•) 
developed into a tumour which grew exponentially following a 
prolonged lag phase. 
The growth patterns depicted in this figure are representative of 
those observed in many other experiments. For the sake of clarity 
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FIGURE 7 
Inverse relationship between in vivo and in vitro growth rates 
Tumours derived from 8th passage UCT-Mel 7 cells, which had an in 
vitro doubling time of 103 hours proliferated in vivo much more 
rapidly than tumours derived from 56th passage cells, which had an in 
vitro doubling time of 47 hrs. 
In vivo growth was assessed as the time taken for the tumour to 
attain a volume of lcm3, 
In vitro proliferation was assessed as the time taken for the number 
of cells in the dish to double. 
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FIGURE 8 
Melanomas excised from nude mice and stained for reticulin 
Histological sections of tumours removed from nude mice and stained 
for reticulin. Scale marker= 60µm . 
a) UCT-Mel 7, removed during phase 2, showing abundant reticulin 
arranged in a swirling pattern surrounding individual cells. 
b) UCT-Mel 1, showing much less reticulin which appeared to be 
mainly perivascular. 
c) UCT-Mel 2, showing virtually no reticulin. 
d) UCT-Mel 7, removed during phase 5 . Reticulin fibre formation is 
virtually absent . 
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perivascular or very scant. UCT-Mel 7-derived tumours that were 
removed during phase 5 did not contain detectable reticulin. 
The histological assessment of collagen content was confirmed by 
chemical estimation of the hydroxyproline content of the tumours. 
UCT-Mel 7 tumours contained an average of 83.3 (± 9.8 sem) ng 
hydroxyproline per µg of cellular protein. The average hydroxyproline 
contents of the other melanomas that I examined ranged from 2.4 to 4.5 
ng/µg cellular protein (Fig. 9). 
The collagen content of the UCT-Mel 7 tumours varied at the different 
phases of growth (Fig. 10). Phase 2 tumours (i.e. those that showed a 
desmoplastic response) had high levels of hydoxyproline whereas the 
hydroxyproline content of phase 5 and SP tumours was negligible. 
Cultures of tumours that had been excised from the mice during phase 2 
or phase 5 invariably comprised human cells that were visibly 
contaminated with murine fibroblasts and macrophage-like cells 
(Fig. 11). 
Electrophoretic analyses of phosphoglucoisomerase (PGI) isoenzymes 
present in cell lysates provided a more definitive and quantitative 
estimate of the relative contribution of murine and human elements 





























Tumours derived from different melanoma cell lines were excised and 
hydrolysed. The hydroxyproline content of the hydrolysates was 
measured and expressed in terms of total protein in the sample . 
Error bars represent± 1 sem. The number of tumours assayed to 
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Collagen content of UCT-Mel 7 tumours at different phases of growth 
The collagen present in UCT-Mel 7 tumours removed at different phases 
of growth was determined. The figure is constructed from the results 
of 6 phase 2 tumours, 4 phase 5 tumours and 12 phase SP tumours. 








Cellular composition of UCT-Mel 7 tumours re-established in tissue 
culture 
UCT-Mel 7 tumours were removed from mice and re-established in tissue 
culture. Host cell contamination varied between tumours. Scale 
marker - SOµm 
Fig. lla shows the cultures established from tumours removed during 
phase S. A nest of tumour cells (arrow head) is shown with 
occasional macrophages (arrow) on a background of murine fibroblasts. 
Fig. llb shows the cultures established from tumours removed after 
two passages in vivo. Clusters of tumour cells are shown surrounded 
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FIGURE 12 
FIGURE 12 
Relative contributions of hwnan and murine cells to UCT-Mel 7 tumours 
grown in nude mice: phosphoglucoisomerase (PG!) zymography 
Fig. 12a Twnours removed from the nude mice 
Twnours were excised, homogenized and analysed electrophoretically as 
detailed in th~ Methods section, to determine the species and 
relative concentration of PG! enzymes present . 




- Hwnan breast tissue showing a band with electrophoretic 
mobility of the hwnan enzyme. 
- Mouse liver homogenate, showing PG! enzyme band of 
mouse origin. 
- UCT-Mel 7 twnour tissue homogenate, showing PG! bands 
of both hwnan and mouse origin. 
Lane 4 to 7 - UCT-Mel 7 twnour tissue homogenates from passage 1, 2, 
2 and 3 respectively, showing both enzyme bands . 
Fig . 12b Cells derived from twnours removed during phase SP growth 
in vivo 
As above, but in these samples homogenates were prepared from cells 
re-established as in vitro cultures from excised twnours . 
Samples of cell lysates were as follows: 
Lane 1 - Hwnan breast homogenate, showing PG! enzyme band of 
hwnan origin. 
Lane 2 & 3 - UCT-Mel 7 cells from in vivo passage nwnbers 10 and 5 




- UCT-Mel 7 cells from in vivo passage No. 7 showing a 
mixture of hwnan and murine bands. 
- UCT-Mel 7 cells from in vivo passage No. 5 showing only 
murine bands. 
- Mouse liver homogenate, showing PG! bands of mouse 
origin. 
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In all analyses performed on lysates of tumours immediately after 
excision, I found a mixture of human and murine PGI's with the human 
isoenzymes as the predominant species. In interesting contrast, 
lysates examined after a period of re-established in vitro culture, 
occasionally contained predominantly murine PGI's. Of the 9 tumours 
re-established in vitro as pure cultures of tumour cells, 4 consisted 
of only murine cells despite the fact that they comprised a mixture of 
human and mouse cells at the time of excision with the human elements 
predominating. These murine cell lines were tumorigenic in syngeneic 
immunocompetent mice. 
The six melanoma cell lines differed remarkably in the frequency with 
which they formed metastatic tumours (Table 2), varying from 6% in the 
case of UCT-Mel 1 to 100% with tumours of UCT-Mel 3. Tumours arising 
from UCT-Mel 7 cells consistently failed to give rise to metastases. 
The chemotactic capacity of the UCT-Mel 7 cells was investigated using 
a standard micropore filter assay (Table 3). UCT-Mel 7 cells were 
shown to produce a soluble factor that was chemotactic for mouse 
peritoneal macrophages in a dose dependent manner. The amount of 
chemoattractant produced was dependent on the number of cells present. 
The macrophages, UCT-Mel 7 cells and foreskin fibroblasts all reduced 
cytochrome c that was added to the medium. In doing so they displayed 
notable differences (Figs. 13 & 14, Table 4). 
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TABLE 2 
Incidence of metastases 
Cell line No. of mice Metastases 
No. % 
UCT-Mel 1 17 1 6 
UCT-Mel 2 26 3 12 
UCT-Mel 3 35 35 100 
UCT-Mel 4 10 1 10 
UCT-Mel 5 22 3 14 



















The incidence of metastases was evaluated by detailed autopsy after excision of 
the primary tumour and a prolonged period of observation. 
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TABLE 3 
Chemotactic activity of UCT-Mel 7 
Chemoattractant 
0.5% Na caseinate 
Medium (RPlO) 
UCT-Mel 7 conditioned medium 
1: 2 dilution 
1: 5 dilution 
UCT-Mel 7 cells 
3xl05 
0.6x105 
Mean Distance travelled (µm) ± SEM 
47.5 ± 3.7 
21.5 ± 4.5 
51.3 ± 9.1 
38.6 ± 6.2 
68.1 ± 4.5 
37.1 ± 5.7 
The ability of UCT-Mel 7 cells to attract BALB/c peritoneal 
macrophages was assessed using a standard filter assay. Sartorius 8µm 
cellulose acetate depth filters separated two chambers; the upper 
one contained 106 macrophages/ml of medium and the lower contained 
either UCT-Mel 7 cells, UCT-Mel 7 cell-conditioned medium or 
appropriate controls. 
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Firstly, all of the cytochrome c reduction by macrophage products was 
superoxide dismutase (SOD)-sensitive indicating that the only reactive 
oxygen intermediate (ROI) released by these cells was superoxide anion 
(02 -). UCT-Mel 7 cells and foreskin fibroblasts, however, released 
reductants that were only partially sensitive to SOD (Fig. 13). The 
nature of the SOD-resistant ferricytochrome c reduction by these cells 
was not investigated further. 
Secondly, 02 - released by macrophages was highly inducible by PMA: 
addition of this compound at lOng/ml caused an approximately 4-fold 
increase in the rate of ferricytochrome c reduction. Release of ROI's 
by fibroblasts and UCT-Mel 7 cells was constitutive and refractory to 
PMA induction. 
Finally, in most experiments the release of 02 - by PMA stimulated 
macrophages was linear for two hours after which it ceased. UCT-Mel 7 
cells and fibroblasts released 02 - linearly for three hours. 
SOD-resistant reduction of the ferricytochrome c by fibroblasts 
proceeded linearly for three hours whereas in the case of UCT-Mel 7 
cells the rate diminished between 1 hr and 3 hrs after addition of 
ferricytochrome c to the medium. 
In view of these results the rate of 02 - released was calculated over 
the first hour and expressed as nanomoles of ferricytochrome c reduced 
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Reduction of ferricytochrome c by cultured cells 
The production of cytochrome c reductants by resting and 
PMA-stimulated (lOng/ml) mouse peri~oneal cells, UCT-Mel 7 cells and 
foreskin fibroblasts was measured spectrophotometrically. 
Murine macrophages (Fig 13a) only produced cytochrome c reductants 
when stimulated by PMA. All of the reductants produced were 
inhibitable by superoxide dismutase, indicating that the macrophages 
produced mainly superoxide anion in response to PMA. 
UCT-Mel 7 cells (Fig. 13b) and foreskin fibroblasts (Fig. 13c) 
produced cytochrome c reductants constitutively. Not all of the 
reduction observed was inhibitable by superoxide dismutase indicating 












Ferricytochrome c reduction by different melanoma cell lines 
SOD-resistant (hatched bars) and SOD-sensitive (open bars) reduction 
of ferricytochrome c by different melanoma cell cultures was measured 
\ 
with and without added PMA (lOng/ml). 
Note that all cultures generated cytochrome c reductants, 
approximately half of which could be identified as superoxide anion. 
Phorbol ester had no striking effect on the release of reductants and 
the rate of reductant release was unrelated to fibrogenic potential 





Ferric;:i:tochrome c reduction; interaction between UCT-Mel 7 cells and 
peritoneal macrophages 
Culture Time nM cytc red/µg protein/min 
(hr) 
Expt 1 Expt 2 
SOD-sens SOD-res is SOD-sens SOD-res is 
UCT-Mel 7 1 0.37 0.17 0.35 0.24 
alone 3 0.32 0.11 0.24 0.19 
7 0.19 0.08 0.10 0.10 
M/phages 1 0.18 0 0.12 0 
alone 3 0.11 0.03 0.11 0 
7 0.05 0.03 0.08 0.01 
UCT-Mel 7 1 0.18 0.07 0.16 0.02 
+ M/phage 3 0.09 0.08 0.10 0.05 
observed 7 0.05 0.05 0.05 0.03 
UCT-Mel 7 1 0.27 0.09 0.23 0.11 
+ M/phage 3 0.21 0.07 0.17 0.09 
expected 7 0.15 0.06 0.09 0.05 
UCT-Mel 7 cells and macrophages were cultured, either alone or as 
co-cultures in medium containing 10-5M ferricytochrome c. 
SOD-sensitive and resistant cytochrome c reduction was measured at 1, 
3 and 7 hours after the addition of the pigment. Co-cultures 
generated less reductants than would have been expected from the 
results of the individual cultures. 
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Three other melanoma cell lines tested also released ferricytochrome c 
reductants, some of which were SOD-inhibitable and others not 
(Fig. 14). The reductants were released constitutively and production 
could not be enhanced by stimulation with PMA. 
On two occasions, when UCT-Mel 7 cells and macrophages were 
co-cultured, the release of SOD-sensitive reductants was inhibited 
(Table 4). There was an approximate 30% reduction in the rate of ROI 
release observed over the first hour as compared to the expected rate. 
DISCUSSION 
The data I present in this chapter document the behaviour of tumours 
that developed when cells from a melanoma cell line, UCT-Mel 7, were 
inoculated into athymic mice. Compared to the other melanomas that I 
studied, these tumours were unusual in their phasic growth pattern; 
in that they elicited an intense desmoplastic response; and in the 
fact that, on occasions, they yielded malignant cells of murine origin 
after re-establishment in culture. 
The phasic growth pattern was only seen after a prolonged period of 
repeated in vitro passage. Tumours that developed from 8th passage 
cells grew with the usual exponential kinetics whereas those from the 
20th or subsequent passages grew to a plateau, regressed and 
subsequently burgeoned. These observations are readily explicable on 
the basis of in vitro selection for the "phasic phenotype". 
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Phenotypic drift of cell lines during the course of repeated in vitro 
passaging is well known (Neri and Nicolson, 1981; Welch et al., 1983) 
and is, in most cases, ascribed to selective forces that favour the 
emergence of subpopulations that have a proliferative advantage in the 
in vitro milieu . The differences that I observed in the doubling 
times of UCT-Mel 7 cells are consistent with this view. Cells at the 
52nd passage had a doubling time (47 hours) that was approximately 
half that of the 8th passage cells (103 hours). 
Continued in vitro passaging further selected for cells that produced 
tumours whose initial growth was so slow that the "plateau" and 
"regression" phases were not seen. These tumours (exemplified by 
those derived from 56th passage cells) eventually (i.e. after a period 
of approximately 6 months) became rapidly growing and lethal tumours. 
Here, too, selection for cells that proliferated rapidly in vitro 
could be documented (Fig. 7). 
In many ways the growth pattern of the later passage cells showed the 
features of "dormancy" that are well described for many human tumours 
and for which few animal models exist . The tumour dormant state has 
been defined as "the state in which tumour cells persist in a host for 
prolonged periods of time with little net growth and which is 
terminated by an event which permits their rapid outgrowth" (Weinhold 
et al., 1979) . 
The first person to draw attention to the concept of the dormancy was 
Hadfield (1954) who recorded the long intervals of time that 
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frequently elapsed between excision of the primary tumour and the 
eventual reappearance of identical tumours at a much later stage. In 
clinical situations and in most experimental systems described (Eccles 
and Alexander, 1975; Gimbrone et al., 1972; Noble and Hoover, 1975; 
Weinhold et al., 1979) the local or metastatic tumours that terminate 
dormancy are, to all intents and purposes, the same as the primary 
tumour. It is, therefore, generally believed that residual cells 
remain after excision and that their growth is restrained by such 
factors as immunological suppression (Eccles and Alexander, 1975; 
Weinhold et al., 1979), lack of vascular supply (Gimbrone et al., 
1972), hormonal deprivation (Noble and Hoover, 1975) or the 
concomitance of surgical "stress" (Fisher and Fisher, 1959). 
Phenotypic changes in the residual cells have not been emphasized as 
the "events" that terminate dormancy. 
The experiments that I describe illustrate, quite clearly, that 
dormancy may be terminated by an alteration in the innate 
characteristics of the restrained cells. The lines that grew during 
stage 5 remained, when passaged into new recipients, rapidly growing 
neoplasms that showed none of the growth or other characteristics of 
the initial tumours. 
I have no definitive explanation for the phenotypic changes that did 
occur, but several possibilities exist. The phase 5 tumours may have 
represented a reversion to the original rapidly growing phenotype that 
I observed when early passage cells were inoculated. Alternatively, 
they may have arisen as a result of genetic changes that conferred 
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growth factor independence or the capacity for the synthesis of other 
factors, such as angiogenic factor. In either event such developments 
would imply mutations in the slowly growing residual cell population 
mutations that I felt may have been due to factors released by 
macrophages that infiltrated the tumours. 
Tumours may produce chemoattractants for macrophages (Botazzi et al., 
1985; Mantovani et al., 1986; Meltzer et al., 1977) and, in one case 
(Benomar et al., 1987), this could be correlated with the macrophage 
content of the tumours in vivo. I have shown that the UCT-Mel 7 cells 
are no exception in this respect (Table 3). Conditioned medium from 
cultures of UCT-Mel 7 cells were chemotactic for macrophages and 
significantly more so than similar harvest fluid from other melanoma 
cells that did not show the same degree of macrophage infiltration. 
Phagocytic cells are also known to have mutagenic properties . 
Neutrophils have been shown to produce mutations in bacteria (Weitzman 
and Stossel, 1982) and in mammalian cells (Weitberg et al., 1983; 
Weitzman et al., 1985) and tumour-associated macrophages harvested 
from mouse mammary tumours increased the rate of mutation of the TA98 
strain of Salmonella typhimurium (Fulton et al., 1984) and led to the 
emergence of drug-resistant variants in mouse mammary tumours at 
frequencies that were S to 10-fold higher than the spontaneous 
frequency (Yamashira et al., 1983). 
Since phagocyte-induced mutagenesis is generally believed (Weitberg et 
al., 1983; Weitzman and Stossel, 1982; Weitzman et al., 1985) to be 
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mediated by active oxygen species that are generated by these cells 
(Johnston, 1978 ; Takemura and Werb, 1984), I studied the release of 
active oxygen metabolites by murine macrophages, fibroblasts, 
UCT-Mel 7 cells and other melanoma cells as measured by their ability 
to reduce cytochrome c. 
I confirmed the fact that macrophages release superoxide anion as 
their principal or only cytochrome c reductants, but do so only when 
stimulated by agents such as PMA . If one assumes , in my experiments , 
that the tumour-associated macrophages were "activated", one might say 
that the presence of these cells in quiescent tumours was responsible 
for the eventual escape from dormancy. The matter, however, is far 
from resolved. If oxidative mutagenesis was primarily responsible for 
the change in phenotype of the residual cells, the importance of 
macrophages is put in doubt by the fact that the UCT-Mel 7 cells 
themselves released cytochrome c reductants, some of which were 
SOD-sensitive and others, of obscure nature, that were not . 
Furthermore, fibroblasts and other melanoma cells that did not show 
the growth kinetics of UCT-Mel 7 cells produced cytochrome c 
reductants at rates that were equivalent to those observed with 
UCT-Mel 7. 
The case for the involvement of oxidative metabolism in the escape 
from tumour dormancy is further weakened by the demonstration of 
inhibition of release of ROI's in co-cultures of macrophages and 
melanoma cells. Other workers have documented the effect of malignant 
cell products on the release of reactive oxygen metabolites by 
macrophages (Szuro-Sudol and Nathan, 1982). My experiments have 
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extended these observations by showing that, in the case of melanomas 
at least, the reverse is also true: macrophages are able to inhibit 
the release of superoxide anion and SOD-resistant reductants by 
malignant cells. 
Although the SOD-resistant reduction of ferricytochrome c by melanomas 
and fibroblasts was an interesting biochemical process and the 
interaction between macrophages and -melanoma cells is potentially 
important, I decided, in the interests of pursuing the main objectives 
of -this thesis, not to investigate them further for the time being. 
The experiments involving ROis were initiated in the hope that they 
would shed light on the behaviour of this unique melanoma cell line in 
vivo in terms of its ability to induce a desmoplastic response and to 
show an unusual pattern of growth. Having satisfied myself that 
oxidative metabolism had little obvious to do with these aspects of 
this study, I set them aside to return to at some later stage. 
In considering the role of macrophages as terminators of tumour 
dormancy, one should take into account mechanisms other than those 
that involve active oxygen species. It is well established, for 
example, that macrophages may promote tumour growth by releasing 
growth factors (Evans, 1977; Nelson et al., 1981), by stimulating 
angiogenesis (Polverini et al., 1977), by contributing to the 
establishment of a supporting stroma (Wahl, 1984), or by remodelling 
of the surrounding tissues in such a way as to favour invasion or 
spread (Henry et al., 1983). 
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There are currently two diametrically opposed theories as to the role 
of the macrophage in neoplasia. The original hypothesis, as put 
forward by Burnet in 1970 (Burnet, 1970), proposes the concept of 
"immune surveillance" in which macrophages, in conjunction with 
lymphocytes, monitor all tissues and eliminate any rogue cells before 
they can establish themselves. Although attractive in theory, this 
hypothesis has been difficult to validate experimentally. More 
recently, Prehn (1977, 1982) has put forward an "immunostimulatory 
theory" in which macrophages and immunocompetent cells, in fact, 
support the growth of the tumour, particularly during a 
"lymphodependent" phase early in progression. 
A far more controversial theory has recently been proposed by 
Munzarova and Kovarik (1987) who suggest that somatic fusion takes 
place between macrophages and other cells, including neoplastic cells. 
This is followed by processes which culminate in malignant 
transformation of the hybrid cells or their progeny. 
There have not been many reports on the functional status of 
tumour-associated macrophages except with regard to their . cytotoxic 
potential (Evans and Lawler, 1980; Mantovani, 1978; Talmadge et al . , 
1981). Some workers have shown a correlation between the cytotoxic 
potential of tumour-associated macrophages and the immunogenicity and 
metastatic capacity of the tumour (Mantovani, 1978; Eccles, 1974) . 
More recent work, however, failed to show any correlation between 
macrophage content and immunogenicity, metastatic capacity or in vitro 
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and in vivo growth rates of the tumour (Evans and Lawler, 1980; Evans 
and Eidlen, 1981; Talmadge et al., 1981) . There is some indication 
that, in some instances, the functional capacity of the 
tumour-associated macrophages may be suppressed. My results and the 
results of others (Szuro-Sudol, 1982) attest to the capacity of 
certain tumours to inhibit the oxidative metabolism of macrophages. 
The ability of macrophages to respond to a chemoattractant may also be 
inhibited (Kalish and Brody, 1983; Snyderman and Pike, 1976) . 
It is of interest that, on four occasions in the experiments that I 
completed, neoplastic murine cells were isolated from cultures 
established from phase 5 tumours that comprised, at the time of their 
removal, malignant cells that were largely of human origin . The 
induction of malignant change in the stroma of transplanted murine 
tumours is a well-described phenomenon (Goldenberg and Pavia, 1981; 
1982) and Giovanella and Fogh (1985) have recently drawn attention to 
the value of the xenografted nude mouse as a model for identifying the 
cellular origins of such tumours. Karyotypic analyses or isoenzyme 
electrophoresis of tumour tissues provided unequivocal identification 
of murine sarcomas that have developed at the site of human tumour 
xenografts in a number of reported instances (Goldenberg and Pavia, 
1981; 1982). My observations contribute additional examples of this 
phenomenon. 
Goldenberg and Pavia (1981, 1982), in reporting the appearance of 
malignant murine cells in xenografted human tumours stated that the 
phenomenon was only observed in human tumours first established in 
nude mice; tumours that resulted from the inoculation of established 
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human tumour cell lines did not induce stromal neoplasia. My results 
showed that their observations do not have general validity and that 
cell lines are, indeed, able to generate tumours that show "horizontal 
oncogenesis". 
In certain cases (Goldenberg et al., 1971) the cells from recipient 
tumours contained both human and animal (hamster or mouse) genetic 
elements as definitive proof of the fact that cell fusion had 
occurred. This has led to the suggestion that "transforming genes" 
had been transferred to host stromal cells to cause malignant change. 
These suggestions draw support from the fact that murine cells that 
have been transfected with DNA extracted from human tumours do grow as 
transformed cells in culture and are tumorigenic in mice (Cooper, 
1982; Shih and Weinberg, 1982; Weinberg, 1982). In most cases the 
transforming genes observed have proven to belong to the ras family 
(Der et al., 1982; Parada et al., 1982). 
It is also possible, as I have suggested above, and as first proposed 
by Ehrlich and Apolant in 1905 (Ehrlich and Apolant, 1905) that the 
UCT-Mel 7 cells either alone or acting in concert with host 
inflammatory cells, generated an oncogenic microenvironment by the 
release of mutagenic substances. 
Unfortunately I have no experimental data to contribute that might 
support either cell fusion or chemically induced mutagenesis as likely 
causes for cellular transformation . Tumour dormancy and horizontal 
oncogenesis are important features of neoplasia and it is my intention 
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to use the UCT-Mel 7:murine stromal cell system to examine this 
further with the modern genetic techniques that have recently become 
available. 
Southern blots of the DNA extracted from UCT-Mel 7-induced host 
tumours probed with human Alu probes, as was done by Shih and ~einberg 
(1982), would be an obvious and initial experiment to perform to 
identify human sequences and the possible human transforming genes in 
the ostensibly murine neoplasms that develop in vivo. 
Desmoplasia, defined as "the production of fibrous connective tissue 
within and surrounding a tumour" (Liotta, 1982; Robbins et al . , 1984) 
was a prominent feature of UCT-Mel 7 derived tumours as shown by the 
prominent presence of collagen and reticulin in the histological 
specimens; the high content of hydroxyproline in tumour hydrolysates; 
and the large numbers of murine stromal cells present in these tumours. 
Despite the prominence of stromal elements in so many human tumours, 
remarkably little effort has been made to assess its significance or 
to devise experimental models that could be used to elucidate its 
genesis. Seemayer et al. (1980) and Schurch et al. (1981) in recording 
the association of myofibroblasts with various neoplasms, suggested 
that proliferation of these stromal cells forms part of the host 
response to neoplasms - particularly neoplasms that are weakly 
antigenic and that grow slowly - and that this leads to containment of 
the tumour so that invasion and metastatic spread occur less readily 
(Schurch et al., 1981). It is interesting, in this regard, to note 
that of all the melanoma cell lines that I s ~udied, only UCT-Mel 7 
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cells gave rise to desmoplastic tumours and these were the only 
tumours that did not metastasize. 
The implicit conclusion to be drawn from these correlations is that a 
desmoplastic response is beneficial in the sense that it "curtails" 
dissemination of the tumour - a conclusion that is supported by the 
observations of others who have shown that the inhibition of the 
desmoplastic response to murine tumours by the administration of 
proline analogs (Barsky and Gopalakrishna, 1987) or corticosteroids 
(Takahashi and Biempica, 1985) increased the incidence of metastasis. 
On the other hand, as I have written previously (cf Introduction) 
clinical experience does not always attest to a beneficial 
relationship between desmoplasia and prognosis. 
The induction of an intense stromal response by UCT-Mel 7 derived 
tumours constitutes the major concern of the remainder of this thesis 
and is taken up in the chapters that follow. 
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CHAPTER 2 
THE EFFECTS OF MACROPHAGES ON 
COLIAGEN SYNTHESIS BY FIBROBIASTS 
When malignant cells are transplanted - either as a single cell 
suspension or as a tissue fragment - into a subcutaneous site in an 
experimental host, their development into a viable tumour is 
critically dependent upon the establishment of a stroma. This loosely 
defined mesenchyrnal structure represents the supportive contribution 
of the host to turnorigenesis and comprises a complex mixture of 
interstitial collagens, glycoproteins, proteoglycans, basement 
membranes and blood vessels (Liotta, 1982) . 
Solid tumours have an obvious and absolute requirement for an adequate 
blood supply and it is thus not surprising that the angiogenic 
component of stromal function has been emphasized in research into 
host:tumour interactions. Developments over the past decade , however, 
have increasingly drawn attention to other ways in which the stroma 
exerts important effects upon cellular behaviour. 
Stromal components are known, for example, to affect cellular 
morphology (Ben-Ze'ev et al., 1988; Blum et al . , 1987; Hay, 1982; 
Montesano et al., 1984; Sugrue and Hay, 1981), differentiation (Chen 
and Bissell, 1987; Fujita et al . , 1987; Reh et al., 1987 ; Spray et 
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a l . , 1987 ), substrate adhesion and patterns of migration (Grabel 
and Watts , 1987; Le Douarin , 1984) when added to in vitro cultures of 
diverse cell types. The most striking of these stromal influences, 
however, are those that involve synergistic interactions between 
cells, extracellular matrix (ECM) and growth factors. 
Experiments to determine the effects of ECM have usually involved 
plating cells on plastic surfaces that have been conditioned 
by prior treatment with isolated matrix components or an ex tract of 
basement membrane (Kleinman et al., 1987) or by co-cultivation of test 
cells with those, such as bone marrow stromal cells, that express 
matrix upon their plasma membranes (Gordon et al., 1987) . Enzymes 
such as heparinase or chondroitinase, that catalyse the degradation of 
specific macromolecules, have been used to identify the components of 
complex matrices that are responsible for the effects obtained. 
These approaches have been successfully used to show that ECM reduces 
both in amount and in numbers the need for growth factors to support 
optimum cell growth (Gatmaitan _et al., 1983). ECM, by binding growth 
factors , is able to sequester them for subsequent release (Folkman et 
al., 1988; Vlodavsky et al., 1987), to focus and present them to 
responsive cells (Gordon et al., 1987; Roberts et al., 1988) and to 
protect them from proteolytic degradation (Saksela et al., 1988). At 
a higher interactive level, the presence of ECM may modify or mediate 
the cellular response to growth factors (Madri et al. , 1988; Salomon 
et al. , 1981). 
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TGF-P, for example, inhibits the growth of endothelial cells plated on 
uncoated plastic; when added to the same cells plated on a collagen 
gel, it induces a proliferative response with the generation of a fine 
capillary network (Madri et al., 1988). The inhibition of endothelial 
cell grow.th by TGF-P, moreover, may well be an indirect effect mediated 
by fibronectin - an ECM component whose synthesis is induced by the 
growth factor (Madri et al., 1988). In the case of haemopoietic stem 
cells and endothelial cells, compounds such as heparan sulphate have 
been identified as the ECM component that synergises with GM-CSF and 
bFGF. 
In chapter 1 I recorded the observations I had made on the- cellular 
constituents of xenografted UCT-Mel 7 tumours and drew attention to 
the intense infiltration of these tumours with murine macrophages. 
Macrophages may influence the growth and behaviour of tumours in a 
number of ways (reviewed in Chapter 1). In this chapter I focus upon 
the possibility that macrophages exert an indirect effect upon tumours 
by modulation of extracellular matrix deposition and composition. 
UCT-Mel 7-derived tumours shows both macrophage infiltration and 
abundant ECM and thus provided the experimental and conceptual points 
of departure for these studies to proceed. 
Several reports attest to the degradative effects of macrophages on 
components of ECM. These cells release hydro~ytic enzymes such as 
elastase (Banda and Werb, 1981), collagenase (Werb and Gordon, 1975; 
Mainardi et al., 1980), and plasminogen activators (Unkeless et al., 
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1974), all of which have obvious relevance to the turnover of ECM and 
its remodelling. The plasminogen activators may provide local 
proteolytic activity for the activation of latent cellular 
collagenases (Werb et al., 1977). 
Macrophage products, such as prostaglandin E2 (Clark and Greenberg, 
1987; Wahl et al., 1977), IL-1 (Laato and Heino, 1988; Postlethwaite 
et al., 1983; Postlethwaite et al., 1988), TNF (Bertolini et al., 
1986; Dayer et al., 1985) and IFN-a (Duncan and Berman, 1987; Jimenez 
et al., 1984) may diminish collagen accumulation by inhibiting 
collagen synthesis in neighbouring cells or by increasing local 
cellular release of collagenases. Macrophage-derived factors are also 
known to inhibit fibroblast proliferation (Calderon et al., 1974; 
Kenyon et al., 1983; Korn et al., 1980). 
On the other hand, macrophages could, in theory, bring about an 
increase in ECM deposition. They are known, for example, to stimulate 
angiogenesis (Polverini et al., 1977), fibroblast proliferation 
(DeLustro et al., 1983; Glenn and Ross, 1981; Schmidt et al . , 1982) 
or collagen synthesis (Hibbs et al., 1983; Jalkanen et al, 1979; 
Jalkanen and Penttinen, 1982; Matsushima et al., 1985) either by 
released soluble factors or by direct cellular contact (Hibbs et al., 
1983). By increasing procoagulant activity in tumours (Guarini et 
al., 1984; Lorenzet et al . , 1983; Rambaldi et al., 1986) macrophages 
might increase local fibrin deposition (Rickles and Edwards, 1983) - a 
feature which is known to be associated with a desmoplastic response 
(Dvorak et al., 1981; Dvorak, 1986). 
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In more general terms, both clinical and experimental evidence exists 
to suggest a role for local macrophages as modulators of the 
fibroplasia that is seen in interstitial pulmonary fibrosis 
(Bittterman et al., 1982; 1983), progressive systemic sclerosis 
(Duncan and Berman, 1987; Korn, 1983; Worrall et al., 1986), 
rheumatoid arthritis (Pulkki, 1986) and other inflammatory conditions 
(Korn, 1980; Wahl, 1984). Wound healing is delayed by experimental 
manipulations that deplete macrophages or impair their function 
(Leibovich and Ross, 1975). 
It was for these reasons that I investigated macrophage:fibroblast 
interactions that might plausibly have been responsible for the 
desmoplasia that I observed in UCT-Mel 7 tumours. 
MATERIALS AND METHODS 
Cells 
Primary cultures of human fibroblasts were established, using standard 
procedures (Freshney, 1987), from fresh foreskins transported to the 
laboratory in tissue culture medium containing 5% FCS. 
The cultures were maintained in Dulbecco's modified Eagle's medium 
supplemented with 10% FCS (DB-10) and passaged as necessary. For 
experiments I describe in this thesis, the fibroblasts were used 
between passage numbers 4 and 10. 
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Two sources of murine macrophages were used:
 those obtained by 
peritoneal lavage and those of the cell line
, P388D1 . 
Resident mouse peritoneal macrophages were c
ollected from 6-8 week old 
female mice by lavage with 4-5 ml of DB-1. 
The cells were pelleted by 
centrifugation at 400g for 5 mins, washed on
ce in serum-free DB and 
adjusted to lxl06 peritoneal cells/ml of seru
m-free DB. 
For one experiment "elicited" peritoneal mac
rophages were harvested 
from animals in which a sterile peritonitis 
had been induced by 
inoculation of thioglycollate or other compo
unds. Details are given 
in the Results section. 
P388D1 is a mouse tumour lin
e originally isolated by Dawe and Potter 
(1957) from a methylcholanthrene-induced lym
phoid neoplasm (P388) in a 
DBA/2 mouse. It exhibits certain macrophag
e-like characteristics such 
as phagocytosis; Fe and complement receptors
; and cytotoxicity in an 
antibody-dependent, cell-mediated cytotoxic 
system. It lacks other 
attributes such as chemotactic responsivenes
s and the enzyme adenosine 
deaminase (Snyderman et al., 1977; Koren et 
al., 1975). I obtained 
the cells from Dr. Lutz Thilo in 1983. The 




Mice of the following inbred strains were obtained from stocks 
maintained in the UCT Animal House. 
C3H/He//UCT; BALB/c//UCT; DBA/2//UCT; CBA/Ca//UCT. 
Doubly deficient athymic nude mice designated 
UCT:NIH(S)II-nu/nu; and UCT:NIH(S)II-nu/+(furry heterozygotes) were 
obtained from stocks originally developed by Hansen (1977) and 
supplied by Dr. Giovanello, of the Cancer Research Laboratory, St. 
Joseph's Hospital, Houston, Texas. 
Co-culture of macrophages and fibroblasts 
Foreskin fibroblasts were plated at lxl05 cells/35mm tissue culture 
dish (Falcon 3001) in DB-10. When confluent (usually 2-3 days after 
plating) the culture medium was changed to serum-free DB containing 
25µg/ml ascorbate (Merck 127) and the cells incubated for 24 hours. 
The next day macrophages, (lxl06 peritoneal cells/35nun dish) harvested 
as described, were ~dded to the fibroblast cultures in serum-free DB 
containing ascorbate. The cells were co-cultured for 24 hours. 
Fresh ascorbate was then added and the cultures labelled for 16 hours 
with lOµCi/ml (3H]-Proline (Amersham TRK 323). The medium was 
collected and assayed for incorporation of radioactivity into newly 
synthesized collagen as described below. 
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Effects of peritoneal cells on fibroblast proliferation were 
determined directly by counting viable fibroblasts released from the 
plastic surface by trypsinization. The relative size of murine 
peritoneal exudate cells and human fibroblasts were such that I had no 
difficulty distinguishing them in the Neubauer counting chamber. 
Radioactive Collagen Synthesis 
Incorporation of [3H]-Proline into collagen was assayed by the method 
of Webster and Harvey (1979). Briefly: acetic acid was added to the 
medium to a final concentration of O.SM. Pepsin (Sigma P-7012) was 
then added to give a final concentration of O.Smg/ml and the samples 
incubated at 4°c overnight with shaking. Neutral salt-soluble rat 
skin collagen (Gross, 1958) was added to give a final concentration of 
166µg/ml. The radioactive and carrier collagen was precipitated, first 
at an acid pH and then at a neutral pH. The final precipitate was 
washed once with 20% ethanol and then dissolved in O.SM acetic acid 
for liquid scintillation counting. The results are expressed as dpm 
3H-incorporated/105 cells. 
Recovery of labelled collagen internal standards exceeded 90% and more 
than 90% of synthesized salt-precipitable radioactivity was 
collagenase sensitive. Incorporation of [3H]-Proline into collagen 
was linear with time over 24 hours (Fig. 1) and only about 1% of the 
total radioactive collagen in the dish was measured as intracellular 
collagen or deposited as a matrix adherent to the plastic surface; 
the remaining approximately 99% was found in the medium. Collagen 
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FIGURE 1 
Incorporation of [3H]-Proline into collagen 
[ 3H]-Proline (SµCi; Sµl) was added to confluent human foreskin 
fibroblast monolayer cultures (35mm dishes;± Sxl05 cells; 1 ml 
serum-free RPM! supplemented with 25µg/ml ascorbate) at time Oto 
provide a medium proline concentration of 0.17mM and a specific 
activity of 63.25xl06 dpm/µmole. The incorporation of [3H]-Proline 
24 
into collagen was measured, at the time points indicated, as described 
in the methods section. 
Each point represents the average of 3 dishes. 
The incorporation of [3H]-Proline into collagen was linear with time 
over 24 hours. 
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TABLE 1 
Collagen synthesis as a fraction of total protein synthesis 
Labelled 
substrate 
[ 3H] -Pro line 
(U-14C] -Protein 
hydrolysate 









Confluent foreskin fibroblast monolayers were covered with 1ml RP-10 
supplemented with 25µg/ml ascorbate and containing lOµCi [3H]-Proline or 
lOµCi uniformly labelled (U- 14C]-Protein hydrolysate (Arnersham CFB.25). 
After 16 hrs incubation, the incorporation of [3H] and [14C] into 
collagen and TCA-precipitable protein was measured. 
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protein and approximately 11% of a mixture of uniformly labelled 
[ 14C]-amino acids incorporated into TCA-precipitable material 
(Table 1) . 
The collagen produced was predominantly Type I with a small amount of 
Type III (Fig. 2). 
The amount of collagen produced per cell was dependent on the number 
of fibroblasts on the dish at the time of labelling . After reaching a 
peak as the fibroblasts reached confluency, cellular collagen 
decreased with increasing cell density (Fig. 3). The negative 
regression and correlation coefficient were significant at a level 
intermediate between p=0.001 and p=0 . 01. 
Collagenase assay 
Radioactive collagen substrate for the collagenase assay was prepared 
by adding SOµCi of [3H]-Proline (S.A. 15-40Ci/mmole; Amersham Cat. 
No . TRK 323) to 10 ml of RPMI-10 supplemented with 25µg/ml of ascorbate 
covering a confluent culture of Sx106 foreskin fibroblasts in a 10cm 
dish. The cells were incubated for 16 h after which rat-tail collagen 
(approximately 1 mg) was added to the conditioned medium . The 
collagen was precipitated as described above to yield 
trypsin-resistant collagenase-sensitive protein with a specific 
activity of approximately 150 000 dpm/µg . 
Collagenase was measured by a minor modification of Peterkofsky and 




Type of collagen produced by human foreskin fibroblasts 
Collagen synthesized by human foreskin fibroblast was labelled with 
25µCi [3H]-Proline for 16 hours. The labelled collagen was 
precipitated with ammonium sulphate, pepsin-treated, re-precipitated 
and then washed with 66% Ethanol. The final precipitate was dissolved 
in O.lN NaOH and electrophoresed on a 7% sodium dodecyl sulphate 
polyacrylamide gel in the presence or absence of P-mercaptoethanol 
(PME). The gel was dried and autoradiographed using Kodak 0-mat ARS 
film. 
The autoradiograph shows bands corresponding to ol(I) and o2(I) chains . 
The starred arrowhead marks the electrophoretic position of a band 
that was occasionally seen in reducing gels but not in non-reducing 
gels. This mobility and behaviour is typical of the ol(III) chain (cf 
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FIGURE 3 
Inverse relationship between fibroblast cell number and cellular 
collagen synthesis 
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This figure depicts the rate of cellular collagen synthesis as a 
function of the number of fibroblasts on the dish. Each point is the 
average of 3 experimental dishes . The regression line was fitted by 
the method of least squares and had a correlation co-efficient of 
- 0.425. The negative regression and correlation co-efficent were 
significant at a level intermediate between p- 0.001 and p=0.01. 
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10 OOOdpm of radioactive collagen in 1 ml of 0.15M NaCl in O. SM Tris 
HCl pH 7.5 . The assay mixture was incubated at 37°C for 24h. 
Collagen hydrolysed was estimated as the difference in 
salt-precipitable radioactivity, after the addition of carrier 
collagen, before and after incubation. 
Superinduction of P388D1 
P388D1 cells were superinduced by a minor modification of the protocol 
of Mizel and Mizel (1981) in which cells were plated at lxl06 cells/ml 
i n DB-1 . The following day 12-0-tetradecanoyl phorbol - 13-acetate 
( PMA; Consolidated Midlands Corporation , New York, USA; final 
concentration of lOµg/ml) and cycloheximide (Sigma C-6255; final 
concentration of lOµg/ml) were added for 5 hours at 37°c. Actinomycin 
D (Sigma A-4262; final concentration of lµg/ml) was added for the last 
hour. The cultures were then washed 4 times with DB and incubated for 
an additional 24 hours in DB-1. The superinduced conditioned medium 
was collected, centrifuged to remove cellular debris and stored at 4°c. 
RESULTS 
The addition of murine peritoneal cells to cultures of human foreskin 
f ibroblasts had no effect on fibroblast proliferation but induced a 
two-fold increase in the rate of fibroblast collagen synthesis 
(Fig . 4). Medium that had been conditioned for 24 hours by 
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FIGURE 4 
Effect of co-culturing with peritoneal macrophages on collagen 
synthesis by the fibroblasts 
Confluent fibroblast monolayers (approximately Sxl05 cells/35mm dish) 
were serum-starved for 3 days with daily medium changes. The cultures 
were then covered with medium or medium that had been conditioned by 
lxl06 peritoneal macrophages; or approximately lxl06 peritoneal 
macrophages were added to each dish. After 24 hours each dish 
received lOµCi [3H]-Proline. The cultures were processed for the 
measurement of [3H]-Proline incorporation into collagen after 16 hours. 
The graph depicts the experimental results represented as follows: 
Each point represents the average rate of fibroblast collagen 
synthesis in triplicate cultures without (left) and with (right) added 
macrophages or macrophage conditioned medium. The average results 
obtained in each experiment are connected by a line. Open circles and 
vertical bars indicate means and standard errors, respectively. 
Student's t test for paired observations gave a value oft 
corresponding to 0.001 < p < 0.002 for macrophages. Macrophage 
conditioned medium had no significant effect. 
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My failure to detect stimulatory activity in peritoneal 
cell-conditioned medium may have been due to a lack of activation of 
the peritoneal cells when these were incubated alone; co-cultivation 
may have stimulated them to release factors which then mediated the 
effect on fibroblasts. I accordingly collected supernatant medium 
from peritoneal cell:fibroblast co-cultures and added this to 
I 
confluent fibroblasts. Slight stimulation of collagen synthesis was 
observed at 'high concentrations (1:2 or 1:5) only (Fig. 5). 
Stimulation of collagen synthesis was directly related to the number 
of peritoneal cells added (Fig. 6); a maximal effect was seen at a 
peritoneal cell:fibroblast ratio of approximately 4:1. 
Resident peritoneal cells and peritoneal cells that had been elicited 
by a variety of inflammatory agents stimulated collagen synthesis to a 
similar degree (Fig. 7). 
Resident peritoneal cells from 6 different mouse strains stimulated 
collagen synthesis to an approximately equal extent and cells from 
athymic nude mice were as effective as those from heterozygotic litter 
mates or from other T cell sufficient strains (Fig. 8) ; 
Graphic analysis (Eisenthal and Cornish-Bowden, 1974) of the kinetics 
of praline incorporation into collagen, indicated that the effect of 
adding peritoneal cells was to increase the maximal velocity of 
collagen synthesis from 1.3 µmoles praline incorporated/108 cells/16 hr 
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Effect of fibroblast:peritoneal macrophage co-culture supernatants on 
fibroblast collagen synthesis 
Peritoneal cells (lxl06/ml) and confluent fibroblasts were co-cultured 
in 10 ml of serum-free DB for 48 hrs. The conditioned medium was 
collected, spun and tested at the dilutions indicated for their abiliy 
to stimulate fibroblast collagen production . The results are 
expressed as a percentage of the control values obtained when 
supernatants of fibroblast cultures were added to the confluent 
fibroblasts. 
At high concentrations (1:2 and 1:5) a slight stimulation of collagen 
production was observed. 
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FIGURE 6 
Dose-dependent stimulation of collagen synthesis by peritoneal 
macrophages 
Confluent fibroblast monolayers were deprived of serum for 2 days, 
after which peritoneal cells at increasing concentrations were added 
to the fibroblasts. 
After 24 hours, the cultures were labelled with lOµCi [3H]-Proline. 
The cultures were processed for the measurement of [3H]-Proline 
incorporation into collagen after 16 hours. 
Increasing numbers of macrophages resulted in an increase in the 
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FIGURE 7 
Effect of the state of activation of peritoneal cells on their ability 
to stimulate collagen synthesis 
Confluent fibroblast monolayers were deprived of serum for 1 day. 
Peritoneal cells, either resident or stimulated, were harvested from 
BALB/c mice and added to the fibroblasts at a concentration of 
Sxl05 cells/16mm well. The cells were co-cultured for 24 hours, 
labelled for 16 hours with SµCi (3HJ-Proline, after which the cultures 
were processed for the incorporation of radioactivity into collagen. 
Each point represents the average of the results of triplicate dishes 
for a single mouse. Bar heights represent the average of 3 mice . 




Starch (2X suspension) or Latex (1:1000 dilution) 5 days 
before · harvesting; 
Thioglycollate (3X broth) or lipopolysaccharide (60 µg/ml) 
4 days before harvesting; 
Foetal calf serum, 1 day before harvesting. 
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Comparative ability of peritoneal cells from different mouse strains 
to stimulate collagen synthesis 
Confluent fibroblast monolayers were deprived of serum for 2 days. 
Resident peritoneal cells from the different mouse strains were added 
to the fibroblasts at lxl06 cells/35mm plate. The cells were 
co-cultured for 24 hours and labelled for 16 hours with lOµCi 
[ 3H]-Proline for the measurement of collagen synthesis. 
The results are expressed as a X of the control values obtained when 
fibroblasts were cultured alone. Each point represents the mean value 
of the results obtained from 3 dishes in a single experiment. Bar 
heights indicate average values for all the experiments. 




synthetic process {approximately l . 7mM proline) was unaffected 
(Fig. 9). 
Lavage of the unstimulated peritoneal cavity of the mouse provides a 
limited number of cells of mixed composition with macrophages 
comprising only a variable proportion. The fibrogenic effects of 
soluble factors released by the macrophages present in such a cell 
population may thus have been quantitatively insignificant or obscured 
by the products of other cell types. I thus resorted to the use of 
macrophage-like cells of the P388D1 line in the hope that they would 
provide a relatively pure cell population that could be induced to 
release factors in amounts that would offer better opportunities for 
characterization. 
The addition of P388D1 cells to fibroblast cultures had no appreciable 
effect on [3H]-Proline incorporation but medium that had been 
conditioned by P388D1 cells did cause a consistent, though slight and 
variable (23% - 86%) increase in collagen synthesis (Fig. 10). 
Encouraged by these results, I added various compounds to the P388D1 
cultures in an attempt to induce them to release more of the factor(s) 
that stimulate fibroblasts to synthesize collagen. The effects of 
adding lipopolysaccharide to the P388D1 cells were unremarkable in 
this respect. Induction with PMA or superinduction with PMA, 
cycloheximide and actinomycin D {Mizel and Mizel, 1981), however, 
caused the unexpected release of potent inhibitors of collagen 
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FIGURE 9 
Lineweaver-Burk analysis of Proline incorporation 
In this figure the reciprocal of the rate of proline incorporation 
into collagen (µmoles proline/108 cells/16 hr) has been plotted as a 
function of the reciprocal of the proline concentration (mM) for 
graphic analysis according to the method of Lineweaver and Burk. 
Fibroblasts cultured in the presence of peritoneal macrophages 
(8x105/dish;•----a) and those cultured alone (A----A) showed similar 
apparent "Km" values (1.724mM) but different extrapolated maximal 
rates of incorporation (4.4 and 1.3 µmoles proline incorporated/108 





Effect on fibroblast collagen synthesis of P388D1 cells or conditioned 
media taken from these cells after stimulation 
Confluent fibroblast monolayers were serum starved for 2 days. The 
cultures were then treated by adding P388D1 cells or medium 
conditioned by lx106 of these cells cultured in 1 ml of DB after 
exposure to various compounds. Results are expressed as a percentage 
of the control values obtained from fibroblasts cultured alone. Each 
point represents the - results of individual dishes; -bar heights 
represent the average.- The labels signify additions as follows: 
Cells: 




lx106 P388D1 cells added to each 35mm dish. 
Medium conditioned for 24 hours by P388D1 cells , 
diluted 1:5 with fresh DB. 
P388D1 cells were stimulated with 20µg/ml 
lipopolysaccharide (LPS) for 48 hours and the 
conditioned medium added. 
P388D1 cells were stimulated with lOµg/ml PMA for 5 hr
s. 
The cultures were then washed and conditioned medium 
was collected over the next 24 hrs. 
P388D1 cells were treated with PMA (lOµg/ml) , 
cycloheximide (lOµg/ml) and actinomycin D (lOµg/ml) for 5 
hrs. The cultures were then washed and the medium 
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FIGURE 10 
Although the cultures of P388D1 cells were washed extensively after 
superinduction and before collection of the conditioned medium, it was 
none the less possible that the subsequent inhibition of fibroblast 
collagen synthesis could have been caused by carryover of trace 
amounts of PMA, cycloheximide or actinomycin D. I therefore titrated 
these compounds for their ability to inhibit collagen synthesis and 
found that 50% inhibitory concentrations of PMA, cycloheximide and 
actinomcyin D were l.2ng/ml, 56ng/ml and 7.6ng/ml respectively. 
These concentrations were in excess of those that could have been 
present in harvest fluids from the washed superinduced P388D1 cells. 
The inhibitor showed the following characteristics : it was retained by 
a dialysis membrane; relatively heat stable and capable of 
withstanding 56°c for 30 minutes, 80°c for 10 minutes or l00°c for 1 
minute without loss of activity; it was acid labile with loss of 
activity by exposure to pH 2.5 for 4h and very stable on storage, 
retaining its activity after 6 months storage at 4°c. 
Inhibition of collagen synthesis by superinduced conditioned medium 
was dose dependent (Fig. 11) and reversible (Fig. 12). Although some 
batch variation was seen, in most cases, superinduced conditioned 
media inhibited fibroblast collagen synthesis by 50% at a dilution of 
about 1 : 300 and was toxic (by trypan blue exclusion) at a dilution of 
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Dose-dependent inhibition of collagen synthesis by superinduced 
conditioned medium 
Superinduced P388D1 conditioned medium was prepared by treating the 
cells with PMA, cycloheximide and actinomycin Das described in the 
text and added to confluent fibroblast monolayers at the dilutions 
shown. After 24 hrs, the cultures were labelled for 16 hrs with lOµCi 
[ 3H]-Proline for the measurement of collagen synthesis. 
The rate of collagen synthesis in control cultures is indicated by the 
horizontal dashed line. Each point represents the average of the 
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FIGURE 12 
Reversibility of inhibition by superinduced conditioned medium 
The superinduced conditioned medium, diluted 1:10 in DB-1, was added 
to confluent fibroblast monolayers for 48 hours. The cells were then 
washed and incubated for the indicated times before labelling with a 
16 hr pulse of (3H]-Proline . Radioactive collagen was then 
precipitated and counted as usual. 
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The rate of collagen synthesis in control cultures is indicated by the 
horizontal dashed line. Each point represents the average of the 
r esults of 3 dishes . 
The effect of the superinduced conditioned medium is reversible. 
Collagen synthesis ,had reverted to control levels 24 hr after removal 
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Effect of superinduced conditioned medium on macromolecular synthesis 
Superinduced P388D1 conditioned medium was diluted 1:2 in DB-1 and 
added to confluent fibroblast monolayers . After 24 hrs of incubation 
the cultures were pulsed for 5 hrs with [3H]-Leucine, [3H]-Uridine or 
[ 3HJ-Thymidine (SµCi in each case). The cultures were then washed with 
PBS and the labelled macromolecules precipitated with 5% TCA (final 
concentration) for 30 min at 4°C. Precipitates were collected and 
counted as described in the text. 
Each point represents the results of individual dishes. 
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FIGURE 14 
Effect of superinduced conditioned medium on plasminogen activator 
activity released by fibroblasts 
Superinduced conditioned medium at the dilutions indicated was added 
to confluent fibroblast monolayers. After 48 hrs of incubation, the 
cultures were washed with DB and incubated for a further 24 hrs in 
serum-free DB. This conditioned medium was collected and assayed for 
plasminogen activator activity using a solid phase [1251]-fibrin assay 
(Wilson and Dowdle, 1978). 
Plasminogen activator activity in control cultures is indicated by the 
horizontal dashed line. Each point represents the average of the 
results obtained with 3 cultures. 
Plasminogen activator (PA) activity released by fibroblasts treated 
with superinduced conditioned medium at a dilution of 1:10 was 
moderately elevated relative to that released by control cultures. A 
significant depression of PA activity in fibroblast harvest fluids at 
all higher superinduced conditioned medium dilutions was seen. No 
effect of superinduced conditioned medium on fibroblast cell number 
(approximately 2.5-3xl05 per dish) was observed . 
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DISCUSSION 
The results that I report in this chapter confirm other reports that 
have shown that collagen synthesis by confluent in vitro cultures of 
fibroblasts is a constitutive process that is, to a limited extent, 
inducible by the addition of resident murine peritoneal cells. 
Although induced rates of synthesis were no higher than SOX to 300% of 
unstimulated background levels, it should be noted that collagen 
turnover is a slow process in vivo (Woessner, 1968). 
By making the simplifying assumptions that collagen breakdown is 
governed by a first-order rate constant Kd in the overall process that 
is described by the equation (6C/6t - KdC) and that peritoneal cells 
induce an increase (fiK5 ) in a zero order synthetic rate constant K5 , it 
can readily be shown that the change (fiC) in total collagen content at 
equilibrium is given by: 
If, as is implied by a slow rate of turnover, the Kd is low, a small 
change (fiK5 ) in synthetic rate would result in a relatively large 
change (fiC) in total collagen content at equilibrium. It is possible, 
therefore, that the magnitude of the stimulation in synthesis that is 
observed in vitro may have accounted for the extensive collagen 
deposition as seen in vivo. 
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I was consistently unable to confirm the reports of others (Hibbs et 
al., 1983; Jalkanen et al., 1979; Jalkanen and Penttinen, 1982; 
Matsushima et al., 1985) to indicate that mononuclear-cell conditioned 
medium contains soluble factors that induce collagen synthesis. 
It occurred to me that the state of "activation" of the peritoneal 
cell population may have had something to do with my inability to 
demonstrate the release of fibroblast-stimulating factors, but 
experiments to examine this notion were unhelpful. Peritoneal exudate 
cells that had been activated in vivo by various inflammatory agents 
did not appear to be any more effective than resident cells as 
stimulators of collagen synthesis (Fig. 7). Medium conditioned by 
co-cultivated peritoneal cells and fibroblasts, in which in vitro 
activation may have taken place, was marginally and inconsistently 
stimulatory. 
The effects of peritoneal cells on the kinetics of proline 
I 
incorporation into collagen (Fig. 9) showed, consistently, that the 
addition of these cells increased the maximal rate of collagen 
synthesis but had no effect upon the apparent "Km" of the process. To 
the extent that one may draw detailed conclusions from overall results 
of this sort, I interpret these findings as indicating that 
co-cultivation with peritoneal exudate cells had no effect upon 
proline transport into the fibroblasts or upon the affinity constants 
involved in the enzymatic conversion of proline to collagen. The 
effect was rather to recruit a greater number of cells into collagen 
synthesis or to mobilise a greater fraction of the protein cellular 
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synthetic machinery for the manufacture of this particular protein. I 
hope to resolve this question by examining the cellular induction of 
' 
collagen rnRNA by in situ hybridization. 
Murine macrophage responses to activating factors are known to be 
subject to genetic control: a fact that has been particularly well 
I 
documented in studies on the responses of C3H/HeJ mice to 
lipopolysaccharide (Sultzer, 1968). Strain variation has also been 
reported for BCG-induced activation of tumoricidal cytotoxic 
macrophages (Boraschi and Meltzer, 1979) and in the development of 
non-specific resistance to pathogens (Civil and Mahmond, 1978; Medina 
et al., 1975). I accordingly felt that it would be of interest if I 
could show str~in differences in the ability of murine peritoneal 
exudate cells to react to exposure to foreign fibroblasts by inducing 
collagen synthesis. Unfortunately (Fig. 8) the results of these 
experiments were uninteresting. 
Attempts to obtain larger amounts of a putative 
"fibroblast-stimulating" factor by superinduction of P388D1 cells led 
to the surprising discovery of a trypsin-sensitive, heat-stable, 
acid-labile substance that had a profound inhibitory effect upon 
collagen synthesis and upon the apparent release of plasminogen 
activator. 
The inhibition of collagen synthesis was selective in that it did not 
depress overall radioactive leucine incorporation into other proteins. 
The reduction of plasminogen activator activity may have been due to 
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the induction of a plasminogen activator inhibitor such as PAI-1 . This 
possibility has not been explored further. 
The identity of the inhibitor(s) induced by superinduction of P388D1 
cells is unknown. Similar selective inhibition of collagen synthesis 
has been reported for TNF (Bertolini et al., 1986) and IFN (Rosenbloom 
et al., 1984; Stephenson et al., 1985) . However IFN-~, the most potent 
of the IFNs, is a T cell product. IFNa, although also effective but to 
a lesser degree (Jimenez et al., 1984), is usually acid stable. 
Therefore it is unlikely that the inhibitor is IFN. The possibility 
that the inhibitor is TNF needs still to be investigated. 
P388D1 cells were initially chosen in the hope that this would provide 
a constant expedient source of stimulatory activity for fibroblast 
collagen synthesis. The unexpected discovery of a potent inhibitor of 
collagen synthesis, although interesting, was not pertinent to the 




THE EFFECTS OF UCT-MEL 7 CELLS 
ON COLIAGEN SYNTHESIS BY FIBROBIASTS 
In the previous chapter, I presented data to show that the induction 
of a desmoplastic response to melanoma cells could be mediated 
i ndirectly by macrophages. In this chapter , I address the question of 
whether or not tumour cells are able to interact directly with 
mesenchymal cells to elicit the deposition of extracellular matrix. 
The idea that neoplastic cells may influence the quantity and 
composition of ECM in the environment is by no means new . Iozzo 
(1984) and Liotta (1982) have suggested three possible ways in which 
this may take place: by direct synthesis of matrix components; by 
degradation of the matrix; or by induction of synthesis of matrix 
components by host cells . 
Generally speaking, malignant cells continue to produce matrix 
constituents characteristic of their normal untransformed state 
(Alitalo et al . , 1981) but, in most cases, at a reduced rate (Hakomori 
et al., 1984; Sandmeyer and Bornstein, 1979). Qualitative 
and quantitative exceptions to these general rules have, however, been 
reported . For example, SV-40 transformed cells and clones selected 
for their high tumorigenicity produce an abnormal heparan sulphate 
with a reduced degree of sulphation (Winterbourne and Mora, 1981). 
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Furthermore, overproduction of hyaluronate (Biswas and Toole, 1987; 
Toole et al., 1979) or failure to produce or maintain a complete basal 
lamina (Ingber et al., 1981) are well documented quantitative 
abnormalities of ECM synthesis that have been correlated with tumour 
invasiveness. 
There have also been reports of changes in the number of receptors for 
matrix components and in their cellular distribution. For example, 
neoplastic cells may show increased expression of laminin receptors 
which are no longer localized to the basal surface of the cell but are 
evenly distributed over the whole cell (Hand et al., 1985). 
The ability of tumour cells to degrade the ECM may be regarded as a 
pre-requisite for invasion and metastasis if the solubilization of 
microbarriers to tissue penetration is necessary for these processes 
to occur. Some tumours have been shown to synthesize increased 
amounts of proteases - such as Type 1- and Type 4- collagenases 
(Liotta et al., 1980; Woolley et al., 1980), endoglycosidases 
(Fiszer-Szafarz and Gullino, 1970; Kramer et al., 1982) or cathepsin B 
(Poole et al., 1978; Sloane et al., 1981) - that degrade matrix 
components directly. Other neutral proteases, such as plasminogen 
activators, may increase degradation indirectly by activating latent 
collagenases (Werb et al., 1977). 
Other tumours have the capacity to induce host mesenchymal cells to 
secrete matrix-degrading proteolytic enzymes. Basal cell carcinomas, 
f or example , have been shown (Bauer et al., 1977; 1979) to contain 
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high levels of collagenase, which is usually localized to the stroma 
and is not found associated with the tumour cells themselves. An 
explanation for this phenomenon is provided by the finding that 
extracts of basal cell carcinomas contained a 19 kD cytokine that 
stimulated collagenase synthesis by fibroblasts (Goslen et al., 1985). 
Biswas et al. (1982; 1985; 1987) have identified a 
collagenase-stimulatory protein that is localized in the plasma 
membrane of Bl6 melanoma cells. This interacts with fibroblasts 
(possibly with heparan sulphate molecules in the fibroblast-associated 
matrix) and leads to the induction of collagenase synthesis. 
Similarly, rabbit V2 carcinoma cells induce the synthesis of cathepsin 
B (Graf et al., 1981). 
Finally, tumours may modulate their environment by inducing the 
formation of excessive connective tissue around the neoplasm. The 
mechanisms involved are poorly understood but the evidence to date 
suggests that host stromal cells are induc.ed by tumour cells to 
synthesize increased amounts of ECM components. Increased amounts of 
collagen have been documented in human breast carcinomas (Barsky et 
al., 1982) and gastric carcinomas (Minamoto et al., 1988), in rat 
mammary carcinomas (Bano et al., 1983), in V2 carcinoma in rabbits 
(Haemmerli et al., 1985) and in BL6 melanoma grown in 18 month old 
C57BL/6 mice (Barsky and Gopalakrishna, 1987). Other matrix 
components that show similar increases include proteoglycans 
(Haemmerli et al ., 1985; Iozzo and Muller-Glauser, 1985; Iozzo et 
al., 1982) and elastin (Martinez-Hernandez and Catalano, 1980). 
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I ncreased levels of protease inhibitors may also contribute to the 
accumulation of matrix e . g. desmoplastic stroma surrounding human 
breast carcinomas contain high levels of inhibitors of both Type I and 
Type IV collagenases (Barsky and Gopalakrishna, 1986) . 
The idea that cells can influence adjacent cells is not limited to 
tumour:host interactions but occurs within normal situations as well. 
Cell-cell interactions are important for the development of hormonal 
responsiveness. This has been shown for the mammary gland (Heuberger 
et al., 1982; Haslam, 1986), retinal tissue (Saad et al., 1981) and 
embryonic urinary bladder (Cuhna et al., 1980) . Co-operative cellular 
interactions are also involved in regulating the synthesis of 
compounds such as prostaglandins in the endometrium (Gal et al . , 
1982); collagenase in fibroblasts (Johnson-Wint and Gross, 1978 ; 
1984) and proteoglycan synthesis and secretion by various cell types 
(Merrilees and Scott, 1980; 1981). 
For the most part, the inductive effect of neoplastic cells on 
mesencymal macromolecular synthesis has been deduced from the results 
of in vivo studies : very few attempts have been made (Knudson et al., 
1984; Merrilees and Findlay, 1985; Naito et al., 1984) to elucidate 
the mechanisms involved at a cellular or molecular level using an in 
vitro approach. 
The experiments that I report in this chapter were designed to use 
t his approach by co-cultivation of melanoma cells and fibroblasts and 
noting the effects of such co-culture on the rate of fibroblast 
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collagen synthesis. The results have shown that UCT-
Mel 7 cells were 
consistent in their ability to stimulate fibroblast c
ollagen synthesis 
by a mechanism that induced increased intracellular l
evels of collagen 
mRNA and that had an absolute requirement for intimat
e cell-cell 
contact. Elements of the ECM appeared to be importan
t as mediators of 
this effect: soluble factors did not appear to be inv
olved. 
MATERIALS AND METHODS 
~ 
Cell lines used in this chapter are: 
Human cells: 
-four melanoma· cell lines: UCT-Mel 1, UCT-Mel 2, UCT
-Mel 7 and 
RPMI 7272 (Bowes) 
-four breast carcinoma cell lines: MCF 7, ZR-75-1, M
DA-231 and T47-D 
-foreskin fibroblasts 
Animal cells: 
-mouse fibroblast line, 3T3-J2 
-rat embryo skin fibroblasts 
-Chinese hamster fibroblast line, Don 
Details of the cell lines are presented in the append
ix. 
Co-culture of UCT-Mel 7 cells and fibroblasts 
Foreskin fibroblasts were plated at lx10
5 cells/35mm dish in DB-10 and 
grown to confluence (3 days). At confluence, UCT-Mel
 7 cells 
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(3xlos;~smm dish) were plated on top of the fibroblasts in RPMI-10 and 
the cells were co-cultured for 24 hours. The next day, the medium was 
changed to serum-free RPM! containing 25µg/ml ascorbate and 220µg/ml 
praline (Merck 7434). The cultures were preincubated for 4 hours and 
then labelled for 16 hours with SµCi [3H]-Proline. The medium was 
collected and assayed for the incorporation of radioactivity into 
I 
newly synthesized collagen as described in the methods section of 
Chapter 2. The results are expressed as µmoles proline/108 cells/16h. 
Effects on fibroblast proliferation were determined by counting viable 
fibroblasts released from the dish by trypsinization. It was not 
possible to distinguish between fibroblasts and UCT-Mel 7 cells in the 
haemocytometer. All data presented for co-cultured fibroblasts were 
~ 
therefore calculated using the fibroblast cell number on the 
assumption that UCT-Mel 7 cells had no effect on fibroblast 
proliferation. 
Where the effects of various compounds were investigated, the 
compounds were added together with the melanoma cells at the start of 
the 24 hour incubation and were presented throughout the duration of 
the experiment. 
Monoclonal Antibody Production 
Monoclonal antibodies were raised against UCT-Mel 7 cells and against 
foreskin fibroblasts. BALB/c mice were immunized with 4xlos UCT-Mel 7 
cells or 3xl06 fibroblasts. The immune spleens were removed and the 
splenocytes fused with SP2 myeloma cells using standard hybridoma 
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fusion techniques (Campbell, 1984). The final clone selected and used 
to make ascitic fluid was specific to the cell type ag~inst which it 
was raised. The monoclonal antibody, oFIB - D7, recognized fibroblasts 
and not UCT-Mel 7 cells. The monoclohal antibody, oNM-Bl2, was 
specific for UCT-Mel 7 cells and did not recognize fibroblasts. The 
characteristics of the 2 monoclonal antibodies are summarised in 
Table 1. 
Conjugation of antibody to erythrocytes 
The monoclonal antibodies were conjugated to red blood cells according 
to the method of Parish and McKenzie (1978). Human or sheep 
erythrocytes were washed 4 times in saline. To 4 ml saline, containing 
up to 1.6 mg of the appropriate antibody, was added 250µ1 of packed red 
cells. To this · was added 0.4 ml of a 0.1% chromic chloride (BDH 10078) 
solution. The reaction was stopped after 5 minutes at room 
temperature by the addition of 7 ml of phosphate buffered saline 
(PBS). The conjugated erythrocytes were washed once in PBS and 
resuspended in 12.5 ml RPMI-10. They could be kept at 4°c for up to 
24 hours before use. 
Separation of a mixed cell population using conjugated erythrocytes. 
The conjugated red blood cells were used to separate a mixture of 
UCT-Mel 7 cells and fibroblasts . After 24 hours co-culture, the cells 
were released with trypsin, resuspended in RPMI-10, mixed with an 
equal volume of conjugated red 1blood cells and incubated at room 
temperature for 15 minutes. The cell mixture was layered onto a 
Ficoll-Hypaque cushion and spun at 1000g for 15 minutes. The pellet 
132 
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contained the conjugated red blood cells and the cells recognized by 
I 
the antibody conjugated to erythrocytes. The interface contained the 
cells not recognized by the antibody. The cells from the interface 
could be harvested and used in further experiments. A rapid and 
efficient separation of the 2 cell types was thus achieved. 
Extraction of RNA and Northern blot analysis 
Total RNA was extracted using guanidinium thiocyanate (Fluka 50990) as 
described by Chirgwin et al. (1979). The quality and quantity of the 
extracted RNA was checked by spectrophotometric analysis at 260nm and 
280nm. 
Twenty microgr~ms of RNA was heat denatured in formamide (Merck 9684) 
~ 
and electrophoresed in a 1.5% agarose gel containing 2.8M formaldehyde 
(BDH 10113) and transblotted electrophoretically onto nitrocellulose 
paper (Hybond N, Amersham RPN 303N) at 300mA for 16 hr in 25mM sodium 
' 
phosphate buffer pH 6.5 (Amersham booklet: Membrane transfer and 
detection methods). The RNA was fixed to the Hybond by a 5 min 
exposure to UV light on a standard UV transilluminator. 
The recombinant plasmids, Hf 677 (Chu et al.,1982) and Hf 32 (Myers et 
al. ,1981), containing cDNA sequences specific for human al(I) collagen 
gene and a2(I) collagen gene, respectively, were the gift of Dr. F. 
Ramirez, Rutgers Medical School, Piscataway, N.J. The recombinant 
plasmid, pHF PA-1 (Gunning et al. ,1983), containing cDNA sequences 
specific for human cytoplasmic p-actin, was the gift of Dr. I. Parker, 
University of Cape Town Medical School. The cDNA plasmid probes were 
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nick-translated with [32P)-dCTP (Arnersham PB 10205) using the Arnersham 
nick translation kit (Arnersham N5000). The nitrocellulose filters were 
incubated in prehybridisation buffer for 6 hr at 55°c. The 
nick-translated probes were denatured at 100°c for 5 min, cooled, and 
added to the prehybridisation solution. Following hybridisation for 
16 hr at 55°c, the RNA blots were washed extensively with washes of 
I 
increasing stringency. The final wash was in 0.5X SSPE containing 
0.1% SOS at 68°C for 15 min. The blots were then wrapped _in Saran 
wrap and put up for autoradiography at -80°C using X-ray film. 
Measurement of macromolecular synthesis 
After a 5hr pulse with [3H]-Leucine (SµCi/ml), [3H]-Uridine 
(5µCi/ml;lµg/m~) or [ 3H]-Thymidine (5µCi/ml;lµg/ml) the cultures were 
washed with PBS. The cells were released with trypsin and counted in a 
haemocytometer. Labelled macromolecules were then precipitated by the 
addition of ice-cold TCA (5% final cone). The TCA precipitate was 
collected on a filter and washed with ice-cold 5% TCA. The filter was 
dried overnight -'in a hot oven and the radioactivity measured in a 
liquid scintillation counter. 
RESULTS 
In the previous chapter, I reported experiments which showed that 
co-cultivation of fibroblasts and resident peritoneal exudate cells 
would induce fibroblast collagen synthesis in vitro. To look for a 
direct effect of melanoma cells, I co-cultivated melanoma cells and 
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human foreskin foreskin fibroblasts in the presence of [ 3H]-Proline 
and obtained the results summarised in Fig. 1 . 
Melanoma cells alone synthesized negligible amounts of collagen 
(0.1 µmoles proline/108 cells/16 hr); fibroblasts alone incorporated 
1.09 ± 0.1 µmoles proline/108 cells/16 hr. A mixture comprising of 
I 
3xl05 fibroblasts and 3xl05 melanoma cells incorporated 2.02 ± 0.2 
µmoles proline/108 cells/16 hr; had there been no interactive 
stimulation this mixture should have incorporated 1.19 µmoles 
proline/108 cells/16 hr. This synergistic effect was consistently 
seen in a total of 46 experiments . The differences observed were 
highly significant. 
Fibroblasts are known to produce both Type I and Type III collagen. 
Co-culture with UCT-Mel 7 cells induced increased synthesis of both 
Type I and Type III collagen (Fig. 2). 
In view of the well known fact that cells may interact in vivo and in 
vitro by paracrine mechanisms, I examined melanoma cell conditioned 
medium for the presence of factors that might influence the fibroblast 
collagen synthesis. These experiments (Table 2) showed consistently 
that the medium alone was devoid of stimulatory activity. A number 
of experiments were performed to exclude trivial explanations for my 
inability to detect a stimulatory factor: 
(i) The possibility that the released factors were labile was rendered 
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Effect of UCT-Mel 7 cells on fibroblast collagen synthesis 
This figure depicts the results obtained in replicate experiments in 
which fibroblasts and melanoma cells were cultured alone or together 
and the rate of collagen synthesis was measured. In all cases the 
cells were incubated in 35mm dishes under 1 ml of RP - 10 for a 
preliminary period of 24 hrs after which medium was removed and 
replaced with 1 ml of serum-free RPMI containing 5 µCi [3H]-Proline 
(2.087 mM). Radioactive collagen synthesized during this period and 
released into the medium was measured as described in the text. 
Fibroblasts cultured alone (43 experiments; triplicate dishes) were 
studied when they had reached confluence. Melanoma cells (9 
experiments; triplicate dishes) were plated at 3xl05 per dish and 
showed little increase in cell number over the ensuing 40 hrs. In the 
co-cultures (46 experiments; triplicate dishes) UCT-Mel 7 cells (3xld5 
per dish) were plated over confluent fibroblasts at the start of the 
preliminary 24 hr incubation period. 
The height of each bar represents average values for the collagen 
synthesis measured in terms of µmoles proline incorporated/108 cells/16 
hr. Error bars represent 1 s.e.m. 
The approximately 2-fold induction of collagen synthesis by the 
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FIGURE 2 
Type of collagen produced by fibroblasts cultured alone or with 
melanoma cells 
Fibroblasts and melanoma cells were cultured alone or together and 
labelled with [3H] -Proline as described in the legend to Fig. 1 save 
for the addition of 50 µCi of radioactive amino acid instead of 5µCi. 
At the end of incubation the radioactive collagen was pepsin treated 
and purified by two successive salt precipitations as described in the 
Methods section. The final precipitate was dissolved in 0.2M acetic 
acid and electrophoresed in a 7X polyacrylamide gel containing O.lX 
SDS with (lane 1-3) or without (lanes 4-6) reduction. After 
electrophoresis the gel was dried and exposed to autoradiographic film 
for 16 hrs. • 
Labelled arrow heads indicate the typical mobilities of the a chains of 
Type I and Type III collagen (the latter only seen in reducing gels) 
and the so-called p chain that represents a multimeric form of the a 
chains (Miller and Rhodes, 1982).The patterns obtained with melanoma 
cells alone (lanes 1 and 4; no visible collagen synthesis), 
fibroblasts alone (lanes 2 and 5) and fibroblasts and melanoma cells 
(lanes 3 and 6) are shown. 
Note that the fibroblasts synthesized mainly Type I collagen with 
small amounts of Type III. The apparent induction of collagen 
synthesis by the melanoma cells, as indicated by the more intense 
radioactive bands, although probably real is not quantitatively 
reliable since internal standards were not included in this 
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31 729 dpm 
37 682 II 
88 571 dprn 
92 416 dpm 
Footnotes to Table 2 
1. Conditioned medium was prepared by plating UCT-Mel 7 cells at 
3xl05/35mm dish in RP-10 and allowing them to reach 
semi-confluence. The cells were then washed with serum-free 
RPM!, covered with 1 ml of RPM! and incubated for 24 hr. At the 
end of this time the medium was collected, centrifuged to remove 
debris and particulate material and used immediately in 
experiments 2 and 3. For experiment 1, the medium was 
concentrated 7-fold with an Amicon stirred pressure cell using 
an ultrafiltration membrane with nominal molecular weight 
cut-off of 10 kD. The retentate was then used in the experiment. 
2. The effects of media on fibroblast collagen synthesis were 
measured .by adding, in each case, medium without added serum to 
35mm dishes containing confluent fibroblast monolayers. After 24 
hr [ 3H]-Proline (lOµCi/dish) was added and incubation continued 
for a further 16 hr. The radiolabelled collagen was then 
isolated and counted as described in the Methods section. 
3. In this experiment, non-radioactive proline was added to the 
m'edium to a final concentration of 2. 087mM to ensure that the 
concentration of the precursor amino acid would not be 
rate-limiting (cf. Fig. 6). In the other two experiments the 




under conditions of temperature and sterility that would favour 
preservation and by experiments in which fibroblasts and melanoma 
cells were co-cultivated in Cooper dishes in which the cells 
shared the same medium without being contiguous. In these 
experiments fibroblasts were plated on the bottom of the dish and 
the melanoma cells were plated on the under surface of the 
depressed lid (Fig. 3) in such a way that the two monolayers were 
separated by 4 mm. The results (Table 3) showed no effect of the 
melanoma cells on the fibroblasts. 'When the cells were ' 
co-cultivated under the same conditions but intimately mixed 
stimulation of collagen synthesis was seen. 
(ii) The medium was examined for the presence of collagenase 
that might have degraded released collagen. None was found. 
(iii) The possibility that stimulatory factors were released at 
too low a concentration to stimulate without the cumulative 
effect of prolonged exposure of the target cell to the 
factors was explored by testing a seven times concentrate 
of the melanoma cell conditioned medium. The concentrate 
was prepared in an Amicon stirred cell using a YMlO 
membrane with a nominal molecular weight cut-off of 10 kD 
(Amicon Corporation). A concentrate prepared in this 
manner had no effect (Table 2). 
(iv) The possibility that the release of fibroblast stimulatory 
factors by melanoma cells was not constitutive but only 
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FIGURE 3 
Diagrammatic representation of a Cooper dish 
The Cooper dish (Falcon Cat. No. 3009) is designed for the 
co-cultivation of cells such that they share the same medium but are 
not contiguous. Cells may be plated in the conventional manner on the 
bottom of the petri dish and also on the undersurface of the indented 
lid. Co-culture is then established by the simple expedient of 
transferring a lid containing one cell type to a bottom with the other 
cell type as an adherent monolayer. Sufficient medium is then added to 





Cooper dish experimentsl1l 
Expt No. Experimental Conditions121 [3H] -Proline 





1 a) UCT-Mel 7(10) Fib (3) 146 500 
b) Fib (3) 170 200 
c) UCT-Mel 7(10) 2 400 
2 a) UCT-Mel 7(10) Fib(2.6) 51 073 
b) Fib(2.6) 70 859 
c) UCT-Mel 7(10) 6 800 
3 a) UCT-Mel 7(10) Fib (2) 27 327 
b) Fib (2) 21 043 
4 a) Fibs (2) UCT-Mel 7(2.5) 53 716 
b) Fibs (2) 51 524 
5 a) Fibs (1) 47 855 
b) Fibs (1)+ 
UCT-Mel 7(1) 110 540 
6 a) Fibs (1) 14 213 
b) Fibs (1) + 
UCT-Mel 7 (1) 45 580 
7 a) Fibs(l) 26 291 
b) Fibs(l) + 
UCT-Mel 7(1) 61 173 
/ 
Footnotes to Table 3 
1. In these experiments co-cultivation of fibroblasts and UCT-Mel 7 
cells was achieved by plating one cell type on the bottoms and the 
other on the under-surface of the indented lids of Cooper dishes 
(Falcon Cat. No. 3009; see Fig. 3). Under these experimental 
conditions the two cell types shared the same medium separated by 
approximat
1
ely 4mm without cell: cell contact. 
2. In experiments 1-4, cultures were established by plating the 
requisite number of cells of each type on separate dishes, on 
bottoms or lids as indicated. After the cells had adhered, 
co-culture was estabiished by the simple expedient of transferring 
a lid containing one cell type to a bottom with the other cell 
type as an adherent monolayer and sufficient medium to ensure that 
both monolayers were adequately bathed. After 24 hrs of 
co-culture the medium was changed and the cells were co-cultivat~d 
in the pr~sence of medium containing [3H]-Proline for a further 24 
hrs. Radioactive collagen released into the medium was then 
measured as described in the Methods section. 
In experiments 5-7, fibroblasts were plated alone or mixed with 
UCT-Mel 7 cells. The number of each cell type plated is given in 
parentheses. 
3. The results in this table are given as radioactive proline 
incorporated into collagen rather than µmoles incorporated since 
the kinetic experiments (Fig. 6) had not yet been performed; no 
unlabelled proline was added to the medium and the specific 
activity of the precursor proline was uncertain. 
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induced by contact with fibroblasts was investigated by 
testing conditioned medium taken from co-cultures of 
melanoma cells and fibroblasts plated at ratios known to 
cause stimulation. Such conditioned medium had no effect. 
The kinetics of induction of collagen synthesis by co-cultivation 
with melanoma cells were studied in the experiments summarized in 
Fig. 4. The increase in the rate of collagen synthesis that was 
measured as a function of melanoma:fibroblast ratio showed a 
progressive increase up to a maximum of a two-fold stimulation 
observed at a ratio of melanoma cells:fibroblasts of 1:1. Higher 
ratios than this were less stimulatory. 
•. : , 
The addition of melanoma cells to confluent fibroblast monolayers 
caused an increase in the rate of collagen synthesis that was 
evident by the time the first time point was taken four hours after 
initiation of co-culture. Incorporation of [3H]-Proline into 
collagen continued at the same increased rate for the remainder of 
the duration of the experiment (Fig. 5). 
Induction of collagen synthesis by melanoma cells implied the 
existence of rate-limiting steps for the incorporation of proline 
into collagen in unstimulated fibroblasts. To obtain some idea of 
the nature of the kinetic constraints that were overcome by contact 
with melanoma cells, I performed the experiment in which I measured 
fibroblast collagen synthesis as a function of proline 
concentration in the presence and absence of melanoma cells. The 
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Number of UCT-Mel 7 cells added ( xJ0-5) 
FIGURE 4 
Dose-dependent stimulation of collagen synthesis by melanom
a cells 
Increasing numbers of UCT-Mel 7 cells were plated on top of
 confluent 
fibroblast monolayers (approximately Sxl0
5/35mm dish) and co-cultured 
for 24 hrs. The cultures were then labelled for 16 hr with
 SµCi 
[ 3H]-Proline and the supernatant processed for the measurem
ent of 
radiolabelled collagen. Each point represents the average 
of the 
results of 3 dishes. 
Increasing numbers of UCT-Mel 7 cells resulted in an increa
se in the 
stimulation of collagen synthesis by the fibroblasts. Max
imal 
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FIGURE 5 
Co-culture of fibroblasts and UCT-Mel 7 cells: collagen synthesis as 
a function of time 
Confluent fibroblast monolayers, either alone (A~~A) or as 
co-cultures with melanoma cells (a----•), were labelled with lOµCi 
[ 3H]-Proline and the culture supernatant harvested at the indicated 
time points for the measurement of radioactiave collagen. Co-cultures 
' 
60 
were established by plating UCT-Mel 7 cells (3xl05 cells/35mm dish) on 
the confluent fibroblast monolayers at time 0. 
Each point represents the average of the results of 3 dishes. 
Incorporation of proline into collagen was linear over 52 hours. The 
rate of incorporation was greater in the co-cultured fibroblasts than 
in the fibroblasts alone. 
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results, analysed graphically by the method of Lineweaver and 
Burke, are presented in Fig. 6. These show quite clearly that the 
effect of melanoma cells was to increase the apparent maximum rate 
of proline incorporation into collagen from 1.99 µmoles/10
8 cells/16 
hr to 4.89 µmoles/10 8 cells/16 hr. The apparent "Michaelis constant 
(Km)" for the reaction remained unchanged (1.08 mM in the absence 
I 
and 1.01 mM in the presence of melanoma cells). 
The effect of melanoma cells on fibroblast collagen synthesis was 
specific for collagen and not due to an increase in overall protein 
synthesis. Protein synthesis, as measured by [
3H)-Leucine 
incorporation, was studied in cells cultured alone or as 
co-cultures with melanoma cells. There was no stimulation of 
general protein synthesis in the fibroblasts that had been 
co-cultured with UCT-Mel 7 cells (Fig. 7). 
The effect of the melanoma cells on fibroblast collagen synthesis 
was not species specific, 
It is well known that the effects of certain growth factors, such 
as the interferons, are highly species specific, To test for 
similar specificity in my system, I examined the effect of the 
human melanoma cell line on collagen synthesis by fibroblasts 
derived from a number of other species. The results showed that 
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In this figure the reciprocal of the rate of proline incorporation 
into collagen (µmoles/10 8 cells/16 hrs) has been plotted as a function 
of the reciprocal of the proline concentration (mM) for graphic 
analysis according to the method of Lineweaver and Burk. 
Fibroblasts cultured in the presence of UCT-Mel 7 cells (3xl05/dish; 
•----•) and those cultured alone(•-----&) showed similar apparent 
"Km" values (1.01 and 1.08 mM, respectively) but different 
extrapolated maximal rates of incorporation (4.89 and 1.99 µmoles/10 8 
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Confluent fibroblast monolayers either alone or as co-cultures with 
melanoma cells were incubated in RP-10 for 24 hrs after which they 
were labelled for 4 hrs with [3H]-Leucine (SµCi/dish). The co-cultures 
were established by plating UCT-Mel 7 cells (3xl05/35mm dish) on 
confluent fibroblast monolayers at the start of the 24 hr incubation. 
The cells were released with trypsin and the co-cultured cells 
separated using antibody-conjugated erythrocytes as described in the 
Methods section. Radiolabelled protein was precipitated with TCA 
(final concentration SX), collected and counted as described in the 
Methods section. 
Each point represents values for individual dishes; bar heights 
represent the average. 
There was no stimulation of overall protein synthesis in fibroblasts 
that had been co-cultured with UCT-Mel 7 cells . 
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TABLE 4 
Effect of UCT-Mel 7 cells on collagen synthesis by fibroblasts of 
different species 
Source of fibs 
Human foreskin 
Rat embryo skin 












1. 085 (±0. 31) 
Confluent fibroblast monolayers were cultured either alone or as 
co-cultures with melanoma cells for 40 hr. For the last 16 hr of 
culture, SµCi [3H]-Proline was added. The supernatants were then 
processed for the measurement of collagen synthesis. The co-cultu
res 
were established by plating UCT-Mel 7 cells (3xl0
5/35mm dish) on 
confluent fibroblast monolayers. The results are expressed as µmo
les 
proline/108 cells/16 hrs. Values represent the average of the res
ults 
of triplicate dishes± 1 s.e.m. 
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The in vitro effect of melanoma cells on collagen synthesis was 
independent of passage number. 
The desmoplastic responses of nude mice to inocula of UCT-Mel 7 
cells in vivo showed a striking relationship to the melanoma cell 
passage number from which the inocula were prepared (Chapter 1) . 
Cells from early passage numbers were not fibrogenic in vivo; 
desmoplasia was seen maximally with inocula of cells from 20 - 30th 
passage; cells taken from in vitro passage number >50 produced 
tumours that were too small during the dormant phase to evaluate 
desmoplasia. A similar correlation between passage number and 
induction of collagen synthesis in vitro was not observed. 
Melanoma cells from early, middle and late passages were equally 
effective in this regard (Fig. 8). 
Other tumour cell lines also stimulated collagen synthesis but none 
as effectively as UCT-Mel 7. 
The results of in vivo studies with other melanoma cell lines 
showed that UCT-Mel 7 was particularly effective as an inducer of a 
desmoplastic response (Chapter 1, Figure 9). 
In view of this observation, I tested a number of other melanoma 
cell lines and cell lines derived from tumours that are known to 
elicit a desmoplastic response, for their ability to stimulate 
collagen synthesis in vitro. The results of these experiments 
(Fig. 9) showed that all of the cell lines tested increased 
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Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of in vitro passage number 
UCT-Mel 7 cells (3xl05/35mm dish) at in vitro passage numbers 7, 46 or 
56 were added to confluent fibroblast monolayers. After 24 hours of 
co-culture the cells were labelled for 16 hrs with 5µCi [ 3H]-Proline 
for the measurement of radiolabelled collagen. Average values (bar 
heights) and results for individual dishes (circles) are given. 
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Effect of other cell lines on fibroblast colla&en synthesis 
Confluent fibroblast monolayers were cultured either alone or as 
co-cultures with cell lines to be tested. After 24 hr of co-culture, 
the cells were labelled for 16 hrs with SµCi (3H]-Proline for the 
measurement of collagen synthesis. Co-cultures were established by 
plating the tumour cells (3xl05/3Srnrn dish) on confluent fibroblast 
monolayers. 
Each point represents the value for an individual dish of co-cultured 
cells expresse? as a percentage of the average value for triplicate 
dishes, in the · same experiment, in which fibroblasts were cultured 
alone. UCT-Mel 7, UCT-Mel 1, UCT-Mel 2 and RPMI 7272 are melanoma cell 
lines. MCF-7, ZR-75-1, MDA 231 and T47D are breast carcinoma cell 
lines. 
Co-culture with other tumour cells induced variable stimulation of 
collagen synthesis. With the exception of MDA 231, none was as 
effective as UCT-Mel 7. 
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was as effective as UCT-Mel 7 which consistently stimulated to an 
extent >two-fold (Fig . 1). 
Inhibition of protein synthesis but not of DNA synthesis interfered 
wi~h melanoma cell stimulatory activity, 
To investigate the extent to which the induction of collagen 
synthesis in fibroblasts required intact melanoma cell function, I 
pre-treated the melanoma cells with different inhibitors before 
adding the fibroblasts and noted the effects of such pre-treatment. 
In two experiments, UCT-Mel 7 cells that had been pre-treated with 
concentrations of mitomycin C that were sufficient to inhibit 
( 3H)-Thymidine incorporation completely, were nevertheless capable 
of inducing an . increase in fibroblast collagen synthesis that was 
equal to or, slightly greater than, the stimulatory effect seen 
with untreated melanoma cells (Table 5). To investigate the need 
for melanoma cell mRNA synthesis, I pre-incubated cultures of 
UCT-Mel 7 cells with actinomycin D for one hour at concentrations 
ranging from lOµg - 2.Sµg/ml. The cells were washed 3 times and 
fibroblasts added to measure the effect on collagen synthesis using 
the usual protocol . The concentration of actinomycin D required to 
inhibit the melanoma cell RNA synthesis were previously determined 
by titration (Fig. 10). In two separate experiments, I found that, 
despite extens·ive washing of the melanoma cell cultures, the 
actinomycin D treatment carried over a profound inhibitory effect 
on collagen synthesis to ' co-cultivated fibroblasts so that rates of 
incorporation of [3H]-Proline into collagen were reduced to levels 
approximately 1/10 of the level seen with unstimulated fibroblasts. 
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TABLE 5 






















UCT-Mel 7 cells (3x105/35mm dish) were treated with mitomycin C for 18 
hrs. The cultures were then washed with warmed RPMI (3xl0 mins) and 
fibroblasts (3xl05/35mm dish) were added. After 24 hr of culture the 
cells were labelled for 16 hr with 5µCi [3H]-Proline and the supernatant 
processed for the measurement of radioactive collagen. Values 
represent the average of the results of triplicate cultures. 
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0 2 4 6 
ACTINOMYCIN D ( fig/ml) 
FIGURE 10 
' Inhibition of RNA synthesis: titration of actinomycin D 
Semi-confluent UCT-Mel 7 cultures (± 3xl05 cells/35mm dish) were 
treated ;with actinomycin D for 1 hr at 37°C at the concentrations 
) 
shown. The cultures were then washed 3 times with RPM!, incubated for 
24hr in 1 ml RP-10, and for a further 4 hrs in the presence of 2µCi 
[ 3H)-Uridine. The cells were released with trypsin and the TCA 
precipitable material determined as described in the Methods section. 
Each point represents the average of the results of triplicate 




It was not possible, therefore, with this inhibitor to obtain 
useful data in my co-cultivation system. 
Cycloheximide is commonly used to evaluate the need for protein 
synthesis since this compound is a fairly specific inhibitor of 
peptidyl transferase, the ribosomal enzyme that forms peptide bonds 
(Alberts et al., 1983). Under other circumstances it would thus 
have been a useful reagent to establish the need for melanoma cell 
protein synthesis but, unfortunately, cycloheximide is a reversible 
inhibitor that would have been removed during the obligatory wash 
before the fibroblasts were added and thus have yielded equivocal 
results. Although it is commonly stated that puromycin is an 
irreversible inhibitor of protein synthesis, I found that 
puromycin at high concentrations (>10-6M) was toxic to the cells . 
Exposure to concentrations of 10-6M or less for 18hrs had no effect 
upon protein synthesis (Table 6). I, therefore, discarded 
puromycin as a potentially useful reagent. 
In my quest for a more suitable inhibitor, it occurred to me that 
glutaraldehyde may prove valuable. This compound, known for its 
efficacy as a · fixative, is also known to preserve cell surface 
enzymatic function (Poznansky, 1988) and, in many instances, to 
preserve antigenicity of labile cell surface epitopes (Adler et 
al . , 1985). Since the requirement for melanoma cell:fibroblast 
contact implied the possible interaction of viable fibroblasts with 
melanoma cell surface molecular structures, I felt that I might be 
able to determine a glutaraldehyde concentration that would 
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TABLE 6 






[ 3H]-Leucine incorporation 





UCT-Mel 7 cultures (5x105 cells/35mm dish) were treated with puromycin 
for 18 hr at the concentrations shown. The cultures were then washed, 
3 times with RPM!, incubated for 24 hr in 1 ml RP-10 and a further 5 
hrs in the presence of [3H]-Leucine (2µCi/dish). The cells were then 
released with trypsin and the radioactive protein precipitated with 
TCA (SX final concentration), collected and counted. 
Puromycin at concentrations> 10-s M were toxic for the cells. At 
concentrations~ 10-s M no effects on protein synthesis were seen. 
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preserve stimulatory capacity in melanoma cells that were no longer 
viable. I therefore studied the effects of various concentrations 
of glutaraldehyde on melanocyte macromolecular synthesis as 
measured by incorporation of [ 3H]-Thymidine and [ 3H]-Leucine. The 
results of these experiments showed that it was reproducibly 
possible to abolish DNA synthesis yet preserve approximately 60% of 
protein synthetic capacity by treating melanoma cells with 0.002% 
solution of glutaraldehyde in PBS for 5 min at room temperature 
(Table 7). 
I accordingly treated melanoma cell cultures with 0.002% 
glutaraldehyde, washed them extensively with PBS and blocked with 
O.lM glycine in RP-10 for 1 hr at 37°C to inactivate residual 
glutaraldehyde molecules. I then added the test fibroblasts. As 
can be seen from the results summarized in Fig. 11, melanoma cells 
in which DNA synthesis had been abolished by glutaraldehyde 
treatment but in which protein synthetic capacity was reasonably 
intact, were still capable of inducing fibroblast collagen 
synthesis. Higher concentrations of glutaraldehyde, that abolished 
melanoma cell protein synthesis, also abolished the stimulatory 
effect upon fibroblasts. No inhibition of fibroblast collagen 
synthesis was seen, when these cells were co-cultivated with 
melanoma cells exposed to 0.05% glutaraldehyde, 
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TABLE 7 
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UCT-Mel 7 cultures _(3xl05/35mm dish) were treated with glutaraldehyde 
for 5 mins at room temperature at the indicated concentrations. After 
washing with RPM!, reactive aldehyqe groups were blocked by incubating 
the cultures in lOOmM glycine in RP-10 for 1 hr at 37°C. The cultures 
were then incubated for 24 hrs in RP-10 before being pulsed for 4 hrs 
with [3H]-Thymidine or [3H]-Leucine (5µCi/dish in each case). The 
cultures were then washed with PBS and the radiolabelled 
macromolecules precipited with TCA (5% final concentration), collected 
and counted. 
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Effect of pretreatment of UCT-Mel 7 cells with glutaraldehyde on their 
ability to stimulate fibroblast collagen synthesis 
UCT-Mel 7 cells (3xl05/35mm dish) were treated with glutaraldehyde for 
5 min at room temperature at concentrations ranging from 0.002% to 
0 . 05%. After washing with RPMI, reactive aldehyde groups were blocked 
by incubating the cultures in lOOmM glycine in RP-10 for 1 hr at 37°C. 
Fibroblasts (3xl0 5/35mm dish) were then added and the cultures 
incubated for 24 hr before being labelled for 16 hr with SµCi 
[ 3H]-Proline for the measurement of collagen synthesis. Each point 
represents the values of individual dishes. Bar heights represent the 
average of the results of the triplicate dishes. 
UCT-Mel 7 cells treated with 0.002% glutaraldehyde - a concentration 
that partially inhibited protein synthesis but totally blocked DNA 
synthesis - retained their ability to stimulate fibroblast collagen 
synthesis. Higher concentrations of glutaraldehyde abolished the 
stimulatory effect of UCT-Mel 7 cells. 
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Effect of retinoids, dexamethasone. PMA and indomethacin. 
It has recently become clear that pharmacological modulators of 
cellular function may act synergistically with physiological 
stimuli to alter their effects in a biologically significant way. 
Glucocorticoids (Barouski-Miller and Gelehrter, 1982; Yoshikawa and 
Sabol, 1986) and tumour promoters (Pluznik and Mergenhagen, 1986; 
Kido et al., 1987) provide well documented examples of this 
phenomenon. I, thus, felt that it would be of interest to examine 
the consequences of adding these compounds to fibroblasts growing 
alone or in co-culture with melanoma cells. The results of these 
experiments are shown in Tables 8-11 and may be summarized as 
f ollows: 
(i) Dexamethasone at 10-5 M consistently and significantly 
inhibited fibroblast collagen synthesis (Table 8). The 
inhibitory effect was also evident at 10-7 M but only reached 
an acceptable level of statistical significance in 1 of the 3 
exp'eriments. Of interest is the fact that at 10-a M 
dexamethasone stimulated collagen synthesis in all 3 
experiments and in all cases this was significant at the 5% 
level or less. With the exception of 2 dexamethasone 
concentrations in one experiment, no significant interaction 
between melanoma cells and dexamethasone was observed 
indicating that the hormone had no major effect upon the 
ability of melanoma cells to stimulate collagen synthesis. 
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(ii) Retinoic acid at 10-7 Mand 10-a M significantly {p ~ 0.025) 
increased fibroblast collagen synthesis; 10-5 M had no 
effect (Table 9). At all concentrations of retinoic acid, 
there was no significant interaction between melanoma cells 
and retinoic acid. 
(iii) In one experiment indomethacin had no direct effect on 
fibroblast collagen synthesis (Table 10). At 10-a M, there 
was a significant {p < 0.005) interaction between 
indomethacin and UCT-Mel 7 cells; the compound augmented 
the increased rate of collagen synthesis induced by the 
melanoma cells. 
(iv) The phorbol ester, PMA, showed a highly significant 
dose-dependent inhibition of fibroblast collagen synthesis 
(Table 11). With the exception of one PMA concentration in 
one experiment, no significant interaction between melanoma 
cells and PMA was seen. 
The increase in collagen synthesis induced by melanoma cells did 
not appear to be an effect that was secondary to an effect on 
fibroblast proliferation. 
It is generally taken to be the rule that cellular proliferation 
and expression of the differentiated phenotype are inversely 
related. Inasmuch as collagen synthesis can be regarded as a 






Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of dexamethasoneC 11 ,,. , ~-, 
Expt UCT-Mel Concentration of Dex (M) 
No. 7 0 -6 -7 -8 p[3] 
1 - 1.111c21 0.619 0. 796 1.123 
+ 1. 849 1.911 2.669 2.400 <0.001 
. - -
p£ 41 (Dex) 0.05 NS 0.05 
pC 51 (Dex x Mel 7) 0.025 NS 0.05 
2 - 1.143 0.707 1.036 1.454 
+ 1.452 0.839 1.306 1. 964 <0.001 
p(Dex) <0.001 0.025 <0.001 
p(Dex x Mel 7) NS NS NS 
3 - 1.02 0.702 0.832 1 . 132 
+ 1.638 1.285 1.571 1.821 <0 . 001 
p(Dex) <0.005 NS <0.001 
p(Dex x Mel 7) NS NS NS 
Footnotes to Table 8 
1 . Confluent fibroblast monolayers were cultured with or without 
added melanoma cells in RP-10 containing the different 
concentrations of dexamethasone given. After 24 hr, media were 
replaced with serum-free media containing the same concentration 
of added compound and SµCi [ 3H]-Proline. After a further 16 hr of 
incubation, the dishes were processed for the measurement of 
radioactive collagen. To establish the co-cultures, UCT-Mel 7 , ~ 
cells (3xl05/35mm dish) were added to the confluent fibroblast 
monolayers at time 0. 
2. Figures in the table give the number of µmoles of [ 3H]-Proline 
fincorporated into collagen/108 fibroblasts/16 -hr. Each figure 
is the average of . the results of triplicate dishes. 
3. p values under this heading reflect the level of significance 
associated with the melanoma cell effect. 
4. p values in this row reflect the levels of signficance associated 
with the dexamethasone effect for each dexamethasone 
concentration relative to controls incubated in the absence of 
dexamethasone. 
5. p values in this row indicate the levels of significance for the · 
interaction between dexamethasone and melanoma cells. 
p values in this table were calculated using a standard two-way 
analysis of variance for triplicate dishes. Details of the analysis 






Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
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Footnotes to Table 9 
1. Confluent fibroblast monolayers were cultured with or without 
added melanoma cells in RP-10 containing the different 
concentrations of retinoic acid given. After 24 hr, media were 
replaced with serum-free media containing the same 
concentration of added compound and SµCi [ 3H]-Proline. After a 
further 16 hr of incubation, the dishes were processed for the 
measurem~nt of radioactive collagen . To establish the 
co-cultures, UCT-Mel 7 cells (3x105/35mm dish) were added to 
the confluent fibroblast monolayers at time 0. 
2. Figures in the table give the number of µmoles of [ 3H]-Proline 
incorporated into collagen/108 fibroblasts/16 hr. Each figure 
is the average of the results of triplicate dishes. 
3. p values under this heading reflect the level of significance 
associated with the melanoma cell effect. 
4. p values in this row reflect the levels of signficance 
associated with the retinoic acid effect for each retinoic acid 
concentration relative to controls incubated in the absence of 
retinoic acid. 
5. p values in this row indicate the levels of significance for 
the interaction between retinoic acid and melanoma cells. 
p values in this table were calculated using a standard two way 
analysis of variance for triplicate dishes. Details of the analysis 





Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
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Footnotes to Table 10 
1. Confluent fibroblast monolayers were cultured with or without 
added melanoma cells in RP-10 containing the different 
concentrations of indomethacin given. After 24 hr, media were 
replaced with serum-free media containing the same concentration 
of added compound and SµCi [ 3H]-Proline. After a further 16 hr of 
incubation, the dishes were processed for the measurement of 
radioactive collagen. To establish the co-cultures, UCT-Mel 7 
cells (3xl05/35mm dish) were added to the confluent fibroblast 
monolayers at time 0. 
2. Figures in the table give the number of µmoles of (3H]-Proline 
incorporated into collagen/108 fibroblasts/16 hr. Each figure is 
the average of the results of triplicate dishes. 
3 . p values under this heading reflect the level of significance 
associated with · the melanoma cell effect. 
4. p values in this row reflect the levels of signficance associated 
with the indomethacin effect for each indomethacin concentration 
relative to controls incubated in the absence of indomethacin. 
5. p values in this row indicate the levels of significance for the 
interaction between indomethacin and melanoma cells. 
p values in this table were calculated using a standard two way 
analysis of variance for triplicate dishes. Details of the analysis 





Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of PMAllJ 
Expt UCT-Mel Concentration of PMA(ng/ml) 
No 7 0 10 1 0.1 pl3) 
1 - 1.152121 0.291 0.557 0.936 
+ 2.024 0.511 1.094 1. 831 <0.001 
p(PMA) 14 1 <0.001 <0.001 NS 
p(PMA x Mel 7) (5) 0.025 NS NS 
2 - 0.886 0.142 0.483 1.001 
+ 1.058 0.541 0.738 1.244 <0 .001 
p(PMA) <0.001 <0.001 NS 
p(PMA x Mel 7) NS NS NS 
Footnotes to Table 11 
1 . Confluent fibroblast monolayers were cultured with or without 
added melanoma cells in RP-10 containing the different 
concentrations of PMA given. After 24 hr, media were replaced 
with serum-free media containing the same concentration of added 
compound and SµCi [ 3H)-Proline. After a further 16 hr of 
incubation, the dishes were processed for the measurement of 
radioactive collagen . To establish the co-cultures, UCT-Mel 7 
cells (3xl05/35mm dish) were added to the confluent fibroblast 
monolayers at time 0 . 
2. Figures in the table give the number of µmoles of [ 3H)-Proline 
incorporated into collagen/108 fibroblasts/16 hr . Each figure is 
the average of the results of triplicate dishes. 
3 . p values under this heading reflect the level of significance 
associated with the melanoma cell effect . 
4 . p values in this row reflect the levels of signficance associated 
with the PMA effect for each PMA concentration relative to 
controls incubated in the absence of PMA . 
5. p values in this row indicate the levels of significance for the 
interaction between PMA and melanoma cells. 
p values in this table were calculated using a standard two way 
analysis of variance for triplicate dishes. Details of the analysis 
are given in the Appendix (Table A. 6 to A.8). 
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actively dividing cells synthesize less collagen than those that 
were quiescent. By the same argument melanoma cells, if they were 
to inhibit fibroblast growth, might stimulate collagen synthesis. 
With this possibility in mind, I did a number of experiments 
designed specifically to examine the effects of co-cultivation with 
melanoma cells on fibroblast proliferative potential. 
Fibroblast and melanoma cells were plated at a ratio of 1:1 so that 
each 35 mm dish contained 5x104 fibroblasts. Control dishes 
contained an equivalent number of fibroblasts alone. At time 
points taken 1, 3, 4, 7 and 8 days after plating, the cells were 
released with trypsin and counted. In the mixed cultures 
fibroblasts were separated from melanoma cells by rosetting with 
monoclonal antibody-coated erythrocytes as described in the methods 
section. The melanoma cells had no effect upon the fibroblast 
growth rate (Fig. 12). 
Inductive effects mediated by cell:cell contact. 
As I have indicated in my account of the experiments performed up 
to this point, I was unable to detect a soluble factor that was 
released by melanoma cells that could be held responsible for the 
induction of collagen synthesis. It remains to consider other ways 
in which melanoma cells could have exerted their effects without 








Effect of co-culture on the growth rates of UCT-Mel 7 cells and 
fibroblasts 
Fibroblasts and UCT-Mel 7 cells were plated separately or as mixed 
cultures in 35mm dishes on Day O and the medium (1ml of RP-10) was 
changed on days 2, 3, 5 and 7. The cells in duplicate dishes were 
released with trypsin, separated using antibody-conjugated 
erythrocytes and counted at the indicated times. 
The figure shows the growth curves of: 
1. Fibroblasts, alone•~-• 
2 . Fibroblasts, co-cultured with UCT-Mel 7 cells •----11 
3. UCT-Mel 7, alone +·····+ 
4. UCT-Mel 7, co-cultured with fibroblasts •---• 
Co-culture of the fibroblasts and melanoma cells had no effect on the 




Three broad possibilities come to mind. Firstly, it is well known 
that intimate contact between cells may lead to the establishment 
of gap junctions and cytoplasmic fusion. This process has been 
most strikingly demonstrated by complementation experiments 
involving co-cultivation of two mutant cell types each deficient in 
their ability to perform a different step in a metabolic process. 
The passage of low (ca 1000 daltons) molecular weight metabolite 
intermediates through the junctions reconstitutes the net synthetic 
process (Davidson et al., 1984). Although not strictly analogous, 
it is nonetheless conceivable that gap junctions established 
between UCT-Mel 7 cells and fibroblasts could have transported 
stimulatory molecules to induce collagen synthesis. Such molecules 
could have exerted their effects without necessarily being detected 
in the medium. 
Secondly, it has recently become apparent from a consideration of 
immunological phenomena that cell types may deliver biological 
signals to each other through the medium of surface molecules that 
are integral membrane proteins. It is known, for example, that the 
lymphocyte T cell receptor:CD3 complex responds to MHC Class I or 
Class II proteins in association with antigenic fragments that are 
presented on the cell surface. Similarly, cellular adhesion 
molecules function as mediators of mutual cellular information 
transfer during the course of embryogenesis, morphogenesis and 
histogenesis (Edelman, 1986; Thiery et al., 1985). It is 
therefore possible that UCT-Mel 7 cells possess integral surface 
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structures that are recognized by fibroblasts and transduced into 
effective signals for collagen synthesis. 
Thirdly, it is now well known that intercellular communication in a 
number of interacting systems is mediated by components of the ECM. 
Although an entirely satisfactory model to unify the biochemistry 
of cell:ECM interactions has yet to be developed, a number of 
impressive experiments (Liotta, 1986; Fransson, 1987; Le Douarin, 
1984; Watt, 1986; Gospodarowicz and Greenburg, 1981) have suggested 
ways in which this might occur. ECM components (e.g. heparan 
sulphate) may bind to growth factors or biologically active 
molecules without compromising their activity. By sequestration, 
the local half-lives of the growth factors are prolonged; they are 
protected from proteolytic degradation; and they are concentrated 
on cellular surfaces or other substrata and so depleted from the 
surrounding fluid phase (Roberts et al., 1988; Gordon et al, 1987; 
Folkman et al., 1988; Vlodavsky et al., 1987; Saksela et al., 
1988). 
Experiments that have demonstrated these effects of ECM components 
have generally used a number of approaches to identify ECM:growth 
factor interactions. Heparin, as a close analogue of heparan 
sulphate, proved to be a valuable reagent for the affinity 
purification of fibroblast growth factor and has been shown by a 
number of workers to exert biological effects in cellular systems 
where fibroblast growth factor is active (Uhlrich et al., 1986; 




Others have used enzymes that specifically degrade ECM 
components (such as hyaluronate, chondroitin sulphate, heparan 
sulphate, collagen etc.) to abrogate the effects of added growth 
factors on cellular function. 
Research in haemopoietic growth factors has benefitted from 
experiments in which, for example, GM-CSF could be released from 
its bound state by extracting the ECM:growth factor complex with 
dissociating agents such as 2M sodium chloride, KSCN or high 
concentrations of arginine (Gordon et al., 1987). The biological 
activity of the depleted ECM could be restored by adding back 
growth factor and washing. 
It is known that cellular behaviour may be modified by associations 
with ECM that are mediated by soluble macromolecules, such as 
I 
fibronectin, that engage cellular receptors belonging to the 
recently recognized "integrin" superfamily. Evidence for 
interactions of this sort is usually derived from experiments in 
which small fragments of the binding molecules (usually 
oligopeptides containing the tetrapeptide sequence Arg-Gly-Asp-Ser) 
are shown to inhibit cellular associations or biological effects 
(Grabel and Watts, 1987; Pierschbacher and Ruoslahti, 1984). 
Finally, during the past decade a number of biologically active 
peptides have been identified that have a profound effect upon the 
function of fibroblasts and other cell types (Gospodarowicz, 
1987) . These so-called "fibroblast growth factors" (FGFs) have 
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strong historical and experimental associations with ECM and 
heparin - indeed, their strong affinity for heparin was effectively 
used as a means for their purification - and it is well recognized 
that ECM may have profound effects upon the morphology and function 
of cells cultured in vitro. These known associations between ECM, 
its component proteoglycans and FGFs suggested the possibility that 
they might be involved in the melanoma cell:fibroblast interactions 
that I have observed: a suggestion that was emphasized by the 
apparently absolute requirement for the intimate cell:cell contact 
this interaction required. 
With these considerations in mind, I performed a number of 
experiments to explore cell contact events as possible causes for 
the melanoma:fibroblast effects that I had seen. The results of 
these may be summarized as follows: 
Gap junction inhibitors had no effect on melanoma cell induction of 
fibroblast collagen synthesis. 
In a series of elegant experiments using co-cultivated fibroblasts 
from two patients - one with argininosuccinate synthetase 
(ASS)-deficiency and the other with argininosuccinate lyase 
(ASL)-deficiency - Davidson and his associates (1986) were able to 
show that a-glycyrrhetinic acid is a potent inhibitor of gap 
junctions. I accordingly performed the experiments in which 
melanoma cells and fibroblasts were co-cultured in the presence or 
absence of various concentrations of glycyrrhetinic acid, including 
those that were known to inhibit complementation of Ass- and ASL-
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cells . Appropriate control experiments were done to ensure that 
the inhibitor was not toxic or inhibitory in the non-specific 
sense. The results showed no effect of the inhibitor (Fig. 13). 
bFGF, heparin and melanoma cells acted synergistically to modulate 
fibroblast collagen synthesis. 
To investigate the possible involvement of bFGF and ECM, I started 
with a series of preliminary experiments to define experimental 
conditions. The results of these, in swnmary, were as follows: 
a) bFGF (2.Sng/ml - 40ng/ml) consistently inhibited fibroblast 
collagen synthesis and stimulated fibroblast proliferation in a 
dose-dependent manner. The results of a typical experiment are 
presented in Fig. 14. 
b) Heparin was somewhat inconsistent in the magnitude of the 
effect that it produced. Two stock solutions were prepared, one 
of which (Table 12 Expt. 1) inhibited collagen synthesis at 
concentrations as low as Sµg/ml whereas the other (Table 12 
Expt. 2) had no significant effect upon collagen synthesis, 
producing only minimal inhibition at lOµg/ml. In subsequent 
more definitive experiments, however, both preparations 
inhibited significantly at lOµg/ml (Table 13). 
Much of the interest in the actions of FGFs and ECM lies not so 
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FIGURE 13 
Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of the gap junction inhibitor. glycyrrhetinic acid 
---
Confluent fibroblast monolayers were cultured either alone (A-.~-•) 
or as co-cultures with melanoma cells (a----•) in RP-10 containing 
the indicated concentrations of glycyrrhetinic acid for 24 hrs. 
After a further 16hr of incubation in serum-free RPMI containing SµCi 
[ 3H]-Proline and the inhibitor, the dishes were processed for the 
measurement of collagen synthesis. To establish the co-cultures 
UCT-Mel 7 cells (3xl0 5/35mm dish) were plated on confluent fibroblast 
monolayers at time 0. 
Each point represents the average of the results of triplicate 
dishes. Error bars represent 1 s.e.m . 
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The effect of bFGF on fibroblast collagen synthesis and proliferation 
The figure shows the results of a typical experiment in which 
confluent fibroblast monolayers were incubated with recombinant bFGF 
at the indicated concentrations for 24 hr. The cultures were then 
labelled for 16 hr with SµCi [3H]-Proline for the measurement of 
collagen synthesis. 
Each point represents the average of the results of 3 dishes. Error 
bars represent 1 s.e.m. 
bFGF caused a dose-dependent inhibition of fibroblast collagen 











































Confluent fibroblast monolayers were incubated for 24 hr in RP-10 
containing heparin at the indicated concentrations and then for a 
further 16 hr in RPMI containing SµCi [3H]-Proline. The culture 
supernatants were processed for the measurement of radioactive 
collagen. 
Each value represents the average of the results of triplicate 
cultures . 
Heparin was somewhat inconsistent in the magnitude of the effect that 
it produced. In experiment 1, it inhibited fibroblast collagen 
synthesis. In experiment 2, it produced only minimal inhibition at 
lOµg/ml . 
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interact . Since it is well recognized that experiments that are 
designed on a factorial basis are most suitable for the detection 
of such interactions (Bailey, 1959; Brownlee, 1957). 
I planned the following series of experiments in such a way that 
triplicate cultures were exposed to all possible combinations of 
treatments at 2 levels of each factor (i.e. UCT-Mel 7 cells, bFGF 
and heparin). The results are presented in detail in the Appendix 
and in summary in Table 13 together with p values calculated from 
the standard 3-way analysis of variance (Bailey, 1959; Brownlee, 
1957) to indicate the significance of the primary and synergistic 
effects that were observed. 
Although the magnitude of the effects in each of the 2 experiments 
differed, the results were surprisingly reproducible and allowed 
the same conclusions to be drawn. These may be summarized as 
follows:-
(i) UCT-Mel 7 cells, as previously observed, stimulated collagen 
synthesis. 
(ii) bFGF inhibited collagen synthesis when added at 2.5 or 40 
ng/ml. 
(iii) heparin, when added at 10 or 20µg/ml, inhibited collagen 
synthesis. 
(iv) UCT-Mel 7 cells synergized with bFGF in the sense that the 
effect of the melanoma cells was significantly less marked in 




LEGEND TO TABLE 13 
In considering the results of these 11 2311 factorial experiments it is 
convenient to define the three "treatments" or "factors" as Mel, Hep 
and FGF representing UCT-Mel 7 cells, heparin and bFGF, respectively, 
each applied at two levels. Treatment combinations may then be 
depicted as Mel, Hep, FGF, Mel/Hep, Mel/FGF, Hep/FGF, Mel/Hep/FGF and 
Con where "Mel" signifies treatment with UCT-Mel 7 cells alone; 
Mel/Hep signifies treatment with UCT-Mel 7 cells in the presence of 
heparin etc; and Con signifies controls with no treatments applied. 
The 23 factorial design is conveniently portrayed as a "cubic" 
diagram showing the treatments as points on the corners of a cube (as 
shown in Figure). Reference to this diagram will help to clarify the 
notation used and illustrates the fact that each corner of the cube 
is related to its 
appropriate control by a single edge. 
Hep 
Con 
The primary effects are calculated as follows: 
(i) UCT-Mel 7 cells 
l/4(Mel + Mel/FGF +Mel/Hep+ Mel/Hep/FGF) - l/4(Con + FGF +Hep+ 
Hep/FGF) 
(ii) Heparin 
l/4(Hep +Mel/Hep+ Hep/FGF + Mel/Hep/FGF) - l/4(Con +Mel+ FGF + 
Mel/FGF) 
(iii) bFGF 
l/4(FGF + Mel/FGF + Hep/FGF + Mel/Hep/FGF) - l/4(Con +Mel+ Hep+ 
Mel/Hep) 
The interactions are calculated as follows: 
(i) UCT-Mel 7 x bFGF 
l/2(Con + Hep) - l/2(Mel + Mel/Hep) - l/2(FGF + FGF/Hep) + 
l/2(Mel/FGF + Mel/FGF/Hep) 
(ii) UCT-Mel 7 x Heparin 
l/2(Con + FGF) - l/2(Mel + Mel/FGF) - l/2(Hep + Hep/FGF) + 
l/2(Mel/Hep + Mel/FGF/Hep) 
(iii) Heparin x bFGF 
l/2(Con + Mel) - l/2(Hep + Mel/Hep) - l/2(FGF + Mel/FGF) + 
l/2(Hep/FGF + Mel/Hep/FGF) 
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TABLE 13 
Fibroblast collagen synthesis: effects of bFGF heparin and UCT-Mel 7 
cells. Summary of experimental results 111 
Primary effectsC21 
Expt. 1 














Fibroblast collagen synthesis 
(umoles proline/10~ cells/16hr) 
+ I:>. pC31 
0.600 +0.205 <0 . 001 
0.308 -0.381 <0.001 
0.190 -0.615 <0.001 
0. 776 +0.308 <0.001 
0.440 -0.364 <0.001 
0.510 -0.224 <0.001 
1. These tables summarize the results of factorial experiments in 
which triplicate dishes containing confluent fibroblast monolayers 
were treated with all possible combinations of melanoma cells, 
heparin and recombinant bFGF at the concentrations· indicated. After 
40 hrs of culture, during the last 16 hrs of which the c~lls were 
labelled with 5µCi [3H]-Proline, the cultures were processed for the 
measurement of collagen synthesis. The tables were construd::ed from 
data presented in Table A.9 in the Appendix. 
2. Primary effects and interactions were calculated as defined in the 
legend. 
3. p values indicate the level of significance attributable to 
observed differences due to the compounds themselves. 
4 . p values for the interactions referred to the level of 
significance of the synergistic effect. p values were calculated 
from the 3-way analysis of variance for triplicate samples presented 
in the Appendix (Table A.10). 
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Interactions 
Fibroblast collagen synthesis 
(µmoles proline/108 cells/16 hr) 
(i) UCT-Mel 7 x FGF 
bFGF n ml 
0 
3xl01 Mel 7 cells 
!!.' 
!!." 
(ii) UCT-Mel 7 x Heparin 
He ml 
0 
3xl01 Mel 7 cells 
!!." 
(iii) Heparin x bFGF 








0 . 975 0.220 
0 . 340 0.070 
-0.270(<p0 . 00l)l4] 
0 












0 . 455 0.160 















0 . 506 
0 . 382 
-0.104(p<0.001) 
Expt. 2 
0 2 . 5 
0.865 0.743 




can be given the alternative emphasis of stating that bFGF 
inhibited collagen synthesis more profoundly in the presence 
of melanoma cells than in their absence. 
(v) UCT-Mel 7 cells and heparin acted synergistically in much the 
same way as melanoma cells and bFGF since the inhibitory 
effects of heparin were more pronounced in the presence of 
melanoma cells or, alternatively, the melanoma cells were 
signficantly less stimulatory in the presence of heparin than 
in its absence. 
(vi) As expected, heparin and bFGF showed a significant 
synergistic inhibitory interaction. 
It is of interest to note that the magnitude of the effect induced 
by bFGF was sensitive to the protocol used (Table 14). When bFGF, 
at 2.Sµg/ml, was added to confluent fibroblast monolayers that had 
been established in the absence of bFGF, the average inhibition of . 
collagen synthesis(~ - -0.245 µmoles proline/108 cells/~6 hr) was 
minimal and the interaction between UCT-Mel 7 cells and bFGF not 
significant. Use of a different protocol, however, in which .the 
bFGF was added, together with the fibroblasts, to established 
monolayers of UCT-Mel 7 cells resulted in a highly significant and 







Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of recombinant bFGfCll 
Additions 
Expt. 1. CZl 
(a) None 
(b) bFGF 
(c) UCT-Mel 7 
(d) bFGF + UCT-Mel 7 
Collagen synthesisC4l 
(µmoles proline/10~ cells/16 hr) 
0.564 0.637 0.485 
0.467 0.583 0.628 
1.045 1.138 1 . 320-
0.969 0.810 0.998 





0 . 926 
ii) Effect of UCT-Mel 7 (c + d) - (a+ b) - 0.973 (p < 0.001) 
iii) Interaction (a - b) - (c - d) - -0.239 (NS) 
Expt. 2(3] 
(a) None 1.464 1.702 1.538 1.568 
(b) bFGF 0.558 0.429 0.528 0.505 
(c) UCT-Mel 7 2.547 2.214 2.537 2.432 
(d) bFGF + UCT-Mel 7 1.573 1. 318 1. 550 1.480 
i) Effect of bFGF (b + d) - (a+ c) - -2.015 (p <0.001) 
ii) Effect of UCT-Mel 7 (c + d) - (a+ b) - 1.839 (p <0 . 001) 
iii) Interaction (a - b) - (c - d) - 0 . 111 (NS) 
Footnotes to Table 14 
1. These two experiments, both of which were designed to examine the 
effect of bFGF on melanoma cell stimulation of collagen synthesis, are 
presented to demonstrate the sensitivity of the experimental system to 
the protocol that is used. In experiment 1, melanoma cells and bFGF 
are added to confluent fibroblast monolayers that had been established 
in the absence of bFGF. In experiment 2, it was the melanoma cells 
that were established cultures and fibroblasts and bFGF were added to 
these monolayers. 
2. Confluent fibroblast monolayers(± 6xl05/35mm dish) were washed and 
covered with 1 ml of RP-10 containing 3xl05 UCT-Mel 7 cells and 2.Sng 
bFGF in the various combinations shown. The cultures were incubated 
for 24 hrs followed by 16 hrs in serum-free RPMI containing SµCi 
[3HJ-Proline. 
3. Semi-confluent monolayers of UCT-Mel 7 cells(± Sxl05/3Smm dish) were 
covered with 1 ml RP-10 containing 3xl05 fibroblasts and 2.Sng of bFGF 
in the various combinations shown. Thereafter the protocol was the 
same as for experiment 1. 
4. Values in the body of the table give the rate of collagen synthesis 
(µmoles proline/108 cells/16 hr) measured in each individual . dish and 
the averages. 
5. p values indicate the significance of the 
(i) effect of bFGF 
(ii) effect of melanoma cells 
(iii) interaction between bFGF and melanoma cells 
p values were obtained from F-test ratios in a standard two-way 
analysis of variance presented in the Appendix (Table A.11). 
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Matrix deposited by melanoma cells had no effect on fibroblast 
collagen synthesis. 
In the event that the melanoma cells were depositing a matrix on 
the plastic surface of the tissue culture dish that was responsible 
for inducing fibroblast collagen synthesis, I performed the 
experiment in which the melanoma cells were plated and allowed to 
grow to semi-confluence at which stage they were removed from the 
dish using procedures that are known to leave behind deposited ECM. 
After gentle washing of the dishes, they were used to plate 
fibroblasts for the measurement of collagen synthesis using the 
standard protocol. No effects of the matrix could be discerned 
(Fig. 15). 
Dialysed extracts of cells. cell membranes and conditioned matrix 
components did not show stimulatory activity. 
A number of reports have appeared to indicate that · growth factors 
bound non-covalently to ECM may be released by extraction u~der 
dissociating conditions. I accordingly performed a number of 
experiments in which melanoma cells were treated in such a way as 
to favour the release of bound growth factors. The extracts were 
dialysed to restore a physiological composition and added to 
fibroblasts in the hope that this would detect stimulatory factors . 
None were found. An extract prepared with Tris buffered sodium 
deoxycholate was inhibitory (Fig. 16). 
Lyophilised acetic acid extracts of melanoma cell cultures and 
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Fibroblast collagen synthesis; effect of UCT-Mel 7 cells and 
UCT-Mel 7 derived matrix 
Fibroblasts were plated at a confluent density on melanoma cells 
(3x105/35 mm dish) or on matrix preparations prepared from UCT-Mel 7 
cells according to the following protocols. Literature references 
are given in parentheses. 
(i) Cell-free extracellular matrix {Clear bars) 
a) Tris-DOC (Laiho et al., 1986) - cells were extracted 3 x 5min 
with lOmM Tris-HCl pH 8 + 0.5X Na deoxycholate at room 
temperature. The residue on the plate was washed thoroughly and 
the fibroblasts added. 
b) NH40H (Kao et al., 1984) - cells were removed from the dish by 
treatment with 25mM NH40H for 2 minutes at room temperature. The 
extracted matrix was washed and the fibroblasts added. 
c) EGTA (Biswas, 1985) - cells were released with 0.5mM EGTA at 
37°C. The matrix was washed and the fibroblasts added. 
(ii) Cell-associated matrix (stippled bars) 
Cell-associated matrix was prepared by extracting UCT-Mel 7 · 
monolayers for 30 min at room temperature with: 
a) 2M NaCl in water (Gordon et al., 1987) 
b) 1.6M KSCN in water 
c) O.lM glycine HCl pH 2.8. 
The residue remaining on the dish was washed with PBS, air-dried 
overnight and the fibroblasts plated on to the dishes the next day. 
Cultures were then incubated for 24 hrs in RP-10, following by 16 hr 
in serum-free RPM! containing SµCi [3H]-Proline. The supernatants were 
then processed for the measurement of radiolabelled collagen. 
Points and bar heights depict, respectively, results of individual 
dishes and averages expressed as a percentage of the average values 
for dishes in which fibroblasts were cultured alone. 
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Fibroblasts 

















Extracts of matrix deposited by melanoma cells: effect· on fibroblast 
collagen synthesis 
In this experimen~. performed to complement the experiment described 
in Fig. 15, material extracted from the cells according to the 
protocols described in the legend to Fig. 15 were dialysed 
(Spectra/Por 4 membrane tubing; versus RPMI for 16 hrs at 4°C), 
sterile filtered (0.45µm Millex HA) and added to confluent fibroblast 
monolayers. 
Each dish contained approximately 4x105 fibroblasts and received 
Sx105 cell equivalents of extracted cellular material. The cultures 
were incubated for 40 hrs during the last 16 hrs of which SµCi 
[
3H]-PToline was present in each dish. The dishes were then 
processed for the measurement of radioactive collagen. 
Each point represents the value for an individual dish normalized to 
a value of 100% for the cultures in which fibroblasts were incubated 




An extract of melanoma cells prepared with a mixture of HCl and 
ethanol, according to techniques that are commonly used for the 
isolation of TGF-P (Roberts et al., 1984), showed signficant 
inhibition of collagen synthesis (Fig. 17). 
The effects of melanoma cell on fibroblast collagen synthesis are 
exerted at a transcriptional or post-transcriptional level. 
The synthesis of Type I collagen involves a complex series of 
sequential steps, most of which lend themselves to regulatory 
influences (Reviewed in Literature Review). For the sake of 
discussion and experimental des~-gn. I have found it convenient to 
consider processes that regulate the rate of collagen synthesis as 
those which operate to regulate the amount of mRNA that is 
available for translation and secondly, those that affect 
translation of the mRNA and assembly and secretion of the final 
product. If the inductive effects of co-culture with .melanoma 
cells operated at the first of these two levels - i.e. by 
increasing transcription or by stabilization of the mRNA - one 
would expect to find increased levels of collagen mRNA in the cells 
after contact with melanoma cells. If, on the other hand, melanoma 
cells influenced only the rate of translation of available mRNA or 
the activities of synthetic enzymes involved in the 
post-translational processing, assembly and secretion of collagen, 
one would expect to find similar amounts of collagen mRNA in 
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Fibroblast collagen synthesis: effects of melanoma cells or melanoma 
cell derived membranes or extracts 
In this experiment, confluent fibroblast monolayers were treated with 
melanoma cells (3xl05/35mm dish) or with membranes or extracts 
prepared from melanoma cells according to the following protocols. 
Literature references are given in parentheses. 
a) Membranes. A crude membrane preparation was obtained using the 
method of Nara and McCulloch (1985) in which the cells were lysed by 
hypotonic lysis (lOmM KCl, l.SmM MgC12 , 2mM PMSF, lOmM Tris HCl pH 
7.4), disrupted in a Polytron homogenizer and centrifuged at 400g to 
remove nuclei and 100 OOOg to pellet the membranes. The pellet, 
equivalent to 6xlos cells/ml, was resuspended in RPM! and added to the 
fibroblasts. 
b) Acid extraction . UCT-Mel 7 cells were extracted with 2M acetic 
acid+ lmM PMSF for 16 hr at 4°C. After centrifugation at 12 OOOg, the 
supernatant was lyophilized. The lyophilized extract was 
reconstituted in water and re-lyophilized three times. The extract 
was then reconstituted in RPM! to give 2xl06 cell equivalents/ml and 
added to the fibroblasts. 
c) Acid-Ethanol (Roberts et al., 1984). UCT-Mel 7. cells were 
extracted with hydrochloric acid:ethanol buffer for 2 hrs at room 
temperature after disruption in a Polytron homogenizer. The extract 
was centrifuged at 12 OOOg and the supernatant precipitated -overnight 
with a mixture of ether and ethanol. The precipitate was coilected on 
filter paper, dissolved in 2M acetic acid and lyophilized as for the 
acid extraction. The extract was then reconstituted in RPM! to given 
2xl06 cell equivalents/ml and added to the fibroblasts. 
The cultures were incubated for 40 hrs during the last 16 hrs of which 
SµCi [3H]-Proline was present in each dish. The dishes were then 
processed for the measurement of radiolabelled collagen. 
Each point represents the value for an individual dish normalized to a 
value of 100% for the cultures in which fibroblasts were incubated 
alone. Bar heights represent the average. 
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To resolve this issue I performed an experiment in which 
fibroblasts were cultured either alone or with melanoma cells and 
processed to determine the amount of collagen mRNA they contained. 
The experiment involved separating fibroblasts and melanoma cells 
after cultivation: this was achieved by the use of 
erythrocyte-linked monoclonal antibodies and centrifugation on a 
step density gradient as described in the Methods section. 
Fibroblasts cultured alone were mock separated using the same 
procedure. 
Total cellular RNA was isolated from each of the two fibroblast 
populations and analysed by electrophoresis and Northern blotting 
using nick-translated al(I) and a2(I) collagen gene probes. As a 
reference standard that would allow assessment of the specificity 
of the inductive effect, I compared the signal for collagen mRNA to 
that obtained when Northern blots were probed with nick-translated ·.· 
actin DNA. The results (Fig. 18) showed quite clearly t~at 
co-cultivation with melanoma cells resulted in a selective increase 
of collagen mRNA relative to actin mRNA. 
At any given time, the amounts of collagen mRNA could be expected 
to reflect net processes of transcription and degradation. Had the 
melanoma cell effect resulted in increased mRNA levels by induction 
of increased transcription, one would have predicted that the 
transcriptional inhibitor, a-amanitin, would, when used at a 
concentration that inhibited RNA synthesis, abrogate the melanoma 
cell effect. This prediction was tested in an experiment in which 
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I co-cultivated fibroblasts and melanoma cells in the presence or 
absence of Sµg/ml o-amanitin. 
The results of this experiment are shown in Fig. 19. o-amanitin 
inhibited collagen synthesis by the fibroblasts and totally 
abrogated the inductive effect of UCT-Mel 7. 
Inhibitory effects of bFGF and heparin are associated with 
diminution of intracellular collagen mRNA. 
To determine the regulatory level at which bFGF and heparin were 
operating, I incubated fibroblasts with the compounds, either alone 
or in combination, isolated total cellular RNA and analysed this by 
electrophoresis and Northern blotting using nick-translated ol(I) 
and o2(I) collagen gene probes. The results (Fig. 20) showed quite 
clearly that heparin had negligible effects on intracellular mRNA; 
bFGF alone decreased the amount of collagen mRNA; and heparin and 
bFGF in combination appreciably decreased the amount of collagen 
mRNA. Heparin and bFGF, either alone or in combination, had ~o 
effect on .P-actin mRNA. 
Inhibition of proteoglycan synthesis abrogated the melanoma cell 
induction of fibroblast collagen synthesis 
Cell surface proteoglcans have been shown to be important in a 
number of cell:cell interactions. The proliferation and development 
of haemopoietic stem cells occurs in close association with bone 
marrow stromal cells (Roberts et al., 1988) . Similarly, Schwann 
cell proliferation is stimulated by co-culture with dorsal root 
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FIGURE 18 
Effect of UCT-Mel 7 cells on fibroblast collagen mRNA 
Confluent fibroblast monolayers (approximately 107 cells/lOOmm dish) 
were cultured alone or as co-cultures with 8x106 UCT-Mel 7 cells for 
48 hrs. The cells were then released with trypsin, incubated with 
erythrocytes coated with anti-melanoma cell antibody and centrifuged 
on a Lymphoprep cushion. Fibroblasts separated from melanoma cells 
or mock-separated were collected from the Lymphoprep:medium interface 
and used to prepare total cellular RNA. The RNA (20µg/lane) was 
electrophoresed on a 1 . 5% denaturing formaldehyde-agarose gel, 
blotted on to Hybond N paper and hybridized with nick-translated 
[ 32P]-labelled probes specific for ol(l) collagen, 02(1) collagen and 
,8-actin. 
In each autoradiograph, lane 1 contains RNA from fibroblasts cultured 
alone and lane 2 contains RNA from fibroblasts that had been 
co-cultured with UCT-Mel 7 cells. 
Co-cultured fibroblasts contained more ol(l) and 02(1) collagen mRNA 
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FIGURE 19 
Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of a-amanitin, a specific inhibitor of mRNA synthesis 
Fibroblasts or fibroblast:UCT-Mel 7 co-cultures were incubated for 40 
hrs with or without Sµg/ml of a-amanitin. For the last 16 hrs of 
culture, SµCi [3H]-Proline was added. Cultures were then processed for 
the measurement of radioactive collagen. 
Confluent fibroblast monolayers were established in 35mm dishes; 
UCT-Mel 7 cells (3xl05/dish) and a-amanitin were added to experimental 
dishes at time zero. Points and bar heights represent, respectively, 
values for individual dishes and average values. 
a-amanitin inhibited collagen synthesis by the fibroblasts and totally 
abrogated the inductive effect of UCT-Mel 7 cells. 
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FIGURE 20 
Effect of bFGF and heparin on the accumulation of type I collagen and 
8-actin mRNA's in cultured fibroblasts 
Confluent fibroblast monolayers were treated for 48 hrs with bFGF 
(40ng/ml), heparin (20µg/ml) or a combination of both compounds. The 
compounds were not added to control dishes. Total cellular RNA was 
extracted and 20µg RNA/lane was electrophoresed on a 1.5% denaturing 
formaldehyde-agarose gel. The separated RNA was blotted on to 
Hybond-N paper and hybridized to [32P]-labelled nick-translated DNA 
probes specific for al(l) collagen, a2(1) collagen or ,6-actin. 
Lane 1 contained RNA from control fibroblasts. 
Lanes 2 - 4 contained RNA from fibroblasts treated with heparin (lane 
2), bFGF (lane 3), heparin together with bFGF (lane 4). 
The autoradiographs showed that heparin had negligible effects on 
intracellular collagen mRNA; bFGF alone decreased the amount of 
collagen mRNA; and heparin and bFGF in combination acted 
synergistically to decrease the amount of collagen mRNA. Heparin and 
bFGF, either alone or in combination, had no effect on the amount of 
,6-actin mRNA . 
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ganglion neurons (Ratner et al., 1985). Co-culture of melanoma 
cells with fibroblasts, induces the fibroblasts to synthesize 
increase amounts of collagenase. In all cases, cell surface 
proteoglycans play a role and have been identified as heparan 
sulphate. I therefore decided to look for proteoglycan involvement 
in the interactions between fibroblasts and melanoma cells that I 
had seen. 
Normal biosynthesis of xylose-linked proteoglycans (i . e. 
chondroitin sulphates, dermatan sulphates, heparins and heparan 
sulphates) can be inhibited by the addition of exogenous 
P-D-xylosides (Ratner et al., 1985; Thompson and Spooner, 1983). 
These compounds compete with the xylosated core protein at the 
level of the first galactosyltransferase. This leads to an increase 
in free glycosaminoglycan chains in the medium and inhibits 
glycosaminoglycan addition to proteoglycan core proteins (Galligani·' 
et al., 1975; Lohmander and Hascall, 1979; Thompson and Spooner, 
1983). I, therefore, studied the effects of 
4-methylumbelliferyl-P-D-xyloside (P-D-xyloside) on melanoma cell 
induction of fibroblast collagen synthesis. 
In all, three experiments have been performed to study the effects 
of P-D-xyloside on fibroblast collagen synthesis and the 
fibroblast:melanoma cell interaction. In the first experiment 
(Table 15,Expt 1) confluent fibroblast monolayers established in 
the absence of any added compounds were incubated alone or with 
UCT-Mel 7 cells and P-D-xyloside in DMSO (lmM xyloside in 1% DMSO, 
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final concentrations) in all combinations. The results showed 
highly significant primary effects of UCT-Mel 7 cells and 
P-D-xyloside: UCT-Mel 7 cells stimulated fibroblast collagen 
synthesis and P-D-xyloside inhibited fibroblast collagen synthesis. 
There was also a significant inhibitory interaction between the 
melanoma cells and p-D-xyloside ( p < 0.025 ). In other words, the 
effect of the melanoma cells was less marked in the presence of 
P-D-xyloside than in its absence. 
In the second experiment (Table 15,Expt 2) fibroblasts and 
P-D-xyloside in all combinations were added to monolayers of 
UCT-Mel 7 cells established in the absence of added compounds. Once 
again the primary effects of UCT-Mel 7 cells and P-D-xyloside were 
highly significant (p < 0.001) but, in this experiment, there was 
no significant synergy between the melanoma cells and P-D-xyloside. 
The different results obtained in these 2 experimepts,. as with 
bFGF, highlights the sensitivity of the experimental sys~em to the 
protocol used. 
I felt that the experimental design used in these 2 experiments was 
not really adequate for completely stripping the cell surface of 
its proteoglycans. The addition of P-D-xyloside to established 
cultures would have stopped synthesis of new proteoglycans but need 
not have depleted the peri-cellular matrix to a significant extent 
if the turnover was slow. For this reason, I decided to pretreat 
the fibroblasts with P-D-xyloside for 72hrs before adding the 




Footnotes to Table 15 
1. These two experiments are presented to demonstrate the effect of 
P-D-xyloside on fibroblast collagen synthesis and the fibroblast 
melanoma cell interaction. 
In experiment 1, melanoma cells and P-D-xyloside were added to confluent 
fibroblast monolayers that had been established in the absence of 
P-D-xyloside. 
In experiment 2, it was the melanoma ceLls that were established 
cultures and fibroblasts and p-D-xyloside were added to these monolayers. 
2. Confluent fibroblast monolayers(± 7xl05/35mm dish) were covered with 
1 ml RP-10 containing 3xl05 UCT-Mel 7 cells and lmM 
4-methylumbelliferyl-P-D-xyloside (P-D-xyloside) in the various 
combinations shown. The cultures were incubated for 24 hr, followed by 
16 hr in serum-free RPMI containing SµCi [3H]-Proline. 
3. Monolayers of UCT-Mel 7 cells(± Sxl05/35mm dish) were covered with 1 
ml RP-10 containing 3xl05 fibroblasts and lmM P-D-xyloside in the 
various combinations shown. Thereafter the protocol was the same as 
for Experiment 1. 
4. Values in the body of the table give the rate of collagen synthesis 
(µmoles proline/108 cells/16 hr) measured in each individual dish and 
the averages. 
5. p values indicate the significance of the 
i) effect of P-D-xyloside 
ii) effect of melanoma cells 
iii) interaction between P-D-xyloside and melanoma cells 
p values were obtained from F-test ratios in a standard two-way 
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Stimulation of fibroblast collagen synthesis by UCT-Mel 7 cells: 
effect of 4-metbylumbelliferyl-8-D-xyloside 
Fibroblasts were plated at lxl05 cells/35mm dish in 2ml DB-10. Twenty 
microliters of a lOOmM solution of P-D-xyloside in DMSO was added to 
experimental dishes; control dishes received DMSO alone. The dishes 
were incubated for 72 hrs with daily medium changes until the 
fibroblasts were confluent. UCT-Mel 7 cells (3x105 ) were then added 
to the fibroblast monolayers in RP-10 containing DMSO with or without 
the inhibitor and-the cells incubated for a further 24 hrs during 
which the melanoma cells were seen to attach to the fibroblasts with 
a small number of floating cells. The medium was then replaced with 
serum-free RPM! containing DMSO with or without the inhibitor and SµCi 
[ 3H]-Proline. Radioactive collagen was measured after 16 hrs. 
Bar heights represent averages of the individual points shown for 
each dish. 
The relatively low rate of collagen synthesis seen in this experiment 
is attributable to the large number of fibroblasts in the dish (see 
Fig. 3). 
Note that the melanoma cell effect was abolished by pre-incubation of 
the fibroblasts with the inhibitor of proteoglycan assembly. 
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TABLE 16 














Confluent monolayers of fibroblasts and UCT-Mel 7 cells were labelled 
with lOOµCi [35S]-S04 (New England Nuclear NEX 041~ lO~lOOOmCi/mmol) for 
20 hrs in 1 ml serum-free RPM!. The medium was collected and the cells 
were washed 3x with cold PBS and scraped from the dish into 200µ1 of 
extraction buffer (0.5% Triton X-100, 0.1% SDS, 1 mM PMSF in .PBS). 
Cells were extracted for 30 mins at 4°C, centrifuged and the supernatant 
collected. Aliquots of the medium and the cell extracts were 
precipitated with TCA (10% final conc),centrifuged and the precipitate 
washed once with 10% TCA. The final precipitate was dissolved in 2N 
NaOH and counted. 
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Fibroblasts, plated at low density and grown to confluency in the 
presence of P-D-xyloside, failed to respond to the melanoma cells. 
The analysis of variance of these results showed a significant 
primary effect of UCT-Mel 7 cells, no significant primary effect of 
p-D-xyloside and a significant (p < 0.005) interaction between 
UCT-Mel 7 cells and p-D-xyloside . In other words, the melanoma cell 
effect was less marked in the presence of P-D-xyloside than in its 
absence. 
Unfortunately I could not complete the symmetrical experiment in 
which the melanoma cells were pretreated with P-D-xyloside because 
the P-D-xyloside proved toxic for the melanoma cells. When plated at 
low density in the presence of p-D-xyloside, the melanoma cells 
failed to adhere and proliferate. 
Both fibroblasts and UCT-Mel 7 cells synthesized proteoglycans as 
assessed by incorporation of [35SJ-sulphate into TCA-prec~pitable 
material (Table 16). A major portion of the sulphated 
macromolecules were found in the medium ( 95% for fibroblasts and 
80% for UCT-Mel 7 cells). 
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DISCUSSION 
In this chapter I present data that show, quite clearly, that UCT-Mel 
7 cells induced collagen synthesis in co-cultured fibroblasts. 
Although the magnitude of this in vitro melanoma cell effect varied 
from experiment to experiment, it was consistently stimulatory. At 
UCT-Mel 7:fibroblast ratios of 1:1, fibroblast collagen synthesis 
rates were, on average, 80% higher than those seen in control cultures 
(Fig. 1). 
The effect was relatively specific for collagen synthesis (since the 
incorporation of [ 3H]-leucine was not affected; Fig. 7) and was dose-
dependent over a range of melanoma:fibroblast ratios from 1:50 to 2:1 
(Fig. 4). The induction of collagen synthesis was evident after 4 
hours of co-culture (Fig. 5). Analysis of the kinetics of the effect 
indicated that melanoma cells increased the maximal rate of proline 
incorporation into collagen rather than the apparent "Michaelis 
constant" of the reaction. Although, in a complex multi-step system 
such as this, one cannot legitimately draw conclusions from 
experimental approaches designed to study relatively simple reactions 
between enzyme and substrate, I take these results to indicate that 
the melanoma cells acted primarily to increase the total capacity for 
collagen synthesis by recruiting fibroblasts to the synthesis of this 
protein or by diverting a greater fraction of the protein synthetic 
apparatus for this purpose. It seems that the melanoma cell effect 
was not attributable to an increased rate of proline transport into 
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the cells or to a change in the rate constants of the intracellular 
reactions involved in collagen synthesis. 
This interpretation is consistent with the results of the experiments 
showing that co-culture with UCT-Mel 7 cells consistently increased 
intracellular levels of mRNA for ol(l) and 02(1) collagen. The 
specificity of this induction was established by showing no effect on 
the induction of p-actin mRNA. It is not possible to say, at present, 
whether the increase in intracellular collagen mRNA was due to the 
induction of transcription of new message or to the stabilisation of 
existing mRNA. This question will be resolved by the results of 
appropriate pulse-chase experiments. 
The effects of compounds such as TGF-p (Ignotz et al., 1987; Raghow et 
al., 1987) or interferon (Rosenbloom et al., 1984; Stephenson et al., 
1985) on fibroblast collagen mRNA have been well described, but I have 
found no references to the effects of cellular co-cultivation on 
collagen mRNA. 
Fibroblasts have an in vitro doubling time of approximately 24 hours 
so that the period of culture that was required to demonstrate 
induction of collagen synthesis(± 40 hours) was sufficiently long for 
this effect to have been secondary to stimulation of fibroblast 
proliferation. This trivial explanation for the melanoma cell effect 
was excluded by experiments in which melanoma cells and fibroblasts 
were separated after co-culture for independent counting (Fig.12). 
The use of erythrocyte-linked monoclonal antibodies to mefanoma and 
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fibroblast surface epitopes provided an effective means of achieving 
this separation by rosetting and density gradient centrifugation. 
Natali et al., (1983), Mills et al., (1983) and Wilhelm et al., (1986) 
have also used this useful technique to resolve mixed cell populations. 
Although UCT-Mel 7 cells proved most effective at inducing fibroblast 
collagen synthesis, this was not an exclusive property of melanoma 
cells in general or of these cells in particular. Most cell types 
(e.g. breast carcinoma cells) reacted similarly in this regard and the 
"Bowes" melanoma cell line (RPM! 7272) had no effect. The basis for 
this heterogeneity in inductive capacity is as yet obscure. It is 
still an issue to be resolved since comparisons between inducing and 
non-inducing cells might well shed light upon the mechanism for the 
induction. 
I have been unable to find reports in the literature of attempts to 
understand the desmoplastic response other than those that I have 
summarised in Table 17. These, for the most parts, are not ·strictly 
relevant to the results that I have obtained since few authors have 
addressed the question of tumour effects upon the economy of collagen. 
Notable exceptions are provided by the experiments reported by Naito 
et al., (1984) and those of Biswas (1982,1985,1987,1988). 
Naito et al. co-cultured gastric carcinoma cells and fibroblasts and 
found that collagen synthesis was stimulated. Unlike the results that 
I obtained however, they found that gastric carcinoma cell conditioned 
medium contained a soluble fibrogenic factor that could be 
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demonstrated in their technique of "parabiotic co-culture" in which 
adjacent flasks carrying the different cell types were connected by a 
joining tube that incorporated a semi-permeable membrane. They, 
however, relied heavily on histochemical appraisal for collagen 
synthesis rather than upon quantitative biochemical assays. Such 
quantitative data as they did obtain showed similar effects (an 
increase in hydroxyproline content) to those that I observed. 
My observations are, to some extent, inconsistent with those of Biswas 
and her colleagues who found that Bl6 melanoma cells possess a _surface 
heparin-binding protein that interacts with extracellular matrix to 
induce the release of a factor that increases the synthesis of 
fibroblast collagenase. Had a similar phenomenon occurred in my 
experiments I would have expected a net decrease in the amount of 
collagen released. Furthermore, I found that fibroblasts released 
undetectable amounts of collagenase and that the rate of release of 
this enzyme was not affected by melanoma cells. 
The differences between the elegant experimental results that Biswas 
has reported and those that I have observed may well be attributable 
to species differences (the Bl6 line is a murine line) and to 
differences in the experimental design. She has found that co-culture 
of mouse fibroblasts and mouse melanoma cells does not lead to 
collagenase induction: xenogeneic cultures are required. My 
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If one shifts the emphasis from collagen to other elements of the 
fibroblast-secreted matrix, one finds a number of reports that 
document an effect of malignant cells on the synthesis of these 
extracellular molecules. These reports I have summarised in Table 17 
from which it is evident that, in most cases, where effects have been 
observed they have involved stimulation rather than suppression. 
Furthermore, it is well known that malignant cells are capable of 
releasing collagenase and other proteases that are capable of 
degrading extracellular matrix and this has been inculpated in 
mediating local invasion or metastatic spread. Apart from the 
experiments of Biswas that I have referred to above, I am unaware of 
any reports that have dealt specifically with the question of effects 
of co-culture on the release of such proteolytic enzymes. 
There seems to be no hard and fast rule regarding the existence of 
soluble factors that are capable of modulating the deposition of 
extracellular matrix. Merrilees and Findlay (1985), for example, 
showed that co-culture of fibroblasts with a variety of tumours led to 
the release of a soluble factor that stimulated the deposition of 
glycosaminoglycans. On the other hand, Knudson et al. (1984) who 
performed virtually identical experiments confirmed the stimulation, 
by tumour cells, of glycosaminoglycan synthesis but were unable to 
demonstrate a soluble factor that mediated this effect. It should 
also be noted that Biswas although consistently able to demonstrate 
t he induction of collagenase by co-culture was not always able to 
demonstrate the presence of a soluble factor in the conditioned medium 
t hat was responsbile for mediating this effect: in one paper 
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(Biswas,1985) she records the fact that only 60% of the melanoma 
cultures contained, in the conditioned medium, the inducing molecule. 
In summary therefore, the results of these descriptive experiments 
that I have presented confirm those of other workers and extend their 
observations by quantitating certain kinetic aspects of the 
phenomenon; by defining such biological features as species 
specificity and induced collagen type; and by showing that the effect 
of melanoma cells was relatively specific on collagen synthesis. The 
induction of increased cellular levels of collagen mRNA by co-culture 
has similarly not been reported previously. 
A question arises regarding the relevance of my in vitro experimental 
results to the desmoplastic response that I observed in vivo. It is 
true that the cell line that provoked maximum desmoplasia in vivo 
(UCT-Mel 7; Chap . l Fig.9) was most effective at inducing fibroblast 
collagen synthesis in vitro (Fig.9) and that the magnitude of the 
in vitro inductive effects was, taking into account the slow .turnover 
rate of collagen, quantitatively sufficient to lead to the long term 
accumulation of excessive collagen in tumours in the mice. On the 
other hand, UCT-Mel 1 and UCT-Mel 2 also had an effect in vitro which, 
although less than that shown by UCT-Mel 7, was nevertheless of 
sufficient magnitude to have made me expect a greater in vivo effect 
than that was seen. 
A second inconsistency between UCT-Mel 7 and its effects on collagen 
synthesis in vivo and in vitro is to be found in the fact that early 
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(8'), middle (20 - 30') and late (>50') passages .of UCT-Mel 7 cells 
were equally effective as inducers of collagen synthesis in vitro yet 
it was only cells derived from middle passage cultures that gave rise 
to desmoplastic tumours in vivo. 
I have no convincing explanations to offer for these inconsistencies 
nor do I have any satisfactory speculations to offer. The in vivo 
situation is clearly too complex to warrant confident extrapolation 
from in vitro findings and further experiments are necessary if a 
useful answer is to be obtained. It will be of interest, for example, 
to isolate clones of the mid?le passage cells in the hope that they 
may differ in their ability to induce fibrogenesis in vivo and 
collagen synthesis in vitro, since this might indicate the in vivo 
need for an accessory cell to complement the cells that act only in 
vitro. It would be. particularly interesting if clones could be 
isolated that were synergistic in this respect. The availability of 
such cell types would mean that DNA cloning procedures with 
subtractive hybridization might be applied to the identification of 
the genes involved. 
It is usually desirable in studies of th~s sort to note whether or not 
a particular cellular function or effect requires macromolecular 
synthesis. Unfortunately, I was unable to use conventional inhibitors 
of polypeptide synthesis to see if the melanoma cells required intact 
protein synthetic machinery in order to induce collagen synthesis. 
There were two reasons for my inability to do so, both of which relate 
/ to the washing of the melanoma cells cultures after exposure to the 
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inhibitor to remove inhibitor from the second phase of the experiment 
when UCT-Mel 7 cells and fibroblasts were co-cultured. In the first 
place, cycloheximide is a r~versible inhibitor and washing would have 
restored melanoma cell protein synthesis so invalidating the 
experiment. In the second place, the concentrations of actinomycin D 
required to inhibit [ 3H]-Uridine incorporation into UCT-Mel 7 cells 
were associated with unavoidable transfer of inhibitor into the 
second, co-culture phase of the experiment so that fibroblast function 
was inhibited totally. 
I thus decided to explore glutaraldehyde as a possibly useful 
inhibitor in this context for the reason that the functional integrity 
of many biological macromolecules and structures may be selectively 
preserved or destroyed by exposure to glutaraldehyde at the 
appropriate concentration. The use of glutaraldehyde as a coupling 
agent for affinity chromatography (Kristiansen, 1974) and as a means 
for attaching functional enzymes to solid phase supports 
(Weetall,1976) testify to the usefulness of this compound provided 
optimal conditions for the particular experimental circumstances are 
established by careful titration. By ad~ing a low concentration 
(0.002%) of glutaraldehyde to the medium I was able to inhibit DNA 
synthesis with only a modest reduction in the rate of protein 
synthesis; at higher concentrations of glutaraldehyde both protein and 
DNA synthesis were inhibited (Table 7). 
With this system I was able to show that the melanoma cells did not 
/ require the capacity for DNA synthesis to induce fibroblast collagen 
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synthesis (Fig. 11) - a conclusion that was conf_irmed by the findings 
with mitomycin •C (Table 5). Concentrations of glutaraldehyde that 
inhibited protein synthesis, however, nullified the effect of 
UCT-Mel 7 cells on the fibroblasts (Fig.11). Glutaraldehyde treated 
melanoma cells did not diminish baseline collagen synthesis nor did 
they appear to 1have any other adverse effects, indicating that there 
was no "spill-over" of this inhibitor into the second phase of the 
experiment. 
To the best of my knowledge glutaraldehyde, while commonly used as a 
fixative or coupling reagent, has not been used as an inhibitor in in 
vitro cell culture experiments so that this approach is without 
precedent. Unfortunately the effects of glutaraldehyde are too 
non-specific to conclude, definitively, that melanoma cell protein 
synthesis is required for fibroblast induction but the findings are 
consistent with this interpretation. I know of no other reports to 
demonstrate that protein synthesis in the inducing cells is necessary 
for the induction of macromolecular synthesis in responding cells. 
Collagen synthesis is a prominent feature of the chronic inflammatory 
fibrotic response and it was thus of interest to note the effect, in 
my system, of adding agents that are experimentally and 
pharmacologically associated with the induction or modulation of 
inflammation. Phorbol myristate acetate, retinoic acid, indomethacin 
and dexamethasone are examples of compounds that act in this way . 
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For the most part my results agreed with those of published reports . 
It is well known that dexamethasone and PMA inhibit collagen synthesis 
(Flaherty and Chojkier, 1986; Weiner et al., 1987) and my results 
confirmed this. Retinoic acid, however, which is said to inhibit 
collagen synthesis (Daly and Weston, 1978; Hein et al., 1984; Ohta and 
Uitto, 1987) was significantly stimulatory in my experiments . I have 
no explanation for this discrepancy. Although all three of these 
compounds had significant primary effects on fibroblast collagen 
synthesis, none showed any significant synergy with the melanoma cells 
(Tables 8-11). 
It is also well known the prostaglandins, by increasing intracellular 
cAMP concentrations, have an inhibitory effect on collagen synthesis 
(Baum et al., 1978; Rennard et al., 1982). Indomethacin, by 
inhibiting the action of prostaglandins, blocks their effect on 
collagen synthesis (Clark et al., 1983; Laato and Heino, 1988). I 
have shown that, whilst indomethacin had no effect on fibroblast 
collagen synthesis by itself, it significantly augmented the increased 
rate of collagen synthesis induced by the melanoma cells. These 
results may be of importance for the understanding of the manner in 
which the stimulus delivered by the melanoma cells is transduced, by 
the fibroblast, into an effective trigger to increase the rate of 
collagen synthesis. It is of incidental interest to note that 
prostaglandins are also involved in the modulation of lymphocyte 
responses to antibodies presented by macrophages - another situation 
where intimate cell:cell contact provides the inductive stimulus 
(Snyder et al. ,1982) . 
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The general rule that many cell-cell interactions are mediated by 
paracrine effects led to the obvious suggestion that the effect of 
melanoma cells on fibroblasts was mediated by a soluble polypeptide or 
other "growth factor" released into the co-culture medium. I was, 
however, consistently unable to demonstrate the existence of any such 
compound (Tablei 2); the effect could only be demonstrated by 
co-culture of melanoma cells and fibroblasts. 
Most polypeptide growth factors or mediators have molecular weights of 
approximately 20kD and any such compound should have been retained by 
the Amicon lOkD cut-off filter that I used to concentrate melanoma 
cells conditioned medium. The fact that harvest fluid concentrated in 
this way had no effect on fibroblast collagen synthesis argues against 
low concentration of such a growth factor as a reason for my failure 
to demonstrate its presence. 
Since it was possible that the UCT-Mel 7 cells released labile growth 
factors that did not withstand harvesting or storage, I performed the 
Cooper dish experiments in which monolayers of UCT-Mel 7 cells and 
fibroblasts were separated by no more than 4mm of contiguous medium. 
This, too, gave no indication of a soluble mediator of the melanoma 
cell effect (Table 3). 
Reports in the literature of soluble factors that mediate cellular 
interactions leading to increased deposition of collagen or 
extracellular matrix have been inconsistent (Table 17). Naito et al., 
(1984) and Merilees and Findlay (1985) provided evidence to indicate 
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such factors do exist; Knudson et al., (1984), like myself, were 
unable to demonstrate them. It is of interest to note, in the light 
r 
of these observations and the experimental results that I present 
below, that, in at least two instances, fibroblasts that had failed to 
respond to conditioned medium responded to a membrane fraction 
prepared from the inducing cells (Biswas and Toole, 1987). 
It was also conceivable that, as in the case of the experiments 
reported by Biswas (1985), that the melanoma cells would only release 
their stimulatory soluble factor in response to a stimulus from 
co-cultivated fibroblasts, and this may have explained my inability to 
detect such a factor in medium harvested from melanoma cells 
cultivated alone. I therefore studied the effects of conditoned 
medium taken from co-cultures and I found that this, as in the other 
cases, was devoid of stimulatory activity. 
My consistent inability to demonstrate a soluble factor that was 
resonsible for the melanoma cell effect, in the face of the equally 
consistent observation that co-cultivation with melanoma cells 
increased the rate of fibroblast collagen synthesis, led me to the 
obvious conclusion that the fibroblasts received their inductive 
stimulus from contact with some solid-phase structure. The subsequent 
experiments that I performed were designed to explore the possible 
nature of such a stimulus and the mode of its delivery. 
Three well described mechanisms served as a basis for my experimental 
approach: cells may associate to form gap junctions (Loewenstein, 
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1981; MacDonald, 1985) through which cytoplasmic contents may be 
exchanged; they• may interact by way of complementary cell surface 
molecules (in much the same way as antigen-presenting cells proffer 
processed antigen in association with major histocompatability gene 
products to receptors on responsive T lymphocytes); or they may attach 
to elements of ~he extracellular matrix that function as stimulatory 
molecules - either alone or as structures that present growth factors 
or other regulatory peptides. 
Gap junctions are structures that are visible under the electron 
microscope (Loewenstein, 1981) and are functionally demonstrable by 
complementation experiments such as those so elegantly performed by 
Davidson et al. (1984, 1986). These workers showed unequivocally that 
a-glycyrrhetinic acid is a potent and specific inhibitor of cytoplasmic 
transfer through intercellular gap junctions. I have used the lack of 
effect of this compound upon melanoma:fibroblast interactions as 
strong evidence against these being mediated by gap junctions (Fig.13). 
The identification of functional cell surface molecules requires 
reagents that bind to the receptor or the cell surface agonist (such 
as monoclonal antibodies or other ligands); or cloned genes that can 
be shown, by transfection or similar experiments, to code for the 
structures in question. Unfortunately the monoclonal antibodies that 
I raised to melanoma and fibroblast cell surface epitopes had no 
effect on the cellular interactions that concerned me and I have not 
as yet completed the work that needs to be done with mutant cells 
lines or cloned genetic material. I am, therefore, unable to comment 
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definitively on the nature of cell surface molecules that a re 
functionally involved in the phenomenon that I have described. 
During the past decade the notion of the extracellular (ECM) or 
peri-cellular matrix as a regulator of cell function has gained 
acceptance and one now sees this heterogeneous assembly of diverse 
macromolecules as an important component of tissues in vivo and 
experimental systems in vitro. Thanks largely to the contributions of 
workers such as Folkman et al., 1988; Gospodarowicz, 1987; Moscatelli 
and Rifkin, 1988, it is now clear that the ECM may influence cellular 
behaviour in any of several ways. 
Firstly, ECM components such as fibronectin, laminin or vitronectin, 
in association with the "integrin" family of cell surface receptors 
(Hynes, 1987), provide substrata for adherence, directed motility, 
tissue structure and cellular morphology. 
Secondly, the ECM may associate with growth factors or other 
regulatory molecules to present them more efficiently to cellular 
receptors (Roberts et al., 1988) to localise them to a particular 
cellular environment (Vlodavsky et al., 1987) or to protect them from 
proteolytic degradation (Saksela et al., 1988). This function is well 
demonstrated by studies of Roberts et al. (1988), who showed that 
peri-cellular matrix on bone marrow stromal cells was essential for 
the effective presentation of GM-CSF to haemopoietic progenitor cells 
and by the work of Saksela et al . (1988) who showed that heparin-bound 
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bFGF is resistant to hydrolysis by proteases normally present in cell 
medium . 
Finally , ECM components may bind directly to receptors present on cell 
surfaces to deliver proliferative stimuli - as reported, for example, 
by Ratner et al. (1985) who showed that heparan sulphate proteoglycans 
associated with dorsal root ganglion neurons, deliver mitogenic 
stimuli to Schwann cells - or other inductive stimuli exemplified by 
the case of the melanoma cell heparin-binding protein described by 
Biswas (1988). 
The recent history of ECM research is closely associated with 
angiogenesis and angiogenic factor (now fibroblast growth factor) -
initially for the fact that heparin affinity chromatography provided 
an effective means for the purification of FGF and, more recently, for 
the synergistic interactions between bFGF and ECM that have been so 
well documented by Folkman et al., 1988; Konkle and Ginsburg, 1988; 
Vlodavsky et al., 1987. 
With this knowledge in hand I performed a series of experiments 
designed to explore the role of the ECM in the melanoma 
cell:fibroblast interactions. The results of these experiments warrant 
comment in the following respects: 
(a) Firstly, attempts to stimulate fibroblast collagen synthesis with 
melanoma cell membranes, extracts of melanoma cells or ECM 
deposited by melanoma cells were unsuccessful. In retrospect, 
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these experiments suffered from a number of deficiencies that will 
have to be' rectified when they are repeated: I did not, for 
example, establish definitively that the UCT-Mel 7 cells did 
deposit a matrix on the dish or that the methods I used to remove 
the cells left a residual matrix; nor did I treat such matrix as 
was deposited with melanoma cell conditioned medium to see if a 
soluble factor was present that could synergize with matrix 
components. I did, however, use established procedures that are 
recommended in the literature and that should have detected 
obvious direct effects of matrix components. 
(b) Direct effects of heparin were inconsistent in the sense that the 
compound either had no effect on fibroblast collagen synthesis or 
it suppressed this function (Table 12). On no occasion did 
heparin stimulate. These results would argue against the 
existence of a fibroblast receptor for a melanoma cell 
proteoglycan of the heparan sulphate-type as a mediator of these 
effects. 
(c) Heparin consistently inhibited the effect of the melanoma cells on 
fibroblast collagen synthesis (Table 13). These results strongly 
suggest participation of a heparan sulphate type proteoglycan in 
the melanoma cell:fibroblast interaction, but the nature of this 
participation is as yet obscure. Taken in conjunction with those 
summarised under (b) above, my findings are consistent with the 
view that the cell-associated ECM is important, in which case free 
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heparin would act a competitive inhibitor when added to co-culture 
I 
but it would have little or no effect when added alone. 
(d) In two experiments (Table 15 and Fig. 21) P-D-xyloside, a potent 
inhibitor of proteoglycan assembly, had a direct inhibitory effect 
on fibroblast collagen synthesis. If, for the sake of discussion, 
one disregards the possibility that this inhibitor acted upon some 
other cellular function, one might infer that some measure of 
proteoglycan synthesis is required for basal collagen synthesis to 
proceed in unstimulated fibroblast cultures. I have not taken 
further experimental steps to test this inference. Clearly this 
should be done for the light that it might shed upon normal 
fibroblast metabolism. In a third experiment, P-D-xyloside had no 
direct effect upon collagen synthesis (Table 15). 
(e) In two experiments (Fig. 21 and Table 15) P-D-xyloside inhibited 
the UCT-Mel 7 effect to a greater extent than could be explained 
by its direct effect upon fibroblast collagen synthesis alone. 
These results implied that proteoglycan synthesis was required for 
the
1 melanoma cell effect to be seen . In a third experiment 
(Table 15), however, the interaction between melanoma cells and 
P-D-xyloside was not significant. 
As indicated above, direct and synergistic effects of P-D-xyloside were 
inconsistent - a fact that I attribute to the sensitivity of the assay 
system to the experimental protocol that I used. It proved 
/ impossible, for example, to trypsinise the UCT-Mel 7 cells and to 
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replate them in the presence of ,8-D-xyloside. If. this was done the 
cells failed to'attach to the dish and died. As a result I was not 
able to add fibroblasts to proteoglycan-depleted UCT-Mel 7 cells that 
had proliferated in the presence of the inhibitor. Similarly, the 
direct effects of ,8-D-xyloside on fibroblast collagen synthesis were 
not seen when the cells were plated at low density and grew to 
confluence in the presence of an inhibitor; they were only observed 
when the compound was added to established monolayers or to 
trypsinised cells that were replated at high density and tested within 
48 hours. The resolution of the· apparently conflicting results that I 
obtained therefore will require optimization of the protocol and 
careful titration of the inhibitor and other factors. 
These results, although as yet somewhat inconclusive, indicate that 
proteoglycans are involved in the melanoma cell:fibroblast interaction 
and suggest the following tentative model: a cell-associated 
proteoglycan - possibly heparan sulphate - on either the fibroblasts 
or UCT-Mel 7 cells engages a proteoglycan "receptor" on the other cell 
type. This interaction between proteoglycan and its receptor triggers 
the fibroblast t ·o synthesize increased amounts of collagen. I have 
shown that both melanoma cells and fibroblasts are capable of 
synthesizing cell-associated and secreted sulphated macromolecules 
(Table 16) - an essential pre-requisite for such a model. It is, by 
analogy with GM-CSF or bFGF and the~ interaction with proteoglycan, 
also conceivable that a melanoma cell-derived soluble factor is 
involved but is only capable of delivering an effective stimulus if 
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presented to a fibroblast receptor in association with a melanoma 
cell-surface proteoglycan. 
This model, and by extension that of the soluble factor, are 
consistent with my findings and are amenable to experimental 
verification . Experiments designed to investigate the effect of 
heparanase treatment of the cells; to look for the existence of 
proteoglycan-binding proteins on the surface of the cells; and to 
characterize the proteoglycans produced by the two cell types are 
called for. 
This model is not without precedent in the literature. Biswas and 
Toole (1987) have shown that cell-associated proteoglycans play a role 
in the induction of increased amounts of Type I collagenase in 
fibroblast:melanoma co-cultures. Interaction between 
fibroblast-associated heparan sulphate and a heparin-binding protein 
on the surface of Bl6 melanoma cells leads to the release of a 
collagenase-stimulatory factor from the melanoma cells which then acts 
on the fibroblasts. Removal of the heparan sulphate proteoglycan from 
the surface of fibroblasts by heparanase treatment abrogated the 
effect. 
Heparan sulphate proteoglycans have also been shown to be important in 
the mitogenic stimulation of Schwann cells by dorsal root ganglion 
neurons (Ratner et al . , 1985) and haempoietic stem cells by bone 
marrow stromal cells (Roberts et al., 1988) . Removal of the heparan 
sulphate by heparanase (in the case of the stromal cells) or 
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p-D-xyloside or heparanase (in the case of the neurons) inhibited the 
mitogenic effect. 
Incidental to the possible role of the ECM in the melanoma 
cell:fibroblast interaction were the effects bFGF which, although not 
relevant to thei main theme of this thesis, were nevertheless 
interesting, in that they have not been reported previously. Much 
work has been done on the proliferative capacity of bFGF but no one 
seems to have studied its effects on macromolecular synthesis. I have 
shown the bFGF consistently inhibited fibroblast collagen synthesis in 
dose-dependent manner, and stimulated fibroblast proliferation (Fig. 
14). 
Gospodarowicz, in discussing the biology of FGFs, has drawn attention 
to the fact that they decrease adhesion of normal fibroblasts to the 
substratum; they promote anchorage-independent growth of these cells; 
and they release the cells from contact inhibition to produce a 
"transformed" appearance (Gospodarowicz, 1987). A decrease in 
collagen synthesis (and as a result, a presumed decrease in 
fibronectin binding sites leading to diminished adhesion) and 
increased proliferation (with release from contact inhibition and 
"transformation") are both effects that one would intuitively 
associate with Gospodarowicz's account. 
Heparin and bFGF are known to act synergistically in other systems 
(Konkle and Ginsburg, 1988; Ulrich et al., 1986); my results confirm 
this enhancing interaction (Table 13). It has been suggested that the 
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effect of heparin, in this particular context, is mediated by its 
capacity, shared with other proteoglycans, for stabilization and 
presentation of the growth factor (Saksela et al., 1988; Vlodavsky et 
al., 1987). I have no data to support or refute this reasonable 
hypothesis. 
Of particular interest is the fact that the melanoma cells, while 
consistently stimulatory in the absence of FGF or heparin, synergized 
with the peptide to inhibit fibroblast collagen synthesis when the 
stimuli were delivered simultaneously. This synergy between melanoma 
cells and bFGF is readily explicable by postulating the deposition of 
melanoma cell matrix or the presence of matrix-like structures on the 
melanoma cell surface that are, like heparin, capable of presenting 
bFGF and so delivering a more effective signal. Such a mechanism 
would be entirely analogous to that suggested by the results of the 
edifying experiments done by Roberts et al. (1988) with haemopoietic 




A.1 CELL CULTURE 
A.1.1 Establishment of primary cultures 
Tumours: 
Primary cultures of tumours were established from samples removed 
at the time of surgery. Tumour pieces were placed into bottles 
containing serum-free RPM! and were immediately sent to the 
laboratory. 
With sterile scissors, the specimen was minced finely and the 
tumour fragments transferred to a bottle containing 0.25% trypsin 
and 0.02% EDTA in TD (0 . 14M NaCl, 5mM KCl, 0.7mM Na2HP04 , 24.8mM 
Tris HCl pH 7.4) .. After 15 mins incubation at 37°C with gentle 
agitation, the supernatant was removed and added to an equal volume 
of RP-10 to neutralize the proteolytic activity of the trypsin . 
The cell suspension was centrifuged at 350 g for 5 min and the 
pellet resuspended in RP-10 and plated onto . a tissue culture dish. 
Any tumour tissue left undigested by the trypsin was incubated 
overnight at 4°C in a 3mg/ml solution of collagenase (Sigma C5138) 
in RP-5. The cell suspension was then centrifuged and plated onto 
/ a tissue culture dish as before. 
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After 24 hours the petri dishes were washed gently with fresh 
medium to remove non-adherent cells; these were pooled, centrifuged 
and reseeded in a new petri dish . Thereafter cultures were 
maintained and passaged on the basis of twice-weekly inspection 
I 
under phase contrast microscopy. Standard criteria for pass~ge and 
methods for tissue culture were employed (Freshney,1987). 
Fibroblasts: 
Foreskin fibroblast cultures were established from foreskins 
obtained from neonatal circumcision. The tissue was cut into 1 mm2 
fragments with a scalpel blade taking care not to compress the 
tissue or allow the fragments to become dry. Approximately 20-30 
fragments were placed on a 60mm tissue culture petri dish in a 
small volume of medium such that the fragments were kept moist but 
remained attached to the dish . The next day, an additional 5ml of 
DB-10 was added. Epithelial cell outgrowth was observed after 1-5 
days ' and this was followed by the appearance of fibroblasts. Once 
confluence had been reached (2-6 weeks), cells were passaged with 
0.25% trypsin containing 0.02% EDTA and reseeded . Epithelial cells 
did not adhere following trypsinization and pure fibroblast 
cultures were obtained. 
Rat embryo skin fibroblast cultures were established from 18-19 day 
old rat embryos. The skins were processed as for tumours. 
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A.1.2. Maintenance and storage of cell lines 
Established cell lines were maintained in Dulbecco's modified 
Eagle's medium (DB; Gibco Cat. No. 074-2100) or RPMI-1640 (RP; 
Gibco Cat. No. 074-1800) supplemented with 10% FCS 
(heat-inactivated; S6°C for 30 min), 300µg penicillin/ml, 200µg 
streptomycin sulphate/ml and lOµg tylocine/ml (Gibco Cat. No. ,· 
043-05220H). The cultures were kept at 37°C in a humid atmosphere 
containing 5% CO2 in air in a Hotpack CO2 incubator (Hotpack 
Corporation, Philadelphia, PA, U.S.A . ) 
Cell lines cultured were examined twice weekly under phase contrast 
microscopy and passaged when they approached confluency . Passaging 
was performed by incubating the cells briefly(± 5 min) in 0.25% 
trypsin in TD at 37°C. The detached cells were dispersed by gentle 
pipetting and the suspension added to an equal volume of medium 
containing FCS to neutralize the protease. After centrifugation at 
350 g for 5 min, the pellet was resuspended in medium and reseeded 
in new petri dishes. 
For long-term preservation, cell stocks were frozen in liquid 
nitrogen by resuspending a cell pellet in medium containing 10% FCS 
and 10% DMSO. This suspension was distributed in 1ml volumes into 
screw-topped 38 x 12.5mm nylon tubes (Greiner 121261) . The tubes 
were then frozen following the freezing protocol recommended by 
Farrant et al (1974). 
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A.1.3. Mycoplasma contamination 
All the cell lines used were tested for mycoplasma contamination 
according to the method of Chen (1977). Cells were cultured for 7 
I 
days in medium from which tylocine had been omitted. Cells were 
then fixed with acetic acid:methanol (1:3) and stained with 0.5 
µg/ml of bisbenzimide fluorochrome (Hoechst No. 33258) in Hank's 
balanced salt solution for 30 min. The cell layer was well rinsed 
with deionized water and mounted in buffer containing 0.02M citric 
acid, 0.06M disodium phosphate and SOX glycerol, pH 5.5. Cultures 
were examined with a Nikon fluorescence microscope. 
A.1.4. Assessment of in vitro doubling time 
Cells were seeded at low density (usually lx105 cells/35mm dish) in 
medium containing 10% FCS. Cell monolayers from duplicate dishes 
were trypsinized at 48hr intervals and the cells counted in a 
haemocytometer. Medium was replaced at 48hr intervals. 
A.2. CELL LINES 
A.2.1. Human malignant melanomas 
UCT-Hel l 
The UCT-Mel 1 cell line was established from an inguinal metastasis 
of a 67 year old Caucasian female who presented with a primary 
malignant melanoma of Clark's level III on her right ankle. The 
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tissue sample for culture was a deeply pigmented lymph node and 
showed, on histological examination, the presence of epitheloid 
malignant melanoma with melanin being its prominent feature. 
i 
The cells in tissue culture were non-pigmented at low density and 
deeply pigmented at confluence. They grew with an in vitro 
doubling time of 4lhrs and an in vivo doubling time of 6 days . 
UCT -Hel 2 
Tumour tissue was obtained from a metastatic axillary lesion, 
removed from a 67 year old Caucasian female. The sample for 
culture was non-pigmented and showed, on histological examination, 
an epitheloid type malignant melanoma with pigmentation visible in 
certain areas, while others were non-pigmented. 
The cells were non-pigmented at low density, becoming deeply 
pigmented at confluence. They grew with an in vitro doubling time 
of SOhrs and an in vivo doubling time of 5 days. 
UCT-Hel 3 
This cell line was established from a metastatic liver deposit 
removed from a 71 year old Caucasian female. Histological 
examination of the tissue sample showed the presence of a 
metastatic malignant melanoma of epithelioid type with scanty 
intracellular melanin . The cells were non-pigmented at low density 
and at confluence. They grew with an in vitro doubling time of 




This cell line was established from a left inguinal lymph node 
removed from a 67 year old Caucasian female. The tissue sample was 
pigmented and showed, on ~istological examination, the presence of 
i 
a deeply pigmented metastatic melanoma of epithelioid type . The 
cells in culture lost their ability to produce pigment, even at 
high density. They grew ~ith an in vitro doubling time of 52hrs 
and an in vivo doubling time of 6 days. 
UCT-Hel 5 
Tumour tissue was obtained from a metastatic brain deposit removed 
from a 48 year old Caucasian female. The tissue sample was non-
pigmented and showed, on histological examination, a metastatic 
malignant melanoma of a mixed spindle and epithelioid cell type. 
The cells in culture were non-pigmented even at high density . They 
I 
had an in vitro doubling time of 58hrs and an in vivo doubling time 
of 8-10 days. 
UCT-Hel 7 
The UCT-Mel 7 cell line was established from the femoral lymph node 
of a 52 year old African woman who presented with a chronic ulcer 
on the left heel. This was removed and diagnosed as malignant 
melanoma, Clark's level V. Histological examination of the sample 
for culture showed a non-pigmented secondary malignant melanoma 
with spindle cell morphology,minimal melanin production and the 
presence of · extensive reticulin. 
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The cells in culture were non-pigmented, even at high density. 
Their in vitro doubling time varied with the number of passages, as 
did their in vivo doubling time. 
I 
RPHI 7272 (Bowes) 
This melanoma cell line was originally established by Dr G. Moore 
of Denver, Colarado. A subculture of this line was provided by Dr 
E. Reich of the Rockefeller University, New York. 
A.2.2 Human breast carcinomas 
HDA-231 
This cell line was established by Cailleau et al. (1974) from a 
pleural effusion obtained from a patient with adenocarcinoma of the 
breast. 
T47-D is a differentiated epithelial substrain of the the T47 line 
which was isolated by I. Keydar from a pleural effusion obtained 
from a patient with infiltrating ductal carcinoma of the breast. 
This breast carcinoma cell line was isolated by Soule et al. (1973) 




This cell line was derived from a malignant ascitic effusion in a 
63 year old, Caucasian female with infiltrating ductal carcinoma of 
i 
the breast. (Engel et al. 1978) 
A.2.3. Fibroblast cultures 
Foreskin fibroblasts and rat embryo skin fibroblasts 
These fibroblast cultures were established as primary cultures in 
this laboratory by the methods described in Section A.1.1. 
This diploid cell line was established from a lung biopsy from a 
! 
normal male adult Chinese hamster (Cricetulus griseus). A 
subculture of this line was obtained from Dr A. Retief at 
Stellenbosch University Medical School, Cape Town. 
3T3-J2 
Mouse 3T3-J2 fibroblast culture was obtained from Dr H. Green 
A.2.4. Macrophage cultures 
P388D1 
P388D1 is a mouse tumour line originally isolated by Dawe and 
Potter (1957) from a methylcholanthrene-induced lymphoid neoplasm 
(P388) in a DBA/2 mouse. It exhibits certain macrophage-like 
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characteristics such as phagocytosis; Fe and complement receptors; 
and cytotoxicity in an antibody-dependent, cell-mediated cytotoxic 
I 
system. It lacks other attributes such as chemotactic 
responsiveness and the enzyme adenosine (Snyderman et al., 1977; 
I 
Koren et al., 1975). 
Peritoneal exudate cells 
Resident mouse peritoneal exudate cells were collected from 6-8 
week old female mice by lavage with 4-Sml of DB-1. 
Elicited peritoneal exudate cells were harvested from animals in 
which a sterile peritonitis had been induced by intraperitoneal 
inoculation of: 
Starch (2X suspension) or Latex (1:1000 dil) 5 days before 
harvesting; 
Thioglycoltate (3X .broth) or LPS (60µg/ml) 4 days before harvesting; 
FCS 1 day before harvesting. 
A.3. NUDE MICE 
A.3.1. Maintenance of athymic nude mice 
Athymic nude mice of N:NIH (S) II - nu/nu strain (Azar et al., 
1980) were bred in the UCT Animal Unit from breeding stocks 
imported in June 1980 and provided by Dr. B.C. Giovanella of the 
Cancer Research Laboratory, St. Joseph's Hospital, Houston, Texas, 




to the thymic hypoplasia found in the original strain of nu/nu 
mice , both T-cell and B-cell zones of the lymph nodes and spleen 
are depleted of lymphocytes. The colony is maintained by breeding 
pairs of the heterozygous nu/+ females and homozygous nu/nu males. 
I 
The homozygous female offspring were used for experiments. 
The animals were housed in sterile plastic cages covered with 
non-woven spun polyester filter hoods (Laboratory Products Inc . , 
Mainwood, New York) and provided with autoclaved food, water and 
bedding. The mice were fed a commercially prepared rodent food 
(mouse pellets, Epol (Pty) Ltd., Cape Town). The drinking water 
was supplemented with vitamins (0.5 ml/litre of Pancebrin, Lilly 
Pharmaceuticals) and antibiotics (27 mg/litre Cefamandole nafate, 
Lilly Pharmaceuticals). To avoid any possible effects of 
antibiotics on tumour growth, the Cefamandole was discontinued 
seven days before the start of any experiments. 
The mice were handled under stringent sterile conditions at all 
times. All tumour cell inoculations and other manipulations were 
conducted in a laminar flow hood by personnel clothed in sterile 
gowns and wearing sterile rubber gloves. Athymic mice kept under 
these conditions thrived and had lifespans comparable to those of 
normal mice. 
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A. 3.2 Inoculation into nude mice 
Cells to be inoculated into the mice were released from the tissue 
i 
culture dish with 0.25% trypsin containing 0.02% EDTA in a buffered 
salt solution. The trypsin was neutralized by the addition of 
foetal calf serum to a final concentration of 5%, and the cells 
were then pelleted, washed once with serum-free medium, and 
adjusted to give the requisite number of cells in an inoculum of 
0.1 ml. 
The cells were injected subcutaneously into the inter-scapular 
region of 6-8 week old mice. The animals were subsequently 
' examined at weekly intervals when tumour growth was recorded . 
The tumour volume was calculated as the product of 3 major 
diameters. 
When called for by the experimental protocol, tumours were removed 
under light ether anaesthesia and the skin incision closed with 
surgical clips th~t were removed after one week. Alternatively, 
the tumours were removed after killing the animals. 
Each tumour was divided into several representative portions. One 
of these was placed in buffered formol saline for histology. The 
other fragments were variously used for re-inoculation, 
re-establishment in culture, biochemical analysis or 
cryopreservation (Farrant et al., 1974). 
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A.3.3. Analysis of tumours removed from nude mice 
Histology of the Tumours 
Formalin-fixed samples were embedded in paraffin, sectioned and 
i 
stained according to conventional histological techniques (Mayers' 
haematoxylin and eosin). Sections of the tumours were stained for 
reticulin according to the method of Gordon and Sweets (1936). 
Hydroxyproline content of the tumours 
The hydroxyproline content of the tumours was determined using the 
method of Hutterer and Singer (1960) in which 10 mg of tumour 
tissue was hydrolysed in 1 ml 6N HCl at 121°C for 16 hrs. The 
hydrolysates were evaporated to dryness under vacuum and the 
residue dissolved in 1 ml water. Samples so obtained were assayed 
for hydroxyproline content by adding p-dimethylaminobenzaldehyde, 
reading the absorbance at 500nm and 560nm and referring to a 
standard curve. 
Phosphoglucoisomerase analysis 
Lysates were prepared by homogenizing the tumours in 2 volumes of 
O.lM sodium phosphate pH 7.4. Samples were loaded onto 11% starch 
gels, using inserts of Whatman's No. 3 chromatography paper, and 
electrophoresed at 8 V/cm for 5 hrs, with cooling. The buffer 
system used was as follows: 
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0.2M Tris, 0.053M citric acid pH 6.5 for the tray buffer. Gel 
buffer was a 1:15 dilution of tray buffer. Phosphoglucoisomerase 
(PGI) isoenzymes moved towards the cathode. 
I 
After electrophoresis the gel was stained with the following 
reaction mixture: 




Methyl Thiazolyl tetrazolium (MTT) 





l.4U in 10µ1 
5mg in hl~ 
5mg in 0.5ml H20 
10ml 
The PG! enzyme converts fructose-6-phosphate to glucose-6-phosphate 
which is then dehydrogenated with the transfer of hydrogen to NADP . 
The NADP is regenerated by the transfer of hydrogen to MTT to give 
the insoluble blue dye, formazan. 
A.4. COLLAGEN ASSAY 
Incorporation of [3H]-Proline into collagen was assayed by the 
method of Webster and Harvey (1979). 
Foreskin fibroblasts were plated at lxl05/35mm tissue culture dish 
(Falcon 3001) in DB-10 and used when confluent (usually 2-3 days 
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after plating). Confluent fibroblast monolayers were cultured 
either alone or as co-cultures for 24 hours in 1ml RP-10. 
Co-cultures were established by plating either UCT-Mel 7 cells 
(3xl05/35mm dish) or peritoneal macrophages (lx106/35mm dish) on 
I 
top of confluent fibroblast monolayers at time O. The medium was 
then changed to 1ml serum-free RPM!, supplemented with 25µg/ml 
ascorbate (Merck 127) and, in some cases, 220µg/ml proline (Merck 
7434). The cultures were then preincubated for 4 hours and then 
labelled for 16 hours with 5-lOµCi [3H)-Proline (15-40 Ci/mmol; 
Amersham TRK 323). The medium was collected and assayed for 
radioactive collagen . 
. To 1ml of radiolabelled medium, I added 100µ1 SM acetic acid and 
100µ1 pepsin (Smg/ml in O.SM acetic acid; Sigma P-7012) and then 
incubated the samples at 4°C overnight with shaking. All subsequent 
steps were performed at 4°C. The next day, I added 1ml neutral 
salt-soluble rat skin collagen (O.Smg/ml in O.SM acetic acid) as 
carrier and made the volume up to 3 ml with O.SM acetic acid. The 
collagen was precipitated by the addition of 750µ1 25% NaCl in O.SM 
acetic acid. After incubating for 2 hours, the samples were 
centrifuged at 3000g for 30 mins. The pellet was re-dissolved in 
1ml 0.15M NaCl in 0.05M Tris HCl pH 7.5 and the collagen 
re-precipitated by the addition of 10ml 4.SM NaCl in 0.05M Tris Hcl 
pH 7.5. The samples were incubated and centrifuged as before. The 
pellet was washed in 10ml 20% ethanol. The final precipitate was 




A.4.1. Preparation of neutral salt-soluble carrier colla&en 
Rat skin collagen was purified by the method of Gross (1958). Rats 
were killed by CO2 inhalation. The skins were shaved, removed from 
I 
the animal and cleared of subcutaneous fat and tissue by scraping 
with a scalpel blade. All subsequent steps were performed at 4°C. 
The skins were minced in a meat grinder and extracted by shaking 
for 16 hours in 2 volumes of 0.45M NaCl. The suspension was 
centrifuged at 40 OOOg for 1 hour, and the supernatant filtered 
through several layers of surgical gauze and then through a 
porosity 2, pyrex sintered glass filter. The filtrate was dialysed 
against four changes of 0.45M NaCl over 2 ·days. 
The concentration of NaCl in the solution was brought to 16% by the 
slow addition, with stirring, of solid salt and the solution was 
left to stand for 6 hours. The precipitate was pelleted by 
centrifugation (7000g; 30 min) and dissolved in distilled water 
such that the concentration of NaCl was approximately 0.4M. The 
resulting turbid solution was dialysed against 0.067M sodium 
phosphate pH 7.6 for 12 hours with 3 changes. The small amount of 
insoluble material that formed after dialysis was removed by 
centrifugation at 1000g for 30 min. The collagen was 
reprecipitated in this manner three times. The final precipitate 
was dialysed against 0.5 M acetic acid and adjusted to give a final 
concentration of 0.5mg/ml. 
250 
/ 
A.5. SUPEROXIDE ANION PRODUCTION 
Superoxide anion secretion was assayed by the superoxide 
dismutase-inhibitable reduction of ferricytochrome c. (Johnston et 
I 
al., 1978). UCT-Mel 7 cells and foreskin fibroblasts were plated 
at lxl05 cells/16mm well in 1ml Hanks balanced salt solution 
without phenol red (Gibco 076-1201) and supplemented with 5.SmM 
glucose, (BDH 10117), 25mM Hepes (Boehringer Mannheim 223778), MEM 
amino acid mix (SOx cone.; Gibco 043-1130H), L-glutamine (Sigma 
G3126) and MEM vitamin mix (lOOx cone.; Gibco 043-1120H). 
Thioglycollate-elicited mouse peritoneal macrophages were harvested 
by peritoneal lavage of BALB/c mice and plated at 8xl05 cells/16mm 
well. Non-adherent cells were removed by washing after 2 hours 
incubation. 
At the start of the experiment ferricytochrome c (Sigma C-2506) was 
added to give a final concentration of 10-5 M. To some assay 
wells was added superoxide dismutase (Oxinorm) at a final 
concentration of lSOU/ml and to other wells tetradecanoyl phorbol 
acetate (PMA; Consolidated Midland Corporation) at a final 
concentration of lOng/ml. 
The cells were incubated at 37°C in 5% CO2 - 95% air. At the 
indicated times, the reaction mixture was removed from the wells, 
centrifuged at 3000g in an Eppendorf microcentrifuge and the 
optical density measured at 550nm. The concentration of cytochrome 
c reduced was determined using the equation ~E550nm- 21 mM-1 cm-1. 
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At the end of the experiment, the cells were digested with lM NaOH 
and 10% Na deoxycholate (O/N at 37°C) and the protein content of the 
digest was determined by the method of Lowry et al. (1957) using 
BSA as standard. 
A.6 PLASMINOGEN ACTIVATOR ASSAY 
Plasminogen activator was assayed as described by Wilson and Dowdle 
(1978). The assay relies on the measurement of plasminogen 
dependent release of soluble, radioactive fibrin degradation 
peptides from an insoluble substrate of [1251]-labelled fibrin 
adhering to the surface of a plastic well. 
[ 1251]-labelled human fibrinogen (30µg fibrinogen/well; 120-130 000 
cpm/well) was used to coat the surface of the wells and the plates 
(24-well multiwell plates) were dried at 37°C for 3 days before use. 
[ 1251]-fibrinogen was converted to fibrin by the addition of 1ml 
Eagle's Minimal essential medium (Gibco Cat. No. 072-1100). After 
incubation at 37°C for 2 hours, the wells were washed twice with PBS 
and once with O.lM Tris HCl pH 8.1. 
For the assay each well contained 2µg of purified human plasminogen 
and 80µg of BSA in a final volume of 300µ1 of O.lM Tris HCl pH 8 . 1. 
Twenty microlitre aliquots of harvest fluid were added to initiate 
the reaction. 
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Control wells contained 1) 300µ1 trypsin (to give the total 
radioactivity present in each well); 2) 20µ1 of sample without 
plasminogen (to detect plasminogen-independent proteolysis) and 3) 
plasminogen without sample (to detect background lysis due to 
I 
plasmin contamination of the plasminogen solution). Standard wells 
included in each assay contained urokinase in 12 doubling 
dilutions, usually commencing with 0.2 Ploug units per well. 
The multi-well plates were incubated at 37°C in a humid atmosphere. 
Fibrinolysis was monitored by measuring the solubilized 
radioactivity in 50µ1 aliquots at three separate time points. 
For each time point, the urokinase standard curve was plotted and 
sample values falling on the linear range of the standard curve 
were determined and expressed as UK units per assay well. 
A.7. MEASUREMENT OF MACROMOLECULAR SYNTHESIS 
After a 5 hour pulse with [ 3H]-Leucine (5µci/ml; Amersham TRK 170), 
[ 3H]-Uridine (SµCi/ml; lµg/ml; Amersham TRK 410) or [ 3H]-Thymidine 
(SµCi/ml; lµg/ml; Amersham TRK 61) the cultures were washed 3 times 
with 2ml PBS and the cells released by incubation in 1ml of 0.25% 
trypsin. An aliquot (10µ1) of the suspension was taken for cell 
counting; the culture dishes were placed on ice; and 1ml of 
ice-cold 10% TCA was added. The dishes were kept at 4°C for 30 min. 
The TCA precipitate was collected on a "'man GF/c filter and 
washed with 30ml of ice-cold 5% TCA. The ·filter was dried 




addition of 5ml of Instagel, in a Packard liquid scintillation 
counter. 
A.8. MONOCLONAL ANTIBODY PRODUCTION 
I 
Monoclonal antibodies were raised against UCT-Mel 7 cells and 
foreskin fibroblasts. BALB/c mice were immunized by 
intraperitoneal injection of 4xl06 UCT-Mel 7 cells or 3xl06 
fibroblasts in complete Freund's adjuvant. Two weeks later they 
received a second similar injection in incomplete Freund's 
adjuvant. A booster injection of cells in PBS was given 3-4 days 
before the fusion. 
The immune spleens were removed aseptically and single cell 
suspensions of the splenocytes were prepared and then fused with 
SP2 myeloma cells using standard techniques (Campbell, 1984). 
Clones were screened in an ELISA assay against 1-5 x 104 UCT-Mel 7 
cells or fibroblasts attached to a microtitre well with 
poly-L-lysine and fixed with 0.1% glutaraldehyde. 
The final clone, which was selected and used to make ascitic fluid, 
was specific for the cell type against which it was raised. The 
monoclonal antibody, aFIB-D7, recognized fibroblasts and not UCT-Mel 
7 cells. The monoclonal antibody, aNM-Bl2, was specific for UCT-Mel 
7 cells and did not recognize fibroblasts. 
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A.9. CONJUGATION OF ANTIBODY TO ERYTHROCYTES 
Monoclonal antibodies were conjugated to erythrocytes according to 
the method of Parish and McKenzie (1978). Human or sheep 
i 
erythrocytes were washed 4 times in saline by repeated 
centrifugation and resuspension. Washed packed red cells (250µ1) 
were added to a tube containing 1.6mg of the appropriate antibody 
in 4ml of saline. Chromic chloride (BDH 10078; 0.4ml of a 0.1% 
solution in 0.9% NaCl) was then added and the coupling reaction 
allowed to proceed at room temperature for 5min . The reaction was 
stopped by the addition of 7ml of PBS. The conjugated erythrocytes 
were washed once in PBS and resuspended in 12.5ml RP-10. They 
could be kept at 4°C for up to 24 hours without loss of 
effectiveness. 
A.10. SEPARATION OF A MIXED CELL POPULATION USING CONJUGATED 
ERYTHROCYTES 
After the 24 hours co-culture, the cells were released with 
trypsin. The trypsinized cells were resuspended in RPMI-10, mixed 
with an equal volume of conjugated red blood cells and incubated at 
room temperature for 15 minutes. The cell mixture was layered onto 
a Ficoll-Hypaque cushion and spun at 1000g for 15 minutes. The 
pellet contained the conjugated red blood cells and the cells 
recognized by the antibody conjugated to erythrocytes. The 
interface contained the cells not recognized by the antibody . The 
cells from the interface could be harvested and used in further 
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experiments. A rapid and efficient separation of the 2 cell types 
was thus achieved. 
A.11. EXTRACTION OF RNA AND NORTHERN BLOT ANALYSIS 
i 
Total RNA was extracted using guanidinium thiocyanate (Fluka 50990) 
as described by Chirgwin et al. (1979). The quality and quantity 
of the extracted RNA was checked by spectrophotometric analysis at 
260nm and 280nm. 
Twenty micrograms of RNA were heat denatured in formamide (Merck 
9684), electrophoresed in a 1.5% agarose gel containing 2.8M 
formaldehyde (BDH 10113) and transblotted electrophoretically onto 
nitrocellulose paper (Hybond N, Amersham RPN 303N) at 300mA for 16 
hours in 25mM sodium phosphate buffer pH 6.5 (Amersham booklet: 
Membrane transfer and detection methods). The RNA was fixed to the 
Hybond by a 5 min exposure to UV light on a standard UV 
transilluminator. 
The recombinant plasmids, Hf 677 (Chu et al. 1982) and Hf 32 (Myers 
et al. 1981), containing cDNA sequences specific for the human al(I) 
and a2(1) collagen genes, respectively, were the gift of Dr. F. 
Ramirez, Rutgers Medical School, Piscataway, N.J. The recombinant 
plasmid, pHF ~ A-1 (Gunning et al., 1983), containing cDNA sequences 
specific for human cytoplasmic ~-actin, was the gift of Dr I. 
Parker, University of Cape Town, Medical School. The cDNA plasmid 
probes were nick-translated with [a- 32P]dCTP (Amersham PB 10205) 
using the Amersham nick translation kit (Amersham N 5000). The 
256 
nitrocellulose filters were incubated in prehybridization buffer 
for 6 hat 55°C. The nick-translated probes were denatured at 100°G 
for 5 min, cooled, and added to the prehybridization solution. 
i 
Following hybridization for 16 hat SS°C, the RNA blots were washed 
extensively with washes of increasing stringency. The final wash 
was in O.SX SSPE containing 0.1% SOS at 68°C for 15 min. The blots 
were then wrapped in Saran wrap and put up for autoradiography at 
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